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Abstract 
 
 
Evidence in wildlife shows that exposure to synthetic hormone disrupting chemicals 
results in reproductive and developmental damage, suggesting similar effects in humans.  
Therefore, it is to be expected that increased exposure to these hazardous substances 
through consumer products puts human health at risk.  This thesis investigates industrial 
chemicals suspected to have endocrine disrupting effects on human reproduction, and 
explores how endocrine disrupting chemicals (EDCs) could be managed under the EUs 
proposed regulation system, REACH.  We critique the REACH proposal focusing on the 
authorization and classification system with respect to EDCs.  Analyzing the relationship 
between regulators and consumers exposes the institutionalized denial by both scientists 
and policy-makers, that adverse effects in animals are suggestive of similar effects in 
humans.  Additionally, the hegemonic influence of institutions is achieved through 
defining research parameters and hence subsequent decision-making.  We discuss the 
argumentation of different actors of the chemical regulation debate and analyze the 
accepted scientific paradigms and the state of human health through consumer issues.  
By applying the theory of Risk Society, we conclude that regulation thus far has been a 
continual exercise in applying band-aid solutions. Unless REACH closes existing 
loopholes and adds compulsory stipulations it may turn out to be yet another band-aid 
solution.  The theory stresses a re-examination of the use of scientific data, allowing us to 
apply the approach of risk society to the control of endocrine disrupting chemicals.  We 
recommend, among other things, a re-examination of the use of scientific data in order to 
attain chemical regulation that is consistent, flexible, enforceable and open to public 
scrutiny.  
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"Man's attitude toward nature is today critically important simply because 
we have now acquired a fateful power to alter and destroy nature. But man 
is a part of nature, and his war against nature is inevitably a war against 
himself…We are challenged as mankind has never been challenged before to 
prove our maturity and our mastery, not of nature, but of ourselves." 
 
-Rachel Carson- 
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1  Problem Field 
1.1 Research Area  
Mankind continues to exist paradoxically through production and preservation, 
consumption and conservation, pollution and purification.  The presence and the effects 
of hazardous substances, especially industrial chemicals, can be discerned in almost every 
object that surrounds us.  Consumers seem to accept and favour the convenience and 
efficiency of computers, coffee makers, suntan lotion, aluminium cans, children’s toys or 
plastic food wrap.  They seem to accept, without question, these advances brought about 
by science and technology and do not seem to consider any associated adverse effects.  
The global impact of (chemical) consumption is one of mind-boggling magnitude.  How 
long can this level of consumption we have to come expect in the EU be sustained, if at 
all?  Where is the line to be drawn?  When is enough really enough?  
  
The inherent contradictions are demonstrated clearly through the success of scientific and 
technological development and progress, on the one hand, and by the accompanying 
destruction on the other.  The environment is plagued by numerous kinds of pollution, 
destroying the soil in which we sow, the water we drink and the air we breathe.  Humans, 
as part of the natural world, share in the conditions affecting and maintaining world’s 
biodiversity.  While humans produce to sustain their lifestyle, the rest of the living world 
struggles to survive in the wake of our destructive activities.  Despite our present power 
to manipulate the global ecosystem, we as a population are regretfully not learning from 
past experiences nor heeding previous warnings.  
 
The interconnectedness between man and nature was documented for years by Rachel 
Carson; ecologist, scientist and author, but it was not until her provocative book Silent 
Spring was published in 1962 that the public became aware of the dire consequences of 
exposure of wildlife to industrial pesticides.  Carson documented how a bioaccumulative, 
highly-persistent chemical, such as DDT, affected the natural world using, as an example, 
eggshell thinning in certain bird populations.  At the same time, Carson anticipated that 
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DDT might pose a potential long-term genetic and carcinogenic danger to humans and 
other creatures (Carson, 1962).   
 
In the 1970s, studies in the Great Lakes Basin revealed reproductive and developmental 
deficits, disrupted endocrine function, compromised immune competence, increased 
incidents of cancer, and behavioural anomalies in a wide range of species (Kreuter et al., 
2004).  Specifically, endocrine-mediated adverse effects in reproduction were found 
among fish and birds (Fox et al., 1978; Gilbertson, 1989).1  Investigations in the Great 
Lakes basin have documented reductions in eggshell thickness and even more intricate 
effects: 
 an examination of herring-gull embryos and newly hatched chicks  
 collected in Lake Ontario revealed oviducts and gonads resembling  
 ovaries in male birds and abnormal development of the oviductal  
 system in female birds (Colborn et al., 1993). 
 
Due to the numerous large cities located along the shores of the lakes, most of them 
supporting heavy industries, the Great Lakes have been heavily contaminated with 
synthetic chemicals.2  One very interesting and important aspect of the Great Lakes story 
is the fact that the synthetic chemicals in the lakes have the characteristics of bio-
accumulating compounds and thus are bio-magnified through the food chain; 
encouraging the execution of some early epidemiological studies in the area.  
 
One of the most famous of these studies was the “Michigan Infant Cohort Study.”  
Investigators reported finding neurobehavioral deficits, as well as below-normal IQ levels 
in children whose mothers had eaten significant quantities of contaminated fish during 
pregnancy (Kreuter et al., 2004). This epidemiological investigation combined with 
evidence of adverse effects in wildlife from exposure to synthetic chemicals in the Great 
Lakes, like Carson’s Silent Spring, is another clear illustration of the interrelations 
 
1 Studies on Chinook salmon and fresh water trout have shown poor reproduction (Fox et al. 1978). Seen as 
well as in birds including herring gulls, Foster’s terns, double-crested cormorants, Caspian terns and bald 
eagles (Gilbertson, 1989).  
2 Most of the lakes have been highly contaminated with polychlorinated biphenyls (PCBs), 
dichlorodiphenyl trichloroethane (DDT), polychlorinated dibenzodioxins (PCDDs), polychlorinated 
dibenzofurans (PCDFs), and a number of organochlorines (OCs) (Damstra et al., eds., 2002).  
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between living creatures and their environment.  
 
Synthetic chemicals may or may not be bioaccumulative, but either can interact with the 
endocrine system. Such interactions may interfere with hormone synthesis, 
storage/release, transport, clearance, receptors recognition, receptor binding, and post-
receptor activation (Crisp et al.,1998; De Rosa et al.,1998; Goldman et al.,2000. in: Min 
Choi et al., 2004).  Chemicals exhibiting these effects are categorized as Endocrine 
Disrupting Chemicals (EDCs).    
 
Estrogenic effects, which a variety of man-made chemicals exhibit, can be understood in 
greater detail thanks to lessons learned through studies of the action of diethylstilbestrol 
(DES).  DES, a synthetic estrogen, was administered between 1948 and 1971, to women 
to prevent miscarriages.  By administering DES to pregnant mice, researchers 
(McLachlan, 1993; Newbold, 1995) have been able to induce adenocarcinoma of the 
vagina.  This was the first time the rare form of cancer was seen in laboratory mice.  The 
effects in male mice were much the same when exposed in the womb to the synthetic 
estrogen.  According to Newbold (1995) studies on male mice have uncovered various 
genital defects, including undescended testicles, stunted testicles and cysts of the 
epididymis.  They had abnormal sperm, reduced fertility and genital tumours and showed 
some evidence of female reproductive components (Colborn et al., 1996).  Scientific 
evidence of exposure to estrogenic substances in laboratory animals supported evidence 
found in human beings.  Colborn et al. (1993) point out that “animal models corroborate 
clinical studies in humans.  For example, dysplastic3 changes in the rodent prostate are 
comparable to those seen in stillborn male offspring of women treated with DES” (1993).   
 
 “DES-exposed humans thus serve as a model for exposure during early life to any 
estrogenic chemical, including pollutants in the environment that are estrogen agonists” 
(Colborn et al.,1993).  While DES is an example of an estrogenic pharmaceutical, it 
offers a clear illustration of the adverse effects to the exposed foetuses.  Colborn et al. 
 
3 Science Online defines dysplastic as have to do with dysplasia – abnormality of development, in 
pathology, alteration in size, shape and organisation of adult cells. 
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(1993) document that one major risk of those exposed in utero to estrogenic chemicals 
(DES and/or environmental pollutants that are estrogen agonists) becomes a factor when 
these individuals reach the age at which reproductive cancer normally increases, for as a 
group they will experience a higher incidence of cancer than will unexposed individuals.  
The DES story demonstrates that there is a possibility of there being long-term and 
hidden effects of hormonal exposure, that their consequences may be devastating, and 
that we are not immune to the effects.   
 
The correlated concern for other estrogenic chemicals is directly linked with those effects 
seen with DES.  Substances such as bisphenol A, di-ethylhexyl phthalate (DEHP), and 
nonylphenol are all estrogenic and are all exposed to humans and animals in low doses in 
the environment.  “Toxicologists are fond of the axiom that it is ‘the dose that makes the 
poison’” (Colborn et al., 1996); although the dosage may be low, long-term exposure 
(especially during crucial time of life-cycle development), has caused alarm in political 
and scientific research communities.   
 
The suggestion of a correlation between EDCs and reproductive health was hypothesized 
for the first time by Sharpe and Skakkebæk in 1993.  Specifically, the authors proposed a 
link between synthetic EDCs and developmental events that could result in decreased 
sperm count/quality and increased incidences of testicular cancer, testicular maldescent 
(cryptorchidism), and male reproductive tract malformations, such as hypospadias 
(Sharpe et al., 1993. in: Damstra et al., eds. 2002).  Though Sharpe and Skakkebæk 
focused mainly on the male reproductive system, there are also investigations focusing on 
the female reproductive system, including female hormone concentrations, menstrual 
cycle, fertility, spontaneous abortion and the development of endometriosis 
(Nicolopoulou-Stamati et al., 2001).  
 
The literature highlights many of the limitations associated with drawing conclusions 
linking human reproductive health effects and EDCs exposure. Simply put, the available 
data on human exposure and the size of samples in human studies is not able to support a 
“…conclusion that human reproductive health has been adversely affected by exposure to 
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EDCs” (Damstra et al., eds.2002).  Nevertheless, it is undeniable that the evidence in 
wildlife and laboratory animals is sufficient to warrant further investigation of possible 
links between EDCs and human reproductive health; placing importance on research 
priority and early policy action.  
 
Endocrine disruption has only been recognized as a concern since the mid-1990s.  The 
hitherto regulation of EDCs in the European Union had been restrained due to the lack of 
knowledge about the impacts of many of these chemicals on human health.  Previous 
regulations expose the weaknesses of EU chemicals policy and importance for 
overcoming the huge knowledge gap of substances (White Paper, 2001:6).  In 2001, the 
Commission released a chemical regulation proposal that intended to harmonize existing 
and new substances and close the knowledge gap (safety data was lacking for existing 
substances).  Additional knowledge about the properties of existing substances should 
then improve policy action and as a result enhance human health and the environment. 
This proposal called REACH (Registration, Evaluation, and Authorization of Chemicals), 
aims among other things to include EDCs under its authorization system.  
1.2 Problem Formulation 
 
Given the hitherto chemical regulation in the European Union, what changes are needed 
to handle endocrine disrupting chemicals that cause adverse effects to human 
reproduction?   
 
1.3 Background and Pre-Understanding 
We believe that the presence of endocrine disrupting chemicals in the environment have 
reached an unacceptable point.  Hitherto regulation has not been effective enough in 
handling those EDCs that may cause adverse effects to human reproduction.  We stress 
the ‘handling’ of EDCs instead of ‘managing,’ as management implies control.  We 
believe that those substances that are persistent and bioaccumulative to humans can not 
be controlled and therefore should not be produced.  What is the likelihood that the new 
chemicals proposal REACH will limit exposure to those substances having endocrine 
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disrupting properties?  It is our perception that both scientists and regulators have been in 
denial regarding mankind’s dependence on the environment.  Consequently, the lax 
approach of hitherto regulation is being transferred to the new proposal.   
 
REACH states that substances of very high concern should be brought into an 
authorization scheme.  However, EDCs that are suspected of having an adverse affect to 
reproduction in category 3 (those chemicals where there is not sufficient evidence to 
place them in CMR category 2) are excluded from REACH.  Officially, the REACH 
proposal advocates the protection of human health and the environment and yet, the 
proposal ignores consumer issues as it does not consider the main sources of exposure 
which is an inconsistency.  Other inconsistencies suggest that REACH is likely to fall 
short on adequate implementation and application and the need for continual scientific 
research.  It is becoming increasingly clear that the,  
environmental crisis is as much as a crisis of the institutions that have  
to interpret and regulate risks as it is a physical phenomenon pertaining  
to natural processes.  The conventional political institutions – the  
representative bodies, regulatory agencies, and scientific institutions of 
industrial society – that are assigned the responsibility of negotiating our  
understanding of the risks we face clearly fall short of the assignment  
(Fisher, 2000). 
 
1.4 Methodology 
 
Using REACH as our point of departure, we analyze the management of hazardous 
chemicals that have adverse effects on human health.  Applying EDCs as our case study, 
it is an opportunity to address the chemical regulation problematic, as there are structural 
problems with regards to the management of hazardous substances in general.  This can 
be seen from previous chemical regulation since the original EU Directive in 1967 on 
Classification and Labelling of Hazardous Substances, through to the Strategy for a future 
Chemicals Policy in 2001 (also referred to as the White Paper).  Through the 
understanding of these regulatory changes over time, our fundamental concern is 
enforcement of these policies to further protect humans and the environment, while 
managing these chemicals in a sustainable fashion.   
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Our thesis contains a broad understanding of the chemicals regulation in the EU but more 
specifically on the provision and use of data with respect to endocrine disrupting 
chemicals and the underlying observations seen through the theoretical perspectives of 
Risk Society.  
1.4.1 Approach for Analyzing the EDCs problematic 
 
There is much disagreement in the public about "acceptable levels" of various chemical 
in human bodies, and some threaten the very ability to reproduce, such as endocrine 
disrupting chemicals.  Levels of EDCs in the environment and in wildlife are high and 
effects have been shown to affect humans also.  We intend to explore how EDCs that 
affect reproduction could be handled, in the context of the European Union’s new 
chemical regulation proposal, REACH.  What is being done to make REACH effective 
and consistent in regulating EDCs and what are the obstacles to immediate action?   
 
Our Stolen Future by Theo Colborn et al. introduced us to the adverse effects of 
endocrine disrupting chemicals on wildlife and was a realization of the consequences of 
EDCs that affect reproduction.  We were presented with the understanding that the effects 
were potentially mirrored on human populations, but more importantly, we were able to 
identify unexpected sources of exposure.   
1.4.2 Working Questions 
• Are endocrine disrupting chemicals really a problem? For whom? 
 
• What impact does the hitherto regulation of chemicals have on the current 
proposal REACH with respect to those hazardous chemicals that may be exempt? 
 
• Is the management of EDCs within REACH? 
 
• How is science applied in assessing and managing EDCs? 
 
• How can one take control of those highly technical and invisible risks that are 
attached to EDCs? 
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1.4.3 Methods  
Our conception of the project begins with providing an in-depth understanding of the 
foundations of current science behind EDCs.  We then analyse the historical management 
of chemicals, the new EU chemical proposal REACH, and conclude the first section with 
a comprehension of the risk assessment and the handling of EDCs.  Subsequently, we 
apply Ulrich Beck’s theoretical framework of Risk Society, which in effect, undermines 
the previous understanding of the EDCs problematic.   
 
The theory presupposes a holistic approach using argumentation from various fields, and 
thereby it challenges traditional scholarship, which sectionalizes knowledge.  It is one of 
the few theories that deal with chemical regulation in a consistent and informative 
manner, while applying beyond state level.  As our project deals with inter-state chemical 
regulation, the theory was directly applicable.  The theory deals with risk in the post-
modern world (the “second-Modernity”) with case studies of chemicals that address 
many of the same problems as the ones we treat in our project.   
 
We wanted to analyze the EDC topic in the accepted scientific way without having the 
theory influence our thoughts.  The theory challenges accepted scientific evidence with 
arguments, some of which are considered “unscientific,” therefore the theory is better 
placed at the end for the sake of clarity.  This leaves science on the one hand and 
sociology on the other.  Additionally, by first understanding the power relations between 
different actors in the “risk game,” and secondly applying the risk society, we expose 
those power relations at a meta-level.  
 
In an effort to focus more specifically on the EDCs that interrupt hormonal messages in 
the reproductive system, and the corresponding regulation from past EU policies to the 
prospective agendas such as REACH, we have participated in three local conferences and 
interviewed relevant persons from authorities, green and consumer groups.  In doing so, 
we have gained more insight into the problematic of EDCs in consumer products, where 
human exposure is high.  
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Group members were able to participate in a conference on the 18th of October, 2004 at 
the University of Copenhagen, Denmark titled, “Hormone Disrupting Substances.”  
Discussions included an analysis of estrogens, an introduction to the status and effects of 
hormone disrupting chemicals on man and the environment, i.e. the endocrine system and 
the fundamental aspects of hormonal functioning of the body and development of sexual 
characteristics.  Response from government and industry was a crucial element in the 
meeting.  
 
Also, some members of our group participated in a seminar on the 3rd of November, 
2004, organized by the Økologiske Råd, titled “EUs kemikalie reform og erstatning af 
farlige kemiske stoffer i industrien (European Union’s Reform on Chemicals and the 
Substitution of Hazardous Substances in the Industry).”  The main purpose of attending 
the seminar was to know the position and opinion of the Danish industry regarding the 
new EU proposal for the chemical regulation, REACH.  Discussions were based around 
the substitution of dangerous chemical substances within the industry.  As a follow up to 
this seminar, it was relevant to look at actual or possible substitutions of substances under 
suspicion of being EDCs that affect reproduction.  
 
A good illustration of this is Danish enterprise Danisco (one of the world’s largest 
producer of food ingredients) which, according to a note published in Erhvervsbladet, 21st 
of January, 2005, is ready to substitute phthalates with a new product named “Soft-n-
Safe.”  The tests run over the new product have shown no hormonal disruption effect, so 
far.  Further investigation of the new product and an interview with Torben Svejgård, 
division of emulsifier’s director at Danisco, has been conducted. 
 
Group members attended the 3rd Copenhagen Conference of Environment, Reproductive 
Health and Fertility from the 15th to 18th of January, 2005.  During these four days we 
met with professionals from the medical and scientific field and discussed the regulation 
of endocrine disrupting chemicals and whether or not they foresee it possible to include 
these chemicals in the REACH proposal. Although the content of the conference was 
scientific in nature, we were able to understand the issues regarding the effects of these 
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chemicals on the reproductive system from informal talks with individuals that work with 
these substances not just daily, but over decades.  This opportunity allowed us to more 
closely understand the relationship between science and policy regulation.  
 
The Interview Process 
An integral part in social and natural science projects are interviews.  We conducted 
several qualitative interviews using the social constructivist style of Steinar Kvale.  We 
recorded all interviews, with a dictaphone and hand-written notes.  All interviews with 
relevant stakeholders were semi-structured and followed the interview method proposed 
by Kvale. Exploratory interviews should be loosely structured leaving room for 
conversation by asking questions in regards to the topic, allowing the interview to expand 
while keeping focus on the topic (Kvale, 1996).  These interviews played a central role in 
the collection of empirical data and knowledge with respect to hormonal disrupting 
substances and their assessment and regulation.  By participating in the aforementioned 
conferences, we had an opportunity to discuss the EDCs issue with various scientists who 
helped us to focus our research to an applicable and important area within policy making.   
 
Due to the downfall of email communication, our email questionnaire to CREDO Cluster 
scientist Ragnor Pedersen, was not as helpful as we had anticipated as we did not receive 
a great deal of relevant information.  In the future we would conduct a more insightful 
interview via telephone or personal visit in expectation to receive the most valuable 
information.  All other interviews directed our attention to issues we had not previously 
identified as significant; including test procedures with regards to substitution, the 
identification of priority substances and the deficiency of political preparations compared 
to developments in the scientific research.   
 
1.4.4 Project Limitations 
 
Our project has several research limitations, one of which is the limitation of the wide 
variety of modes of action (the unknown mechanisms of EDCs).  It is hard to draw 
conclusions from something that has not yet been properly defined.  Given that infertility 
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in Northern Europe is rising, human reproductive health is becoming increasingly 
important. Therefore, we have defined our project to contain only those EDCs that affect 
reproduction, however, it should be noted that these substances may cause adverse effects 
to other bodily systems, such as the thyroid or development of allergies.  Studying EDCs 
and their effects as a group instead of on a case-by-case basis may have yielded different 
results.  
 
When conducting the interviews we were made aware of institutional limitations place on 
interviewees.  Given the controversial nature of the EDCs problematic, some 
interviewees made it clear that their institutional responses did not necessarily reflect 
their personal beliefs.  This made it difficult to extract the relevant and ‘accepted’ 
knowledge from the interviews towards our project.   
 
Although we do not touch upon natural chemicals in our project we can not deny that 
they exist and pose a problem to the complexity of the EDC problematic.  When arguing 
that EDCs must be taken off the market to avoid exposure, a common response is “what 
then will you do with those endocrine disrupters that occur naturally?”  In reply, one 
could say, “those chemicals in nature that affect human reproduction, occur naturally – in 
other words – we cannot control them.  However, synthetic chemicals are man-made and 
hence the production of them can be controlled.  To invoke the argument that the release 
of EDCs is somehow unimportant, because these chemicals also occur naturally is 
foolishness.  One could then argue, “there is lead in nature therefore we can keep 
releasing lead in large volumes.”  
 
1.5 Outline and Importance of Chapters 
 
Chapters two, three and four describe a general overview of the understanding of 
science, regulation and finally REACH respectively. As a result, the following 
descriptions listed below will describe more thoroughly our conception of the appropriate 
chapters and their implicit importance therein.    
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Chapter two brings us to a better comprehension of what Endocrine Disrupting 
Chemicals (EDCs) are, the ways in which they may act, and the significance of their 
interaction with the human reproductive endocrine system.  A journey through the history 
of the synthetic chemistry enables us to recognize the importance that synthetic chemicals 
have in our daily life.  This chapter includes relevant information of the four chemicals 
we are considering as EDCs, and the consumer products that these chemicals are found.   
 
An introduction to the regulation of industrial EDCs through an examination of the 
hitherto regulation of the European Union is discussed in the third chapter.  
Modifications in the legislation were created as a continual attempt to harmonize trade 
between member states, while effectively managing the adverse effects of chemicals to 
human health and the environment.  A series of international and regional efforts in the 
form of declarations and conventions have tried as well to challenge the growing 
difficulties of regulating hazardous substances in the EU.  These factors all helped lead to 
the development of a Community Strategy on the Future of Chemicals regulation in the 
EU called REACH.  Finally, this chapter discusses the events leading up to REACH 
while examining the regulation of endocrine disrupting chemicals in the EU.   
 
REACH in general, is outlined in chapter four including the letters of REACH, a 
discussion of the antagonists and the protagonists.  It situates the proposal in relation to 
the different stakeholders.  The emphasis will be on how endocrine disrupters are to be 
handled under REACH and if the proposal is likely to include them in a satisfactory 
manner. 
 
By analyzing the relationship between risk assessment and risk management of EDCs, 
chapter five attempts to convey the concepts discussed in the first three chapters.  The 
chapter endeavours to contribute to a better comprehension of the applications of 
scientific data, by reviewing principal instruments used to assess the risks that EDCs may 
possess and in what way the results from risk assessments are being used in the 
regulatory process.  
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The sixth chapter defines risk and places it in a historical perspective.  It introduces the 
theoretical background for discussing chemical regulation in general and endocrine 
disrupters in particular.  The sociological theory of Risk Society is related to the idea of 
Reflexive Modernization and the chapter discusses endocrine disrupters as entering a 
scene of complexity, not only in technical terms, but also in the socio-political context. 
Lastly, the chapter discusses the use of science in regulating endocrine disrupters, the 
resulting prioritization and risk acceptance with regards to consumers. 
 
The subsequent chapters answer our problem formulation by way of the conclusions and 
recommendations.  The theoretical framework of risk society is used in the eighth 
chapter, titled Wider Implications of Risk Society, which extrapolates the trends seen 
from our case study of EDCs to chemical regulation on a global scale.   
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2 Endocrine Disrupting Chemicals and the Reproductive System 
This chapter brings us to a better comprehension of what endocrine disrupting chemicals 
(EDCs) are, the ways in which they may act, and the significance of their interaction with 
the human reproductive endocrine system.  A journey through the history of the synthetic 
chemistry enables us to recognize the importance that synthetic chemicals have in our 
daily life.  The chapter includes relevant information of four chemicals that are 
considered EDCs, and the consumer products that these chemicals are found in, which 
individual’s access everyday. In order to understand how EDCs work, we will start by 
providing a brief description of the human endocrine system and hormonal control 
mechanisms.   
2.1 What are Endocrine Disrupting Chemicals? 
As the name suggests, Endocrine Disrupting Chemicals (EDCs) are anthropogenic 
substances that can interfere with the endocrine systems of living organisms. The 
endocrine system constitutes one of the major communication systems of the body.  The 
active agents in this communication system are the hormones.  A hormone is a chemical 
messenger that is secreted by specific endocrine glands—such as the thyroid, gonads and 
adrenal glands—in response to specific stimuli and is carried by the blood to other sites in 
the body where it alters cell activity.  Hormones act as chemical couriers control and help 
to integrate many functions: circulation, water and electrolyte balance, digestion and 
absorption of food, organic metabolism and energy balance, reproduction, and responses 
to stress.  The body’s response to hormones is not all-inclusive but highly specific; in 
some cases they involve only one organ or group of cells.  Despite the ubiquitous 
distribution of a hormone via the blood, only certain targeted cells are capable of 
responding to the hormone based on the presence of specific receptors for those 
hormones.  A receptor is a protein to which a chemical messenger specifically binds, thus 
initiating a sequence of events culminating in the target cell’s response (Vander et al., 
1986).  
 
It is important to note that hormones are effective at very low concentrations, meaning 
that any disturbance or alteration of their normal regulatory processes could have 
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dramatic effects on organ activity and subsequently on the development and overall 
functioning of the organism.  In this case, of special interest are those chemicals that have 
the potential to alter the normal functioning of the human reproductive hormone system.  
 
 
 
FIGURE 1:  Representation of some important glands, organs, and tissues 
sending receiving hormonal messages in the human body. The illustration is from 
“Our Stolen Future” (Colborn et al., 1996).  Illustration by K. Brown, 1995. 
 
 
Following the identification of the problem of EDCs, a workshop was held by the 
EU/WHO/OECD in December 1996.  This workshop held in Weybridge, UK, agreed 
upon and adopted the following OECD working definition for EDCs and potential EDCs:  
 
An endocrine disrupter is an exogenous substance or mixture that  
alters function(s) of the endocrine system and consequently causes 
adverse health effects in an intact organism, or its progeny, or (sub)  
populations. 
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A potential endocrine disrupter is an exogenous substance or mixture 
that possesses properties that might be expected to lead to endocrine  
disruption in an intact organism, or its progeny, or (sub) populations.  
               (EEA, 1997) 
Since the appearance of Rachel Carson’s Silent Spring in 1969, the thalidomide 
experience (James, 1965), and the DES story (Herbst et al., 1971) the public has been 
increasingly concerned about those chemicals that could have harmful effects on human 
health.  More recently, Theo Colborn presented Our Stolen Future, pointing out the likely 
negative reproductive effects that EDCs could have on humans through a study of the 
mounting evidence of the effects of EDCs on the wildlife populations.   
 
How do Endocrine Disrupting Chemicals work? 
Various literature claims that endocrine disrupters could interfere with the functioning of 
the endocrine system by acting in at least three ways: 4
• As agonists, by mimicking the action of a naturally produced hormone, such as 
estrogen or testosterone, and in so doing setting off similar chemical reactions in 
the body. 
 
• As antagonists, by blocking the receptors in cells receiving the hormones 
(hormone receptors), in that way preventing the action of normal hormones. 
 
• As foreign agent affecting the synthesis, transport, metabolism and excretion of 
hormones, thus altering the concentrations of natural hormones.  
 
Theoretically, hormones bind to their specific receptor and thus creating a specific 
reaction.  Research has shown that there are “orphan” receptors which tend to bind to 
foreign substance that maybe behave like a natural hormone, thus creating an unknown 
reaction from this process.  
 
  Theory says that receptors are highly discriminatory about chemicals 
  structure and will bind only to their intended hormone or a very closely 
  related compound, but reality is proving considerably messier and  
  unpredictable not just in the case of the estrogen receptor but with  
  other hormone receptors as well (Colborn et al., 1996). 
 
 
4 More information about this can be found in Colborn, 1996, and in Global Assessment of the State-of-the-
Science of Endocrine Disruptors, published by IPCS, 2002. 
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What would be the effect of interfering with hormonal messengers in the human 
reproductive system? 
 
Suggestions from epidemiological studies have encouraged scientific and public 
discussion on whether human exposure to EDCs may negatively influence the hormonal 
equilibrium of humans.  The likely effects on human reproduction have been debated. In 
January 2005, the 3rd Copenhagen Workshop on Environment, Reproductive Health and 
Fertility was held in Denmark. The event gathered approximately 200 researchers and 
experts on reproductive issues and their likely links to exposure to hazardous substances. 
After several days of discussions, many questions remained without answers.  Questions 
such as: what are the roles, if any, of endocrine disrupters in reproductive failure? Are 
there industrial chemicals of particular concern, for example phthalates, and other agents 
with anti-androgenic action? Is there chemical exposure to the unborn child through the 
placenta and the neonate through breast milk, and if so, does this exposure affect the 
development and function of the male reproductive system (Skakkebæk, 2005)? 
 
Still questions remain, and though some of them currently could have a partial answer, all 
of them would likely take many years and much effort to answer.  At this point, we raise 
the question of “why it is so complicated to establish the connections between decrease in 
fertility and synthetic chemical exposure?”  In the beginning of this chapter we explained 
what an EDC is, and the way(s) they may work within the endocrine system.  Given the 
fact that human reproductive process is almost completely controlled by hormones, a 
better understanding of them can help us analyze their complexity.  
 
What hormones are involved in the human reproductive process? 
Human reproduction is by and large hormonally controlled from the point of 
gametogenesis/fecundation until the delivery.  Previous to the fecundation, there are 
many hormones that make this wonderful event possible.  The hypothalamic/pituitary 
system basically regulates the hormones involved in the process. Thus, we have a number 
of hormones including estrogen, progesterone, and testosterone. The pituitary stimulating 
hormones included in the process are the follicle-stimulating hormone (FSH) and the 
luteinizing hormone (LH). Also involved in the process are the hypothalamic releasing 
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hormones, which are the luteinizing hormone-releasing hormone (LHRH) and the 
gonadotropin-releasing hormone (GnRH).  As previously mentioned, the endocrine 
system regulates many body processes.  However, as this project is focused on EDCs that 
may have an effect on reproduction, we consider only those hormones involved in human 
reproduction.  
 
Hormonal control of male reproduction  
Sperm production in males is under the control of FSH and LH.  LH stimulates 
production of androgens (including testosterone) by the testes, while FSH stimulates the 
testes to produce sperm.  As in females, production of FSH and LH are under the control 
of GnRH.  Androgens control levels of GnRH, FSH, and LH via a negative feedback 
loop.  Additionally, androgens are responsible for development of the male reproductive 
organs during embryonic development, development of secondary sexual characteristics 
(facial hair, deeper voice), and production of sperm.  Also, FSH and LH control 
production of GnRH via negative feedback loops.  
 
 
 
FIGURE 2:  Schematic representation of the hormones involved in the male  
reproductive endocrine system. Illustration from “Alcohol Health & Research  
World.” (22) 3, 1998 
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ycle. These are GnRH, FSH, LH, estrogen and progesterone 
ecreted by the ovaries. 
at reaches the uterus is about 100 
ells in size and ready to implant in the endometrium. 
 
Hormonal control of female reproduction  
With respect to the female part in the process, there are five hormones involved in 
controlling the female c
s
 
The first half of a woman’s cycle is the proliferative phase (follicular phase), during 
which the endometrium starts to thicken. The pituitary secretes FSH, which causes 
(usually one) follicle to mature and the ovaries to secrete estrogen. The ovarian estrogen 
secretion gradually increases until just prior to ovulation.  This gradually suppresses 
secretion of FSH and stimulates the hypothalamus to secrete a larger amount of GnRH, 
which, in turn, triggers the pituitary to secrete a burst of LH, causing ovulation.  Near day 
14 of an average 28-day cycle, ovulation occur (rupture of the follicle and release of the 
egg) in response to the surge of LH.  LH stimulates the remaining follicle cells to form a 
corpus luteum after ovulation.  In this moment LH stimulates the corpus luteum to secrete 
progesterone and estrogen to prepare the uterus for implantation.  The rising/high levels 
of the estrogen-progesterone combination in the blood exert a negative feedback effect on 
the hypothalamus and pituitary, causing levels of LH to decrease.  As LH decreases, the 
corpus luteum starts to disintegrate.  Without the stimulation of LH, the corpus luteum 
stops producing estrogen and progesterone, unless an embryo has implanted.  The 
endometrium is no longer maintained and begins to deteriorate and is shed. Thus, around 
the time a woman’s period starts, all five hormones are at their lowest levels. However 
with the low estrogen and progesterone levels, the hypothalamus can now begin again to 
secrete GnRH so the cycle starts over.  If an egg was fertilized, it begins to divide as it 
travels down the fallopian tube, and the blastocyst th
c
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is successful, the outer embryonic membrane, the chorion secretes human 
dotropin (HCG), which maintains the corpus luteum during the first 
gnancy. The HCG protein hormone is very similar to LH, and strongly 
id secretion. With the presence of estrogen and progesterone in high 
throughout pregnancy, the blood concentrations of GnRH, LH, and FSH 
ely low; by this means, further ovulation and menstrual cycles are 
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adrenal cortex of the fetus, so the teamwork between placenta and fetal adrenals, produce 
the estriol required to maintain the pregnancy.  Since the fetus is necessary for estriol 
production, measurement of this hormone in maternal blood provides a means for 
monitoring the well being of the fetus. 
 
Hormonal control in differentiation of internal and external genitalia 
The male and female gonads derive embryologically from the same site in the body.  
During the seventh week, in the genetic male, the testes begin to develop; in the genetic 
female, several weeks later; ovaries begin to develop instead. A protein called H-Y 
antigen is the link between presence of the Y chromosome and testis differentiation.  H-Y 
antigen is secreted by primitive cells, (Sertoli cell precursors) in the male gonad and 
“directs” testicular development. 
 
At very early stages, the fetus has internal duct system and external genitalia; therefore it 
is capable of developing into either sex.  The primitive reproductive tract contains a 
double genital duct system, known as Wolffian and Müllerian ducts.  The internal 
reproductive organs develop from only one of these ducts systems: in the male, the 
Wolffian ducts persist and the Müllerian ducts regress, whereas in the female, the 
opposite happens. The development of either of the two duct systems depends on the 
presence or absence of two substances secreted by the fetal testes testosterone and 
Müllerian Inhibiting Substance (MIS). MIS causes the Müllerian duct system to 
degenerate, and testosterone causes the Wolffian ducts to differentiate into internal male 
reproductive structures. The female embryo has a lack of the two substances mentioned 
above; by this means Müllerian system develops into uterine tubes and uterus, while 
Wolffian ducts disappear automatically. This makes the female fetus less sensitive for 
changes.  “If a functioning male gonad is present (testes) to secrete testosterone and MIS, 
a male duct system and external genitalia will form, but if these “male” secretions are 
absent or ineffective, a female reproductive system will develop” (Vander, et al., 1986).  
This makes the male fetus more vulnerable to changes.  
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FIGURE 4: Representation of the differentiation of internal and external genitalia.  
The illustration is from PSYC 220.  Images from Class 8/97.5 Revised 10/03,8/04  
w can Endocrine Disrupting Chemicals alter the human reproductive process? 
ce knowing all the hormones involved in the human reproductive process and their 
portance, it may be evident that their disruption could cause adverse effects as a result 
 their performance, or it could result in non performance at all.  It is here where the 
scussion on reproduction alteration begins.  It is rather complicated to accurately 
termine the effects that EDCs can have on human reproduction, or by which way they 
 it.  There are many mechanisms through which EDCs can interact with hormones.  It 
uld be an endless task to determine all of them. There are many details in the process 
at even today, with all the knowledge scientists have, it is still not possible to fully 
plain and determine the actual effects of anthropogenic substances.  In addition, there is 
lack of harmonization within the test guidelines when assessing EDCs and their 
nnections to reproductive disruptions.6  Nevertheless, taking into account a wide range 
 evidence observed in wildlife and laboratory animals, scientist have been able to 
scribe the possible ways in which EDCs may have a negative effect on the human 
productive process.  
 
ttp://cti.itc.virginia.edu/~psyc220/
he issue on EDCs test guidelines harmonization is widely discussed in chapter 5. 
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Evidence of adverse effects of EDC on reproduction 
The adverse effects of synthetic chemicals on the reproductive capacity of wildlife have 
been widely document.  During the 1970s, studies of a wide range of species from the 
Great Lakes revealed reproductive and developmental deficits; specifically endocrine 
mediated adverse effects in reproduction were detected among fish and birds. Studies on 
Chinook salmon and freshwater trout have shown poor reproduction (Fox et al., 1978), 
also seen in birds, including herring gulls, Foster’s terns, double-crested cormorants, 
Caspian terns and bald eagles (Gilbertson, 1989).   
 
In addition to the Great Lakes studies, there are other major researches that bring solid 
evidence of the connection between man-made chemical exposure and reproductive 
adverse effects. A good illustration of this is the work of Guillette et al. (1994) who 
presented a presumed endocrine disruption in alligators in Lake Apopka, Florida. 
 
In 1999, the Working Group on Endocrine Disrupters of the Scientific Committee on 
Toxicity, Ecotoxicity and the Environment (CSTEE), published the report CSTEE 
Opinion on Human and Wildlife Health Effects of Endocrine Disrupting Chemicals, with 
Emphasis on Wildlife and on Ecotoxicology Test Methods. The report makes emphasis on 
the well-documented evidence of the links between adverse effects on reproduction and 
EDCs in wildlife. However, it also stated that there is a lack of data, which enables us to 
establish the connection between reproductive human health and EDCs. Nevertheless, 
they recognized that exposure to certain substances of pregnant women have an adverse 
effect in the physical and mental developments of the offspring. The complete list of the 
CSTEE conclusions on human health and wildlife is presented in boxes 1 and 2.  
 
In 2002, the International Program on Chemical Safety (IPCS) published the “Global 
Assessment of the State-of-the-Science of Endocrine Disruptors.” The publication 
presents a wide rage of studies that introduce evidence of endocrine disruption due to 
synthetic chemical exposure in wildlife and humans. The likely effects in human 
reproduction are introduced with studies on occupational exposures (Fuortes et al., 1997; 
de Cock at al., 1995; Tielemans et al., 1999a).  The association between maternal  
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Box 1: Conclusions from ‘Human and Wildlife Health Effects of Endocrine Disrupting        
Chemicals, with emphasis on Wildlife and on Ecotoxicology test methods’ 
Human Health Effects  
CSTEE, 1999 
•  A meta-analysis of 61 studies has reported a general decrease in sperm concentration and 
semen volume from 1938 to 1990. However, several re-analyses of the same data have indicated 
possible bias and confounding in the meta-analysis, and have reached different conclusions with 
respect to sperm quality, depending on the methodology used. Recent, well-designed studies have 
shown that there are large regional differences in overall sperm quality and time trends, both 
within and between countries.  
 
•  For the reported increased prevalence in cryptorchidism or hypospadias no causative role for 
endocrine disrupting chemicals has been determined.  
 
•  The incidence of testicular cancer has increased significantly during the last 30 years. The 
underlying reason(s) for the increased incidence in testicular cancer has not been identified.  
 
•  There also has been recorded an increased incidence of prostate cancer in Europe during the 
last decades. Any causative role for xeno-oestrogenic chemicals in development of prostate 
cancer has not been established.  
 
•  There has been a steady increase in breast cancer incidence rates over the last decades in 
Europe. The available data associating breast cancer development with exposure to 
organochlorines do not support a causal relationship.  
 
•  There have been several reports on the declining proportion of male new-borns during the last 
decades; this decline in sex ratio remains unexplained.  
 
• High accidental exposure to PCBs/PCDFs of pregnant women has led to delays in physical and 
mental development of the offspring resembling hypothyroidism. There are indications that 
organochlorine compounds may affect neonatal neurological development, possibly by affecting 
thyroid hormone status. 
 
 
consumption of contaminated fish from the Great Lakes, and the reduced fecundability is 
supported by the work of Buck at al. (1999) and Courval et al. (1999).  The link between 
male reproductive tract abnormalities (hypospadias and cryptorchidism) and exposure to 
man-made chemicals is supported by experimental work with pigs (McMahon et al., 
1995; Barthold et al., 1999).  Finally, there are some epidemiological studies that confirm 
the connection between hypospadias and cryptorchidism and synthetic chemical exposure 
(Garcia-Rodriguez et al., 1996; Kristensen et al., 1997; Restrepo et al., 1990; Garry et al., 
1996; Møller and Weidner et al., 1999).  Additionally, IPCS (2002) also reports on the 
well-document evidence of the adverse effects of EDCs in wildlife. 
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Box 2: Conclusions from ‘Human and Wildlife Health Effects of Endocrine Disrupting       
Chemicals, with emphasis on Wildlife and on Ecotoxicology test methods’ 
Wildlife Effects  
CSTEE, 1999 
 
•  Masculinization (imposex) in female marine snails by tributyltin, a biocide used in anti-fouling 
paints, is probably the clearest case of endocrine disruption caused by an environmental chemical. 
The dog whelk is particularly sensitive and imposex has resulted in decline or extinction of local 
populations worldwide, including coastal areas all over Europe and the open North Sea.  
 
•  DDE-induced egg-shell thinning in birds is probably the best example of reproductive 
impairment that caused severe population declines in a number of raptor species in Europe and 
North America. Developmental exposure to the DDT complex has been firmly linked to the 
induction of ovotestis in male Western gulls.  
 
•  Endocrine disrupting chemicals have adversely affected a variety of fish species. In the vicinity 
of certain sources (e.g. effluents of water treatment plants) and in the most contaminated areas is 
this exposure causally linked with effects on reproductive organs, which could have implications 
for fish populations. However, there is also a more widespread occurrence of endocrine 
disruption in fish in the United  
Kingdom, where oestrogenic effects have been demonstrated in freshwater systems, in estuaries 
and in coastal areas.  
 
•  In mammals, the best evidence comes from the field studies on Baltic grey and ringed seals, 
and from the semi-field studies on Wadden Sea harbor seals, where both reproduction and 
immune functions have been impaired by PCBs in the food chain. Reproduction effects resulted 
in population declines, whereas suppression of immune function has likely contributed to the 
mass mortalities due to morbillivirus infections. 
 
 •  Distorted sex organ development and function in alligators has been related to a major 
pesticide spill into a lake in Florida, U.S.A. The observed oestrogenic/anti-androgenic effects in 
this reptile have been causally linked in experimental studies with alligator eggs to the DDT 
complex. 
 
Owen (2004) mentioned that scientists first realized the scale of endocrine disruptors’ 
gender-bending potential in the 1990s7, since then, a series of publications have pointed 
out the likely adverse effects of EDCs on wildlife and human health. According to a 
report published in 2003 from the Scientific Committee on Problems of the Environment 
(SCOPE) and the International Union of Pure and Applied Chemistry (IUPAC), there are 
over 200 animal species around the world that are known or suspected to have been 
affected by EDCs (Miyamoto and Burger Eds. 2003). The report includes a broad area 
                                                 
7 http://news.nationalgeographic.com/news/2004/03/0301_040301_genderbender.html 
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dedicated to point out the effects of EDCs in rodents and humans, as well as one focused 
on the wildlife species.   
 
When analyzing the evidence one can ask, “when did we lose the control of synthetic 
chemical production, or maybe we have never had control?”  Noting this it may be 
relevant to explore the historical development of synthetic chemistry, bringing us to a 
better understanding of chemical production. 
 
2.2  Why are EDCs synthetically produced? 
 
All the evidence of the adverse effects that EDCs have or may have on wildlife and 
human reproductive health, help us to reflect on the reasons why we produce and use 
synthetic chemicals in an uncontrolled manner.  Synthetic EDCs are part of the large 
amount of synthetic chemicals we all are surrounded by.  Therefore, in order to 
understand why they are synthetically produced, we have to look at the development of 
synthetic chemistry and its historical role in society.   
 
We can start by mentioning that the global consumption of industrially produced 
chemicals has increased dramatically in the last two decades.  In 1930 the global 
production of organic chemicals was approximately 1 million tons a year, today, it is 
more than 400 million tonnes a year.  Europe is the largest chemical-producing region in 
the world, accounting for 38% of the total; Western Europe alone accounts for 33% 
(UNICE, 2003). This means that throughout the 20th century the human and 
environmental exposure to synthetic chemicals has gradually intensified.  Tens of 
thousands of industrial chemicals are being marketed and used every day, most of which 
without restrictions and little or no knowledge of their properties (Danish Ecological 
Council, 2004).  At this point we could raise the question: why have we reached these 
dramatic levels of chemical production and consumption?   
 
Historically, chemistry was first introduced as an academic discipline in medical 
faculties, academies, botanical gardens and museums in late 17th century.  The records of 
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the diverse occupations of the chemists of that time (distillations and extractions, 
apothecaries, mining and metallurgy, searchers of surrogates of commodities such as 
sugar, tobacco, coffee, brandy, and liqueurs), show us that chemistry never was 
considered a “pure science.”  This changed when chemists in the early 18th century 
refined techniques of chemicals analysis, restructured the relations between chemical 
analysis and theories of chemical composition, explored cycles of analysis and re-
synthesis of substances in the laboratory, and analyzed experimental results to establish 
laws of chemical affinity between substances.  
 
Still in the early 1800s, scientists believed that organic compounds could only be 
produced by the action of a special life force (vis vitalis).  In 1828 Friedrich Wöhler 
(1800-1882), a German chemist, produced urea from inorganic compounds in the 
laboratory. The synthesis of this organic compound is considered the breaking point in 
the development of the organic chemistry as a pure science.  In this way the early 19th 
century experienced the birth of the “organic chemistry,” which includes the study of 
substances extracted from plants and animals.  From the mid-1850s, it was precisely this 
new type of chemical expertise that became most useful in the emerging synthetic-dye 
industry (Jensen, 1968).  
 
According to Ursula Klein (2004), in her essay on Chemistry in the 18th and 19th 
centuries, the connections between chemical science and technology in the new synthetic-
dye industry are complex.  Nevertheless, it is clear that the subsequent relationship of the 
development of organic chemistry as a pure science, the synthesis of new substances in 
laboratories and the pollution from their wastes and by-products, represented the 
beginning of a new era: The era of Modern Chemistry. 
 
Synthetic chemistry developed rapidly to allow the manufacturing of new compounds, 
which had never existed in nature before.  As the century progressed into the World War 
II era, waste and hazardous by-products of manufacturing increased markedly from 
sources such as chlorinated solvents, synthetic pesticides, plastics, paints, and wood 
preservatives (Manahan, 2000).  The production of large amounts of synthetic chemicals 
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seemed to be the perfect solution for many of the problems faced during the time. The 
1950s saw the advent of an array of synthetic pesticides that were hailed as modern 
miracles in the war against pests and weeds.  First and foremost was dichloro-diphenyl-
trichloroethane, better known as DDT, which was hailed as the “wonder insecticide of the 
World War II” (see box 3). 
 
While DDT made a huge impression among agro industries, the pharmaceutical industry 
in the 1950s also reached a very successful era with the synthesis of diethylstilbestrol 
(DES).  DES was considered as “wonder drug with a host of potential uses” (see box 4).  
The post war era was a time of great optimism, when everyone from physicians to 
farmers rushed to embrace new “miracle” technologies.  DES and DDT were just two of 
many new synthetic chemicals that promised to give us control over the forces of nature 
(Colborn, et al., 1996).   
  
 
 
 
 
 
 
 
 
 
 
Box 3: The DDT (dichloro-diphenyl-trichloroethane) story: 
 
Paul Muller, a chemist at the Swiss firm J.R. Geigy, discovered DDT’s insecticidal 
properties in the late 1930s.  The American military started testing it in 1942 and soon the 
insecticide was being sprayed in war zones to protect American troops against insect-borne 
diseases such as typhus and malaria.  In 1943 DDT famously stopped a typhus epidemic in 
Naples in its tracks shortly after the Allies invaded. DDT was hailed as the “wonder 
insecticide of world war II.” 
 
After the war, American consumers and farmers adopted the wonder pesticide, replacing the 
old-fashioned arsenic-based pesticides.  The US Public Health Service and the Food and 
Drug Administration Division of Pharmacology tested DDT, finding no serious human 
toxicity problems with it.  Muller was awarded the Nobel Prize in 1948.  
 
Bailey, 2002
http://reason.com/rb/rb061202.shtml 
The journey through the history of the synthetic chemistry described above shows the 
way we have been looking and encouraging our development as a society.  It becomes 
visible how all the commodities that we produce and own in order to make our life “easy” 
and more comfortable, have been an important part of the driving forces that command 
our development.  As a result, we have a lack of control over synthetic chemicals that 
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appeared to be very useful, but at the same time seem to be connected to reproductive 
dysfunctions, which may threaten our future as species.  
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vBox 4: The DES (di-ethyl-stilbestrol) story: 
 
In 1938, British scientist and physician Edward Charles Dodds and his colleagues 
announced the synthesis of a chemical that somehow acted in the body like natural estrogen. 
Almost immediately, physicians began giving DES to women with pregnancy problems in 
the belief that insufficient estrogen levels caused miscarriages and premature births.  
 
In June 1957, Grant Chemical Company had an ad in the Journal of Obstetrics and 
Gynecology, which touted the use of DES for “all pregnancies” boasting that it produced 
“bigger and stronger babies.” “Doctors used it to suppress milk production after childbirth, 
to alleviate hot flashes and other menopausal symptoms, and to treat acne, prostate cancer, 
gonorrhoea in children, to stunt the growth in teenage girls, and as a “morning after” 
contraceptive.”  Farmers used DES as a food additive, or as neck or ear implants, because it 
sped up the fattening of chickens and other livestock. 
 
Colborn et al, 1996:48
 
hat substances are known to disrupt the messages involved in the human reproductive 
rocess?  
he European Commission’s Department of Environment along with a panel of experts 
as produced an EU-Strategy for Endocrine Disrupters list of 66 substances with 
lassification of high, medium or low exposure concern.  Given that our project is dealing 
ith those EDCs that affect human reproduction, among the listed 66 chemicals we will 
dentify some that are known or suspected to cause adverse reproductive effects in the 
uman reproductive system (see Appendix C). 
uman beings are most often exposed to EDCs in low doses.  Exposure to EDCs adds 
ncrementally to what is already present in the body as naturally occurring hormone.  
ost standard testing involves high production volume chemicals (HPV), which are used 
o evaluate reproductive and developmental toxicity, rather than the impact of low-
olume production.  The US EPA has been researching the effects of endocrine disrupters 
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to resolve questions concerning the effects of low-dose exposures;8  however, standard 
testing does not take into consideration the low-dose exposure of chemicals suspected to 
have endocrine disrupting effects.  In addition, Dr. Paola Palanza notes that different to 
traditional toxicological approaches, two significant conceptual shifts have emerged by 
recent research on endocrine disrupters.  Firstly, extremely low doses can cause 
measurable and substantial disruption in animal models, and secondly, consistent findings 
during the life-cycle of an organism, show that “developmental stages are typically far 
more vulnerable to signal disruption than adult stages” (Palanza, 1999).  
 
The chemicals below may have a variety of toxicological effects to the human body, 
however, in the interest of this project the listed are chemicals known to cause adverse 
effects to the reproductive system, known also as reproductive toxicants.  United States 
EPA defines reproductive toxicants as a, 
 substance or agent that can cause adverse effects on the reproductive 
 system, in either men or women.  These effects can include alterations 
 to the reproductive sexual organs and/or the endocrine system,  
 chromosomal damage and effects on foetuses (teratogenesis).9
 
Reflecting on this statement creates a sense of confusion and worry about the usage of 
dangerous substances, especially those used during pregnancy and early stages of child 
development.  Found in personal care products used daily, these substances are the ones 
with a higher risk of continual exposure. 
 
What consumer products are known to house these agents? 
In this section, a more specific examination is made at four chemicals chosen to represent 
the investigation of EDCs, which have an estrogenic effect on laboratory animals and 
humans: bisphenol-A (BPA), butyl-paraben, di-ethylhexyl phthalate (DEHP) and 
nonylphenol.  The criteria used for considering these chemicals has been based on 
available data from reliable sources, a possible low-dose exposure, significance to the 
human consumers and whether the substances are assessed in the current chemical 
regulation framework of EDCs.  Other criteria used for selection is the potential to bring 
 
8 http://ehp.niehs.nih.gov /docs / 2001/109-9/niehsnews.html#low
9 http://www.epa.gov/ncea/raf/pdfs/repro51.pdf, 1996. 
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these substances into the discussion of REACH and its principles: the association of 
DEHP to the substitution principle, BPA and nonylphenol and their likely disregard of 
the authorization system, and parabens as being one of the best examples of strong 
suspicion, debatable evidence and the lack of regulatory action.  
 
1. Bisphenol A:  (BPA) 
    CAS No: 80-05-7 
    EINECS No: 201-245-8 
 
Bisphenol A is a high production volume (HPV) chemical used as an intermediate in the 
production of polycarbonate plastic and epoxy resins.  Bisphenol A is one of the most 
widely used chemicals in the world with production seen at over 650,000 tonnes per year 
(100,000-500,000 produced in Germany and the Netherlands).10  It is known to 
synthesize epoxy resins and polycarbonate plastic which can be used in eyeglass lenses, 
medical equipment, water bottles, cell phones, electronics, baby bottles, water cooler 
jugs, drink and food packaging (inside of food cans) and plastic dental fillings.  Epoxy 
resins are industrial floorings, adhesives, industrial protective coatings, powder coatings, 
automotive primers, can coatings and printed circuit boards (TemaNord, 1996; EU 
Commission, 2003;11).   
 
Human exposure to the potential endocrine disrupting effects of bisphenol A may occur 
when this chemical leaches out of the plastic due to the breakdown of the polymer upon 
heating.12  Exposure of humans to the estrogenic hormone becomes a hazard at point 
sources and by contamination of food items (Olsson, 1998).  This can be seen via 
migration from various consumer products, such as heated baby bottles containing infant 
formula when the substance leaches from plastic liners in food cans or plastic water jugs, 
the dissolving of hot, fatty foods onto readily available plastics and finally the release of 
bisphenol A through the filling of dental cavities (EU Commission, 2003).13   
 
10 http://europa.eu.int /comm/environment/docum/pdf /bkhannex14.pdf:20
11 http://www.bisphenol-a.org/pdf/LowDoseUnprovenOctober2002 pdf
12 http://www.epa.gov /ordntrnt/ ORD/NRMRL/Pubs/2001 /edc/ 625r 00015.pdf
13 http://www.checnet.org/ healthehouse/chemicals/chemicals-detail2.asp?Main_ID=275
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Human beings are usually exposed to low doses of endocrine disrupting chemicals.  
Exposure to EDCs adds incrementally to what is already present in the body as naturally 
occurring hormone.  Most standard testing involves large volume chemicals which are 
used to evaluate reproductive and developmental toxicity, rather than the impact of low-
dose exposures.  The US EPA has been researching the effects of endocrine disrupters to 
resolve questions concerning the effects of low-dose exposures.  Other research on low-
dose exposure to BPA has been remarked by vom Saal and Hughes (2005).14   
 
Bisphenol A is a suspected endocrine disrupter and provider of adverse reproductive 
effects, seen through investigations in a number of species.  For example, fish and snails 
have exhibited secondary sexual characteristics, spermatogenesis, and increased egg 
production respectively (EU Commission, 2003).  Among the list of health effects on 
exposed male laboratory rats are: an enlarged prostate weight, shrunken epididymides 
and reduced daily sperm production in males; and female laboratory mice experience an 
alteration in the development and tissue organization of the mammary gland, disruption 
of sexual differentiation in the brain, long-term deleterious effects in the vagina, and 
accelerated growth and puberty in females and an increase in body weight when exposed 
to bisphenol A as embryos (Howdeshell et al. 1999; Kubo et al. 2001; Markey et al. 2001; 
Nagel et al. 1997;Schonfelder et al. 2002; Talsness et al. 2000; vom Saal et al. 1998; 
Welshons et al. 1999).  Palanza (2003) refers to maternal effects of exposure to BPA in 
that the substance affected the female mice in exploration, emotional and cognitive 
behaviours, and maternal behaviour; while males were more sensitive to BPA as far as 
the development of aggression and social interactions.  Additionally, exposure to low 
levels of the chemical induces “aneuploidy, which is an error in cell division that causes 
miscarriages and birth defects, including Down Syndrome in humans.”15
 
Bisphenol A is classified as a reproductive category three substance, which means that 
there is concern for human fertility.  Animal studies provide sufficient evidence to cause 
strong suspicions of impaired fertility in an absence of toxic effects or occurring at the 
 
14 http://ehp.niehs.nih.gov/docs/ 2001/109-9/niehsnews.html#low
15 http://www.checnet.org/heal thehouse/chemicals/chemicals-detail2.asp?MainID =275 
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same dose levels as other toxic effects, when there is insufficient evidence to place the 
substance in category two (European Commission, 2003:4).   
 
In a summary the European Commission states that there is no environmental legislative 
control specific to BPA.  However, because it can migrate from contact materials to food, 
they have recommended only 3 mg of bisphenol A, per kg of food in order to protect the 
EU consumer (European Commission, 2003:5).  
 
2. Butyl-Paraben:  
   CAS No: 99-76-3  
   EINECS No: 204-399-4 
 
Paraben is a synthetic preservative used for more than fifty years in food, cosmetics and 
other personal care products, such as shampoos, soaps, hair sprays, deodorants, skin 
creams, etc.  Parabens have “antimicrobial properties, extended shelf-life and are readily 
absorbed through the skin and gastrointestinal tract” (Harvey, 2004:169).  According to 
Ingerslev et al., (2003), approximately 12 parabens are used commercially as 
preservatives in cosmetics, food, and pharmaceutical products.  In the same report, 
Ingerslev mentioned that the estrogenic effects of parabens have been demonstrated in 
vivo in mice (Hossaini et al., 2000), rats (Routledge et al., 1998), fish (Pedersen et al., 
2000), and in various in vitro assays (Routledge et al., 1998).   
 
The use of paraben in cosmetics is regulated through the European Directive 76/768/EEC 
from 1967.  Danish cosmetic regulations permit the preservations of cosmetics products 
with methyl paraben, ethyl paraben, propyl paraben and butyl paraben up to a maximum 
combines concentrations of 0.8% (w/w) (Oishi, 2002).  
 
Based on several estimates, the total paraben the total  
paraben exposure is 76 mg/day or 1.3 mg/kg body weight/day, 
with food accounting for approximately 1 mg/day, cosmetics  
and personal products 50 mg/day and drugs 25 mg/day 
(Soni et al., 2001). 
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It has been said to have a “very, very good safety profile” and has approval for 
consumption in the European Union.16   However, the continuous dilemma with exposure 
again appears with this pervasive chemical.  “Effects of long-term exposures to low doses 
and mixtures have not been researched and there are no data on the effects of these 
exposure to environmental estrogenic chemicals and therefore human health effects and 
levels of risk are unknown” (Harvey, 2004:168).   
 
Harvey et al. suggests a correlation to the increase in breast cancer and the growth in 
usage of personal care products, namely those with the ingredient paraben.17  “Parabens 
have been suggested as the agents in body care formulation potentially involved in breast 
cancer because of their ready absorption through the skin as intact esters, their hormonal 
activity and their reproductive toxicity” (Harvey, 2004:168).  
 
According to Jette Rank (Personal Comm., 2005), the only paraben that has been 
associated with endocrine disruption and reproductive adverse effects is butyl paraben. 
Oishi (2001 and 2002a) confirmed this statement.  The same author (2002b) pointed out 
that propyl paraben also adversely affects the hormonal secretion, and the male 
reproductive system.  Oishi concluded by saying “the exposure level at which this effects 
was observed is the same as the upper-limit acceptable daily intake (10 mg/kg body 
weight/day) of parabens in the European Community and Japan.  
 
3. Phthalates: Di-(2-ethylhexyl) phthalate (DEHP)  
   CAS No: 117-81-7             
   EINECS No: 204-211-0 
 
Phthalates are a group of persistent, HPV, manufactured chemicals, primarily used as 
additives in plastics, making them more flexible.  Among the twenty different phthalates 
that are being used in the plastics industry, DEHP is the most used “…due to its excellent 
chemicals properties and its low price in the world market” (Rank, 2005:4).  The annual 
 
16 http://www.health-report.co.uk/parabens.htm
17 It should be noted that other environmental dynamics are taken into consideration as factors for the 
increase of breast cancer as well (Harvey, 2004:168) 
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production of DEHP is 1-4 million tonnes (Latini et al., 2004), and it is commonly found 
in PVC products, cosmetics, building products, car products, clothing, food packaging, 
children’s products (but not toys intended for mouthing), and polyvinyl chloride medical 
devices (such as IV bags)18. DEHP has been associated to pregnancy complications such 
as anaemia, toxaemia, and preeclampsia in women living near a plastics manufacturer 
(Tabacova et al., 1999). Cobellis et al., (2003) associated DEHP exposure and 
endometriosis.  Moreover, there is concern about the relation between DEHP exposures 
and male reproductive health. 
…there exists a serious concern that DEHP exposure  
may adversely affect male reproductive health. In particular,  
there is increasing evidence that DEHP is an endocrine  
disruptor, which is an environmental contaminant capable  
of perturbing the reproductive process by mimicking or  
antagonizing steroid hormones action (Sharpe, 2001). 
 
The sources of human exposure to DEHP are very diverse, and may follow different 
paths, however, it has been recently shown (Latini et al., 2003) that the exposure begins 
during intrauterine life. Nevertheless, the most hazardous risk of exposure for humans is 
very likely to be the release of DEHP from PVC medical devices (feeding tubes, infusion 
tubing systems, umbilical catheters, respiratory tubing systems, PVC blood bags, 
transfusion tubing systems, haemodialysis systems, cardiopulmonary bypass, continuous 
peritoneal dialysis, extracorporeal membrane oxygenation circuits (ECMO) and 
endotracheal tubes) into the biological fluids, which they contain.19  Due to its chemical 
properties, DEHP can leak when coming into contact with lipid containing body tissues 
(e.g. blood), and therefore being able to accumulate in blood and liver, kidney and lung 
tissues (Editorial, 1975. In: Latini et al., 2004).  
 
The Agency for Toxic Substances and Disease Registry (ATSDR), estimates that the 
daily intake of DEHP for the general population may grow up to about 2 mg/day (Latini, 
2004).  The tolerable daily intake (TDI) value settled by the EU CSTEE (1998) is 
37mg/kg body weight/day.  
 
18 http://cerhr.niehs.nih.gov/news/fedreg/fr2_4_05.pdf
19 Information from the Center for Devices and Radiological Health, U.S. Food and Drug Administration 
(2001), Health Canada Expert Advisory Panel on DEHP in medical devices. Final Report 2002 January 11. 
 45
European Union Regulation of Endocrine Disrupting Chemicals 
That Affect Reproduction: From Rachel to REACH 
 
DEHP has been reported as inductor of developmental and reproductive toxicities in 
mammals (Parmar et al., 1986), but its ability to induce the same in humans is reported as 
still uncertain. Even so, Latini et al., (2004), stated the association between DEHP and 
reproductive disorders as follows: 
 
DEHP and its main metabolite mono(2-ethylhexyl)phthalate  
(MEHP) appear to target analogous sites within the testis  
(Sertoli cells) and ovary (granulosa cells). In males DEHP is a  
testicular toxicant and its target is likely to be located in the  
Sertoli cell membrane, by inhibiting follicle stimulating  
hormone (FSH) signal transduction. Potential adverse effect  
on male reproductive tract consist into hormonal disturbance  
of the fetal testis development.  
 
For an elaboration on the statement above refer to the section on Hormonal control of 
male reproduction, Hormonal control of female reproduction, Hormonal control during 
pregnancy, and Hormonal control in differentiation of internal and external genitalia, 
from pages 28-31.  Other authors (Kuwada et al., 2002; Moore et al., 2001; and Baskin et 
al., 2001) have also pointed out the association of DEHP exposure and male reproductive 
health.  
 
DEHP has been detected in “drinking water, soil, household dust, fish and other wildlife, 
fatty foods (meat and dairy products), human blood and breast milk and phthalate 
metabolites have been detected in the urine of adults and children” (WWF-UK, 2004:16; 
Koch et al., 2003).  
 
With regards to DEHP regulation within the European Union, Rank (2005) stated that the 
major action taken with regards to this compound is its classification as a reproductive 
toxicant, and accordingly it “will be labelled as such when brought onto the market.”  
However, it will apply only to packing and pure chemicals and leaving out this 
information when using plastic products containing DEHP.  Rank also emphasized the 
existing ban in the use of this chemical in toys for children from 0 to three years, the 
established limit values for migration to food from plastic wrap, and the 
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recommendations of not using PVC containing DEHP in devices for neonatal care (see 
box 11 in chapter three).  
 
4. Nonylphenol  
    CAS No: 25154-52-3 
    EINECS No: 246-672-0 
 
Nonylphenol is viscous, colourless liquid, and a derivative of alkylphenol ethoxylates 
(APEs) as a synthetic surfactant.  It is used in the production of “nonylphenol 
ethoxylates, non-ionic surfactants applied as emulsifying, wetting, dispersing or 
stabilizing agents in industrial, agricultural and domestic consumer products” (EU 
Commission, 2002: 5;20).   
 
Nonylphenol is a suspected endocrine disrupter, mimicking estrogens that bind with the 
estrogen receptor and provoke estrogenic responses.21  Nonylphenol is present in 
polystyrene plastics, cleaning supplies, leather auxiliaries; used in paints, agricultural 
products and photographic equipment, and found at one point in detergents that can 
contain ingredients that degrade into estrogenic chemicals (EU Commission, 2002:5; 
Colborn et al., 1996:134).   
 
Environmentally, the existence of nonylphenol presents a serious problem to our 
ecosystem as a whole.  Nonylphenol is seen as very toxic to the aquatic environment and 
may cause long-term harm as it is not biodegradable as it shows a high potential to 
bioconcentrate (EU Commission, 2002: 9;22).  Nonylphenol is strongly absorbed soils, 
sediments and also in wastewater treatment sludge, which can then be applied to 
agricultural landscapes (EU Commission, 2002:8).  The substance will not travel far as it 
will readily absorb and be bound to the soil; therefore it is unlikely to enter groundwater.  
Despite the fact that the substance may not enter the groundwater, contamination is found 
 
20 http://ehp.niehs.nih/gov/members /2004 /7534/7534.html
21 http://www.ourstolenfuture.org/ NewScience/oncompounds/2002-0326guentheretal.htm
22 http://ptcl.chem.ox.ac.uk/MSDS/MO/nonyl phenol.html
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in surface water and Colborn et al. (1996) mention that modest concentrations of 
nonylphenol has been found to inhibit the growth of fish testicles.   
 
Toxicological studies on laboratory animals, have suggested that exposure to nonylphenol 
and bisphenol A is associated with morphological, functional, and behavioural anomalies 
related to reproduction.23  Multigenerational studies on laboratory rats has show that the 
estrogenic substance causes minor “perturbations in the reproductive system of offspring, 
for example, changes in estrous cycle length, timing of the vaginal opening and possible 
also in ovarian weight and sperm/spermatid count” (EU Commission, 2002:19).  As well, 
evidence of testicular toxicity was reported at a level that could also cause mortality in 
repeated doses.   
 
The effect of exposure to nonylphenol on consumers is a serious and growing concern, 
and one can be at risk through dermal, inhalation and contact, all from various previously 
listed avenues.  Specifically, the main source of exposure to humans via the environment 
is through food (fish and root crops) and to a lesser extent drinking water.  Dermally, 
consumers are exposed through application of cosmetics, hair dyes and through pesticide 
use.  Nonylphenol is “distributed widely throughout the human body with the highest 
concentration in fat” (EU Commission, 2002:18), and there is yet insufficient data to 
comment on bioaccumulation of the hazardous substance.  This widespread use of both 
nonylphenol and bisphenol-A by consumers is a growing concern as consumers become 
more and more reliant on industrial plastics and related products.  
 
 
 
 
 
 
 
 
 
 
 
 
 
23 http://ehp.niehs.nih.gov/members/2004 /7534/ 7534.html  
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3 Chemical Regulation System in the European Union 
This section will discuss more closely the precursors leading to the development of the 
Community Strategy for a future Chemicals Policy, called REACH, as well as the 
Strategy for Endocrine Disrupting Chemicals from 1999-2004.  It will identify the key 
components of these strategies, include international co-ordination needed in the form of 
declarations and conventions and discuss the hitherto regulation in the EU as it will lead 
up to the present proposal (REACH) in the forthcoming chapter.   
3.1 What is the structure of the chemical regulation system in the EU? 
At present, the situation in Europe is characterized by both existing and new substances; 
the balance of testing falling on the new chemicals with the existing substances hardly 
evaluated for adverse effects to human beings or the environment.  In order to have a firm 
understanding of the proposed legislation and how these existing and new substances are 
handled, it is necessary to first explain the evolution of chemical regulation in the 
European Union.   
 
The first EU Directive for hazardous chemicals, 67/548/EEC, is recognized as the 
backbone for chemical regulation in the EU today.  Although amended numerous times 
this directive continues to influence the character of new legislation, which is written to 
complement this initial directive (Lind, 2004: 53).  It is seen through the introduction to 
chemical regulation, the impact and influence, of four significant EU Directives 
(67/548/EEC, 79/831/EEC, 88/379/EEC and 793/93/EEC) (see box 5 and 6) which help 
to construct the legislation to the present day.  
 
Box 5: Fundamental EU Directives  
67/548/EEC Classification, Packaging and Labelling of Dangerous Substances 
79/831/EEC 6th amendment – Classification, Packaging and Labelling of Dangerous Substances 
Creation of EINEC list 
88/379/EEC Classification, Packaging and Labelling of Dangerous Preparations 
Elimination of trade barriers and increased protection of environment and human 
health 
793/93/EEC Evaluation of Existing Substances 
Identification of risks associated with existing chemicals. 
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Box 6: Scheme of Chemical Regulation in the European Union 
 
1976 67/548/EEC Classification, Packaging and Labelling of Dangerous Substances 
1976 76/769/EEC Marketing and Use of Certain Dangerous Substances and 
Preparations 
1979 79/831/EEC 6th amendment – Classification, Packaging and Labelling of 
Dangerous Substances 
Creation of EINEC list 
1988 88/379/EEC Classification, Packaging and Labelling of Dangerous 
Preparations 
Elimination of trade barriers and increased protection of 
environment and human health 
1992 Rio Declaration 
& Agenda 21 
United Nations Conference on Environment and Development 
with emphasis on Sustainable Development and Precautionary 
Principle 
1993 793/93/EEC Evaluation of Existing Substances 
Identification of risks associated with existing chemicals. 
1993 93/76/EEC Principles for Assessment of Risks to Man and the Environment of 
Substances 
1995 Esbjerg 
Declaration 
Ensure sustainable, healthy North Sea ecosystem through 
precautionary approach 
1996 Weybridge, UK International meeting on the impacts of EDCs on humans and 
wildlife with a conclusion to take action on the EDCs problematic 
1998 Chester, UK Informal meeting of Environment Ministers on handling and safe 
management of chemicals. 
1998 Rotterdam 
Convention 
Control of hazardous substance trading and development of Prior 
Informed Consent (PIC) 
1998 Industry Global 
Initiatives 
Long Range Research Initiative developed and funded by 
industry’s 20 million Euros 
1999 Origins of EDC 
regulation   
Introduction of EU Community Strategy for Endocrine Disruption 
2001 Follow – up of 
EDC strategy 
Two year evaluation of accomplishments with respect to EDC 
given strategy  
2001 REACH Introduction to the Community Strategy for a future Chemicals 
Policy  
2002 World Summit Generation goal objective similar to Esbjerg with a goal of safe 
chemical production through risk assessment and risk management 
and use of precautionary principle as seen in Rio Declaration.  
2003 REACH Revised REACH which since has been watered down from 2001 
2004 EDC Working 
Document 
Advances of work on the EDCs problematic since original 
document in 2001 
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Development of Directives 
A directive can be defined as “a legal act that is ‘binding, as to the result to be achieved’ 
but leaves to Member States’ authorities the ‘choice of form and method’” (Pinder, 
2001). The European legislation on chemicals developed in 1967 through Directive 
67/548/EEC was, and remains to this day, the basis for EU regulation of industrial 
chemicals.  The purpose of the directive was to regulate those chemicals that are placed 
on the European market by member states through a system of classification, packaging 
and labelling of dangerous substances (Lind, 2004:52; EU Official Journal, 1967:196).  
The directive was conceived to harmonize Community trade of industrial chemicals 
among the six member states at that time: Belgium, France, Germany, Italy, Luxembourg 
and The Netherlands.  It was responsible for protecting the health and safety of industrial 
workers against acute exposure, but did not yet address the need to safeguard the 
environment or persons against long-term chronic exposure (Lind, 2004:52).   
 
Directive 67/548/EEC on the Classification, Packaging and Labelling of Dangerous 
Substances used the following terms to adequately label chemicals based on their 
ingredients, usages of the product, and the effects of the product on consumers: 
explosive, oxidizing, easily flammable, flammable, toxic, harmful, corrosive and irritant.  
Interestingly, the producers and importers were not required to test, classify or supply any 
data themselves; they were only required to label the substance accordingly if they knew 
or suspected that the substance may be dangerous (Lind, 2004:53). Today, there are 
approximately fifteen different labels for classifying industrial hazardous chemicals.   
 
Following the introduction and implementation of this directive, eleven years passed 
before a supplementary recommendation was introduced.  Directive 76/769/EEC was to 
restrict certain dangerous substances and preparations from being placed on the market 
without steps taken to protect the public and those in contact with such substances.  The 
directive recognized the environment as an entity worthy of protection and preservation 
for the first time.  Additionally, the directive was intended to restore, preserve and 
improve the quality of human life while attempting to harmonize trade among Member 
States, thus alleviating an obstacle affecting the functioning of the common market 
 51
European Union Regulation of Endocrine Disrupting Chemicals 
That Affect Reproduction: From Rachel to REACH 
 
(Council Directive 76/769/EEC).  Continuing with the notion of environmental 
preservation as well as modifications to existing legislation, the sixth amendment to 
directive 67/548/EEC was brought forward two years later, and was of significant 
importance. 
 
In 1979 the Community became aware of the necessity to include within the current 
legislation, the responsibility toward protecting man and the environment while 
maintaining adherence to the health and safety of the workers.  Directive 79/831/EEC 
states that in order to control the effects to people and the environment, any new 
substance placed on the market is subjected to, 
 
a prior study by the manufacturer or importer and a notification  
to the competent authorities conveying mandatorily certain  
information; whereas it is, moreover, important to follow closely 
the evolution and use of new substances placed on the market, and  
that in order to do this it is necessary to institute a system which  
allows all new substances to be listed (EU Directive 79/831/EEC). 
 
The new system was named EINECS (European Inventory of Existing Commercial 
Substances) and was established to list those “existing” substances on the European 
market from 1 January 1971 to 18 September 1981.  There are 100,196 substances 
reported to be featured in the EINECS list (excluding pharmaceuticals, cosmetics, 
consumer products and foodstuffs, as these pertain to other directives).  The substances to 
be placed on the market after this date were to be termed “new.”   
 
The exemptions to existing substances of having to provide safety data, coupled with the 
stricter requirements for new substances, resulted in a “reversed substitution” relying on 
old substances, rather than substituting with safer alternatives.  The development of 
EINECS in the sixth amendment, created a situation of reversed substitution where 
thousands of chemicals, many produced in large volumes and most without basic data 
testing, were freely traded, while new substances were under pressure to receive testing 
and risk assessment (Lind, 2004:53).  Creating a “business as usual” attitude, industry 
continued to produce while new substances struggled to make it on the market.   
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Again, harmonization of chemical trading emerged on the Community agenda, in turn 
creating a new directive to make improvements on directive 67/548/EEC. Directive 
88/379/EEC recommends similar classification and labelling of substances “irrespective 
of how preparations were intended to be used. The objective was to eliminate trade 
barriers and to increase protection of human health and the environment” (EU Directive 
88/379/EEC; Lind, 2004:54). The ubiquitous preparations in mention include industrial 
chemicals, such as solvents, prints, varnishes, inks; agricultural chemicals such as 
pesticides; petrochemical products such as fuels and lubricants; consumer products such 
as detergents, disinfectants and many others24 (Lind, 2004:54). This directive does not 
include medicines, foodstuffs or cosmetics as they undergo stricter legislation elsewhere.  
 
The online reference site for the European Union’s Enterprise and Industry department 
states that the directives pertaining to "classification and labelling" only concern 
themselves with the assessment of the intrinsic hazards of chemicals.  Continuing, it 
mentions there is other EU legislation concerned with the tricky tasks of assessing the 
risks associated from chemicals and their control.25  The initial concern with creating the 
directives was to assess the impact of the hazardous chemicals and the effects to 
industrial workers.  However, over the past forty years, technological and scientific 
improvements, coupled with developing trade markets, have indicated the necessity to 
develop and evolve Community directives in accordance to a changing technological 
world.  In effect, the EU continues to work at maintaining a minimum standard of 
protection from hazardous substances to man as well as to the environment.   
 
The EU recognized the need to control dangerous chemical substances through a system 
of risk assessment, following the discovery of DDT.  In the late 1980’s there were 
inconsistencies in regulatory agreements between Member States, creating trade 
obstacles.  In the effort to relieve these inconsistencies, an attempt was made to create 
trade uniformity among Members, while increasing the level of environmental protection.  
The EU was aware that existing substances posed a substantial threat to human health and 
 
24 http://europa.eu.int/comm/enterprise/ chemicals/legislation/dangerous/ directive_en.htm 
25 http://europa.eu.int/comm/enterprise/ chemicals/legislation/dangerous/directive_en.htm 
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the environment until they had been tested, risk assessed and approved; nevertheless it 
was not until 1993 that a council regulation was adopted.  
 
The Council Regulation on Evaluation of Existing Substances (ESR) 793/93/EEC aims at 
evaluating and controlling those substances not covered by the sixth amendment from 
1979.  More importantly, the identification of risks associated with existing chemicals 
and those of HPV (more than 1,000 tonnes per year), is to be recognized, calling for more 
awareness of chemical information.  By means of the sixth amendment, existing data for 
particular properties and uses of EINECS substances as well as manufacturer information 
will have to be provided in order to have the products placed on the market (EU Directive 
793/93; Lind, 2004:54).  Substances produced in lesser volumes, such as 10-1,000 tonnes 
only the name, quantity produced, classification and foreseeable uses were obligatory.  
According to the UK’s Department of Environment, Food and Rural Affairs (DEFRA), 
the four key steps outlined to reach an effective regulation of existing chemicals are; data 
collection, priority setting, risk assessment and risk reduction.  These steps used by 
DEFRA are the same ones adopted by EEC.  
 
Existing Chemicals Regulation 793/93/EEC: Four Step Programme 
• Data Collection: Depending on whether companies import or produce existing 
substances in quantities between 10 and 100 tonnes per year, they are required to 
provide data sets on those substances. Such data has to be updated at least once 
every three years.   
 
• Priority Setting: The European Commission draws up lists, in consultation with 
Member States of priority substances that require immediate attention.  The data 
provided by companies is put to use in priority setting.  
 
• Risk Assessment: Chemicals that have been priority listed will be subjected to a 
scientific assessment of the risks they pose to human health and the environment. 
Member States are responsible for up reports on risk assessments. 
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• Risk Reduction: In the light of a chemical's risk assessment, risk reduction 
measures may be needed in addition to any that might already be in place. If so, a 
draft strategy is developed by the Member State responsible for the risk 
assessment, to be agreed by all Member States (Defra26).     
 
Working toward the goals set forth in this directive, the Existing Chemicals Work Area, 
through the European Chemical Bureau’s Institute for Health and Consumer Protection, 
provide scientific and technical support to the EU Department of Environment and 
Member State authorities.  Their work consists of implementing the programme of risk 
assessment and aim to align their activities with the strategy for implementing an 
environmentally sound management of toxic chemicals.27 Internationally, they are 
responsible for scientific and technical inputs to the OECD existing chemicals 
programme and several United Nations (UN) initiatives on chemicals.28
 
Progressing with the awareness of chemical risk and the need for evaluation and 
assessment, European Union community directives and agendas place importance on risk 
assessment and implementation.  Directive 93/67/EEC improves on the directive from 
1967, by providing the principles for assessment of risks associated to humans and the 
environment.  With respect to risks, the assessment should be based on a comparison of 
adverse effects to humans, with the reasonably foreseeable exposure of man and the 
environment to the substance.  In addition, measurement of risks should take into account 
physico-chemical and toxicological properties of a substance and the environmental 
effects of a substance.  The directive relies on evaluating and assessing new substances, 
with the results being the chief foundation of community decisions under appropriate 
legislation; reducing the risks arising from the placing of substances on the market, again 
without affecting the functioning of the internal market (EU Directive, 93/67/EEC).  If 
through risk assessment, evidence is found that the substance is suspected to cause harm 
or is of concern, to humans and the environment, the appropriate authorities may require 
 
26 http://www.defra.gov.uk/environment/chemicals/eucurrent.htm 
27Outlined in Ch. 19 of Agenda 21 adopted at UN Conference on Enviro.& Development in 1992. 
28 http://ecb.jrc.it/existing-chemicals/
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more information on the substance’s intrinsic hazardous properties, relating to Article 16 
in the principal directive 67/548/EEC. 
 
Where do we go from here? 
A main objective of the directives had been the elimination and reduction of trade 
barriers, as chemicals were a “commodity before they were potential problems, and 
therefore national regulations followed attempts to mitigate possible trade barriers posed 
by national regulations” (Løkke, 2004).  However, the protection of human health and the 
environment continued to be a challenge.  Particular concern was given to those 
chemicals with no data or testing; the 95 percent of existing chemicals in production in 
the EU today (Lind, 2004: 55).  Of the 100,000 chemicals registered, approximately 
30,000 to 70,000 chemicals are produced currently, whilst among the new substances, 
approximately 3,700 have been registered.  Thus innovation and development of safe and 
non-toxic chemicals has been somewhat limited, due to operational inconsistencies.  
What is needed is a chemical legislation that harmonizes the imbalance between 
knowledge about the existing and new chemicals in the EU. 
 
Creating Change 
Representatives from Austria, Denmark, Finland, Sweden and The Netherlands, 
recognized the necessity to create a structured and comprehensive chemicals policy (see 
box 7).  The conclusions from the March 1998 meeting contributed to a Council meeting 
one month later, where some of the unresolved problems were noted to be extensions 
from the original directive on classification and labelling from 1967.  Important 
discussion topics included: continuing to protect human health and environment and 
inclusion of endocrine disrupting chemicals.  Within this assembly Lind (2004:56) 
indicates the significant components established by the Ministers of the represented 
countries: 
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• Operational goals should be adopted in accordance with the Esbjerg Declaration 
(see box 7). 
 
• Responsibility of different stakeholders needed to be clarified and the ‘burden of 
proof’ that a substance is harmless needed to lie with producers and/or importers 
 
• General guidelines on precaution, substitution, minimization and safe 
management of chemicals introduced 
 
• Substances that are persistent, bioaccumulative or have toxic effects should not be 
in products 
 
• Precautionary Principle should be used 
 
• Costs of risk assessment should be accepted by industry and not community, such 
as it is now 
 
The document created by the Ministers was accepted after it was produced at an 
unofficial Council meeting held in Chester, UK, and was proposed to be used as a 
framework directive.  Lack of progress of risk assessment for the 110 priority substances 
and an increasing concern for endocrine disruption continued with no clear results (Lind, 
2004:56) and the Council was obliged to act.  The Ministers concept could be used as a 
structural backbone to the new chemicals regulation, but the following principles had to 
be considered in the attempt to manage chemicals in a safer manner: 
 
• Protecting the environment and human health as integral part of Sustainable 
Development 
 
• Principles established by Rio Declaration and treaties of the EU 
 
• Economic and social benefits of chemicals to society and quality of life 
 
• Importance of maintaining effective single market 
 
• Wide range of legal instruments associated with chemicals management 
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Box 7: Esbjerg Declaration 
 
North Sea Ministers convened in Esbjerg, Denmark in 1995 to discuss the conditions of 
the North Sea marine environment.  It was at this assembly that a strategy was created in 
attempt to prevent the pollution of the North Sea by hazardous substances.  The Ministers 
adopted several key objectives, for instance: 
 
   - Sustainable, sound and healthy ecosystem 
   -Guiding principle for achieving this objective is the Precautionary Principle 
   -Cessation target of ‘one generation’ (25 years) 
    -Naturally occurring concentrations to a background level 
    -Man-made synthetic substance concentrations close to zero 
    -Risk assessment is a tool for priority setting  
    -PBT reduction target to levels that do not harm humans – aiming at elimination 
 
The Esbjerg Declaration set realistic targets and goals, ones that were adopted in other 
regional and international conventions such as, OSPAR, Barcelona, Helsinki and the 
World Summit on Sustainable Development.  Similarly, the ideals behind this 
Declaration can be found within the objectives of the new EU chemicals strategy called 
REACH (to be discussed further in Chapter Four.  
 
Norwegian Ministry of Environment Website29  
 
Need for international cooperation on testing and assessment of chemicals.  It was 
decided that a review of the system as a whole was needed in addition to an inventory 
account of the legislative instruments dealing with chemicals, more specifically the 
regulation of existing chemicals (Lind, 2004:56).  The Council was to take great 
consideration to the document presented from the Esbjerg Declaration, as well as other 
suggestions from Member States, concluding in a brainstorming exercise to hear all 
stakeholders in an effort to amend or change the existing regulation system.  
 
The Commission recognized that the strategy on EDCs would be considered as simply a 
first step in further research of endocrine disruption, but furthermore, would form an 
integral part of the absolute strategy on hazardous substances.  
 
 
 
                                                 
29 http://odin.dep.no/md/nsc/declaration/022001-990243/dok-bn.html#1.MINISTERIAL
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Industry’s Passive Resistance 
In this section, we will discuss the role of industry in creating a regulation weighted 
mostly from a production perspective as well as exploring the initiatives of industry to 
create consumer consciousness. 
 
Industry began to sense a need for a fresh faced chemical industry, seen through the 
establishment and implementation of various voluntary programmes and measures 
devoted to research and development; continuing their efforts to increase public 
confidence in industry through partnership, accountability and transparency.  The 
International Council of Chemicals Associations (ICCA), the worldwide voice of the 
chemicals associations presented a framework for three new programmes in effort to 
enrich their teamwork with international authorities.  The agenda for industry was; the 
Screening Information Datasets (SIDS) programme for HPV chemicals, the Long-range  
Research Initiative and Responsible Care education programmes.  
 
The first of three initiatives aimed at establishing a priority lists of 1,000 HPV hazardous 
substances and speed up data collection and hazard assessment, this framework uses the 
same screening test methods that are used by the OECD in SIDS for examination of 
potential effect to human health and the environment; it is not a risk assessment. The 
programme for HPV is financed by industry.   
 
The Long-range Research Initiative programme was the second initiative and aimed at 
financing “research on the mechanisms via which chemicals impact on the environment 
and human health (Lind, 2004: 57).  This programme is specifically devoted to endocrine 
disrupters, exposure assessment, carcinogenesis, respiratory toxicity, immunotoxicity and 
allergies.  The website dedicated to research management also states that “further 
research” is being conducted in the following areas; environmental fate and effects of 
chemical substances, environmental and human exposure assessment and risk assessment 
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methodologies.30  One established and functioning operation created under the LRI 
initiative is the CREDO Cluster of Research for Endocrine Disrupting Chemicals.  
 
Lastly, the third initiative was to send industrial representatives to the International 
Labour Organization (ILO) focused on education on Responsible Care.  This programme 
was established by the chemical industry in 1985, and whose membership includes 
approximately 50 different industries from around the globe.  Members are responsible 
per country or region for implementation and enforcement of rules, principles and 
verification schemes.  Responsible Care does not have a lot of significance to the 
management of chemical risk and the long-term exposure of low doses, which this project 
covers.  The programme however, is still the largest of many voluntary initiatives and its 
impact to industry should be duly noted.  It was within these agendas that industry then 
contributed 4.5 million Euros to the continued development of programmes designated 
for research and responsibility to the risk management of chemicals.  
 
Beginning in 1999, industry was feeling pressure from the public to enhance 
transparency, has engaged in conversation with government, green groups, the 
Commission, consumer organizations, the scientific community and academia in an effort 
to increase a public consciousness and confidence in industry.31  Just months after a 
previous donation of 4.5 million Euros, industry made a large contribution to the LRI 
programme of 20 million Euros a year to focus on continued research and education of 
endocrine disrupters.32  One year later, in an attempt to create an alliance with the 
abovementioned groups, European industry issued a statement about the importance of 
delivering a high quality of life to EU citizens through the continued financial support 
from Member governments.  While maintaining the protection of the environment and 
human health, new regulation has to also ensure the competitiveness of the European 
chemical industry.  This new chemical regulation proposal (REACH) was introduced in 
2001 and industry was to maintain a prosperous future (Lind, 2004:58).  
 
 
30 www.cefic-lri.org/Templates/shwStory.asp?NID=34&HID=404 
31 www.cefic.org/Templates/shwStory.asp?NID=10&HID=55 
32 http://www.credocluster.info/docs/credobrochure.pdf 
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International Declarations 
The fact that EDCs and other hazardous substances do not obey political boundaries, 
makes it is necessary to explore the importance and their meaning for the proposed 
regulation of chemicals in the EU.  Declarations are non-binding obligations and 
aspirations of governments and movements.  They give the opportunity for state actors to 
affirm their commitment to common international goals, while using the declaration as a 
guiding document on decision-making.  The following brief introduction to two 
international instruments may be specifically applied to the EDC problematic: Rio 
Declaration (Agenda 21) and the World Summit.  These two international conferences are 
the two largest benchmarks and most recognized meetings on the environment concerned 
with precautionary approaches and sustainable development.      
 
Rio Declaration 
In 1992, United Nations held a Conference on Environment and Development (UNCED) 
in Rio de Janeiro, Brazil seeking to build upon the goals created at the Stockholm 
Convention in 1976.  The conference resulted in the creation of twenty-seven principles 
that outline steps toward increased environmental protection, while adhering to 
fundamentals of sustainable development and the promotion of the precautionary 
principle.  With respect to chemicals, the declaration outlines three principles devoted to 
the management of hazardous substances: principle 15 focuses on the precautionary 
principle (which is discussed later in the chapter) and principle 8 proceeds at looking at 
promoting patterns of sustainable production and consumption.   
 
An action plan was devised titled, Agenda 21, emphasizing sustainable development for 
the 21st century.  Agenda 21 notes that the “use of chemicals is essential to meet the 
social and economic goals of the world community” (UNESC, 2001) and recognizes that 
more needs to be done to adequately deal with the management of chemicals.  Within 
Agenda 21, there are two chapters that deal specifically with relevant information for the 
EDCs problematic.  Chapter 6 deals with the protection and promotion of human health, 
arguing that development and health are directly associated.  One specific area within, 
concentrates on health risks from environmental pollution and hazards with specific 
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attention paid to endocrine disrupting chemicals.  Introducing the below, create 
opportunities for further research on low-dosage chemicals, such as EDCs. By means of 
this one can,   
 develop and carry out interdisciplinary research on the combined  
 health effects of exposure to multiple environmental hazards, including 
 epidemiological investigations of long-term exposures to low levels  
 of pollutants and the use of biological markers capable of estimating 
 human exposures, adverse effects and susceptibility to environmental  
 agents.33  
 
Chapter 19 of the agenda develops the ideas of sound management of toxic chemicals.  
By achieving the goals of the agenda, further national and international awareness of 
those trans-boundary chemicals, such as persistent organic pollutants (POPs) and EDCs 
will strengthen efforts to solve these problems.  Relevant goals of Agenda 21 included:  
information sharing, harmonization of classification and labelling of dangerous 
substances, accelerated and detailed international assessment schemes, and prevention of 
illegal international transferring of dangerous substances, to name only a few.34
 
World Summit on Sustainable Development 
The Summit was held in Johannesburg, South Africa in 2002 and was an opening for the 
state actors to re-commit themselves to achieving the goal of sustainable development put 
forth in 1992 at the Rio Convention (see box 8).  Sustainable development is broadly 
defined as, ‘meeting the needs of today without compromising the needs of future 
generations,’ and the concept seeks to foster integrated economic, social and 
environmental development.  Noting this, one of the major outcomes of the Summit was 
communicating the dangers of hazardous substances, crucial to promoting and enhancing 
human health.  It was also an opportunity for objectives such as the Esbjerg Declarations’ 
generational goal (see box 7), to emerge.  For the coming generations, by the year 2020 
Lind (2004: 42) notes that chemicals should be, 
 
 
 
33 http://www.unep.org/Documents/Default.asp?DocumentID=52&ArticleID=54
34 http://www.unep.org/Documents/Default.asp? DocumentID=52&ArticleID=54 
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used and produced in ways that leads to the minimization of significant  
adverse effects on human health and then environment, using transparent  
science-based risk assessment procedures and risk management procedures,  
taking into account the precautionary approach, as set out in principle 15 of 
the Rio Declaration on Environment and Development. 
 
Although these instruments do not explicitly contain strategies to recognize the EDCs 
problematic, they acknowledge the general importance of conducting further research.  
With respect to REACH, the two principles of sustainable development and 
precautionary principle give the impression through solidarity that they are working 
together toward the same goal.   
 
Community Strategies: 
White Paper –for a future Chemicals Policy  
As earlier explored, the EU Directives placed importance of what Member States deemed 
necessary for protection of the environment, human health but also the single market.  
Suggestions from member states on safety, sustainability and precaution from 
declarations and conventions like from Esbjerg, Denmark, and the directives mentioned 
at the beginning of this chapter, ultimately led to the Community Strategy for a Future 
Chemicals Policy, the White Paper. 
 
Presented by the Commission in 2001, the White Paper’s main objectives are not new to 
the scene of chemicals regulation; the Esbjerg and Rio Convention had a similar basis of 
functioning.  However, the White Paper combines the ideals of Sustainable Development 
and the Precautionary Principle (see box 9) as major foundations.  The new proposal 
considers the need to protect human health and promote a non-toxic environment, while 
observing the need to maintain an efficient internal market and competitive industry.   
Some of the key elements of the proposed strategy (REACH) are: 
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• Protection of human health and promotion of a non-toxic environment 
• Maintenance and enhancement of the competitiveness of the EU chemical 
industry 
 
• Prevent fragmentation of the internal market 
• Increasing transparency 
• Integration with international aspects 
• Promotion of non-animal testing 
• Conformity with EU international obligations under the WTO 
 
Box 8: Sustainable Development 
Sustainable development has achieved prominence in international policy-making by way 
of the Brundtland Report in 1987.  It has maintained appeal with incorporation in Agenda 
21 from the Rio Declaration in 1992.  The common definition of sustainable development 
is the, “development that meets the needs of the present without compromising the ability 
of future generations to meet their own needs.35”  The ideals of sustainable development 
require meeting the needs of humans and increasing the quality of life now and in the 
future, and can be regarded as having economic, social and environmental dimensions 
(Ekins, 2003: 153).  Below is a list of fundamental ideas according to Jacobs (1999:25):  
• Environment-economy integration: the requirement in policy making to consider 
the economy and the environment together.  
 
• Futurity: the requirement in policy making to consider the impact of current 
activities on future generations. 
 
• Environmental protection: the requirement to reduce the depletion and 
degradation of environmental resources.  
 
• Equity: the requirement to seek social justice within and between generations. 
 
• Quality of life: the recognition that human quality of life is not a function just of   
economic growth. 
 
• Participation: the requirement that people are enabled to be involved in the 
decisions and processes, which affect their lives. 
 
Like the precautionary principle and endocrine disrupting chemicals, the definition can be 
highly contested, as there is much room for interpretation. 
 
                                                 
35 http://www.un.org/esa/sustdev/ 
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Box 9: The Precautionary Principle 
The precautionary principle has not one authoritative definition, leaving much room for 
critics to suggest their own versions.  Fundamental ideas of the principle place 
importance on stopping those substances that are persistent, toxic and liable to 
bioaccumulate at their source, such as EDCs.  Principle 15 of the Rio Declaration adheres 
to precaution and states that in order to protect the environment,  
 
 the precautionary approach shall be widely applied by States according 
 to their capabilities. Where there are threats of serious or irreversible  
 damage, lack of full  scientific certainty shall not be used as a reason  
 for postponing cost-effective measures to prevent environmental  
 degradation (Hanson, 2003). 
 
With respect to the EDC problematic, Hanson (2003) outlines that knowledge about a 
situation implies a particular response we might choose in regards to potential threats; 
distinguishing between risk, uncertainty and ignorance.  Under the conditions of ‘risk,’ 
Hanson (2003) notes that,  
 
 both the distribution of probabilities and possible outcomes are known. 
 Theoretically, decisions under these conditions would be ‘relatively 
 unprecautionary’ since one must have enough information to employ 
 more practicable guides to decision-making, such as risk-benefit analysis. 
 The precautionary principle applies, rather to the conditions of uncertainty  
  (when outcomes are known, but we cannot adequately predict them). 
        
Another core element of the precautionary principle is the concept of the burden of proof.   
Shifting this burden of proof can, in essence, be related to the threshold of evidence and 
threats of serious or irreversible damage or scientific uncertainty.  In the case of EDCs, a 
reversal in the burden of proof can be seen through REACH, which shifts the burden of 
proof from regulatory authorities to industry.  The precautionary principle has an 
underlying issue of willingness to act to “anticipate threats to human health and the 
environment in advance of scientific proof of harm and at the end of the day, to be 
precautionary is a political question” (Hanson, 2003:139). 
 
 
3.2 Hitherto Regulation of EDCs in the EU 
 
Community Strategy of Endocrine Disrupting Chemicals – 199936
It has been less than ten years since EDCs made its way into the regulation. The 
Commission along with a group of researchers first discussed the impacts of endocrine 
                                                 
36 Reference to the 2004 Community Strategy of EDCs will be subsequent the original discussion in order     
    to have a better contrast of the issues at hand.  
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disrupters on wildlife and humans in Weybridge, UK in 1996.  The international meeting 
addressed the possible influence of EDCs on wildlife and humans, and sought to identify 
knowledge gaps of the EDCs problematic and the relationship to adverse reproductive 
affects in humans (increase in testicular cancer and decrease in sperm quality).  From the 
concerns and conclusions presented at Weybridge, a proposal was drawn up and 
presented by the Commission on actions need to be taken to effectively counter the EDCs 
crisis. 
 
The first Strategy for Endocrine Disrupters was based on four key elements expressed in 
the 1999 Community Strategy for Endocrine Disrupters37 (listed below) and the 
establishment of short, medium and long term legislative actions and two basic objectives 
based on appropriate policy action (use of the precautionary principle).  The following is 
the recommended set of action:  
1. The need for further research 
2. The need for international co-ordination 
3. The need for communication to the public 
4. The need for policy action. 
 
Communication to the public was addressed as risks are often perceived differently by the 
general public than they are by the scientific community.  In this sense, transparency and 
participation would encourage greater public awareness.  Finally, the strategy called for 
greater policy action through more research and knowledge of EDCs, because the amount 
of scientific evidence for individual substances can vary greatly.  Therefore the key 
consideration was the use of the precautionary principle (EDC Strategy, 1999).   
 
Short, Medium and Long-term Action 
The initial short, medium and long term action goals listed in the 1999 strategy were 
adopted in compliance with the precautionary principle.  Each level of action should thus 
take into account consumer and human well being, environmental protection within an 
 
37 http://europa.eu.int/eur-lex/en/com/cnc/1999/com1999 0706en01.pdf
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international and national context (see box 10) all material referenced from the 
Community Strategy for Endocrine Disrupting Chemicals, 1999-2004). 
 
Box 10: Action Plan for Short, Medium and Long Term Goals 
Action Plan/Year 1999 2001 2004 
Short Term 
1-2 years 
 
-EDC priority list  
-Use of legislative   
  instruments 
-Monitoring program 
-Specific consumer use 
 indicating vulnerable  
 groups 
-Info exchange &    
  int’l co-ordination  
-Priority list  
 established 
-Monitoring, R&D   
 at an international     
 conference –  
 international  
 coordination 
-Finalized study on   
 Information   
 exchange on EDC 
-European  
 Environment and  
 Health Strategy –  
 working group on  
 integrated  
 monitoring 
Medium Term 
2-4 years 
-Identification and   
 assessment of EDCs 
-R&D 
-Identification of 
substitutions 
-Development of  
 agreed test methods 
-Call for research  
 proposals with  
 budget of 20m  
 Euros 
 
-Participation in   
 OECD EDC testing  
 & Assessment Task 
 Force 
-5th Comm.Strategy  
 Research and  
 Tech.  
 Development  
-Launch of CREDO 
Long Term 
4 years + 
-Legislative action by   
 either adaptation or  
 amendments to present 
 directives 
-Proposed revision  
 of general product  
 safety  
-Water policy 
-White paper 
-Data requirements  
 & principles of risk  
 for plant protection 
-Evaluation scheme  
 for biocidal  
 products 
-Other directives  
 with concerns other 
 than reproductive  
 health  
 
Short-term Action (1-2 years) 
 
• Establishing a priority list of substances for further evaluation of their role in 
endocrine disruption was a first step to review the existing regulations. 
Identified sources and pathways of exposure to humans and wildlife and cases of 
high concern or vulnerability of exposure (i.e. children). 
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• Using legislative instruments has been devoted to long-term goals however, 
Member States can participate by speed up risk assessments (as some substances 
may already be placed on priority lists under previous regulations). 
• In establishing monitoring programmes, the policy intends to expose the causal 
links that exist between effects and exposure to specific chemicals, including dose 
and timing of exposure and synergistic effects.   
• Identifying the specific cases of consumer use, such as children exposed to 
EDCs, will lead to independent scientific advice from CSTEE.  From these 
investigations the results will be made public to increase transparency and public 
confidence.  
• Through creating data-bases on risk assessment and European networks, comes an 
improvement of information exchange and international co-ordination.  This 
will also be seen through Community-based initiatives by ensuring a continual 
research regime of national governments, industry and other organizations that 
sponsor research.   
• Communicating information available to the public on the mechanisms, effects 
and uncertainties of the cause-and-effect relationships of EDCs, will be essential 
to public participation.  Important information on hazardous substances will be 
available to consumers from regulatory authorities. A relevant example can be 
seen with the regulation of phthalates (see box 11). 
• Consultation with stakeholders (Member States, industry and NGOs) in the 
form of regular consultation will occur to exchange views on existing scientific 
data and results, in addition to regulatory issues.  
 
Medium-term Action (2-4 years) 
 
• Test methods do exist, for example reproductive toxicity and carcinogenicity, and 
are considered to be insufficient in detecting all effects associated with endocrine 
disruption, and therefore, further identification and assessment of endocrine 
disrupters needs to be conducted using new test methods. Particular attention lies 
in human health.  
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Box 11: Regulation of Phthalates in the European Union 
             22nd Amendment of Community Directive 76/769/EEC 
 
The EU Commission established for the 22nd time an amendment to Directive 
76/769/EEC, regarding the use of phthalates of serious concern for the health of children.  
Scientific Commission on Toxicology and Ecotoxicology and then Environment 
(CSTEE) reviewed the risks posed by phthalates, such as DEHP, and established 
migration limits in soft PVC toys.  CSTEE also found that the testing methods developed 
have not been sufficiently good for regulatory purposes, meaning an approach based on 
migratory limits is currently not possible.  
The proposal adopts the approach of a ban and stipulates that certain phthalates may not 
be used in toys and child care articles intended to be put in the mouth by children under 
the age of three.  The ban restricts placement of these products on the market if they 
contain phthalates.   
One objective of the proposal is to introduce harmonized provisions with regard to 
phthalates in toys and child care articles and thus preserving the internal market.  Costs 
are expected to be limited as industry has adapted to his situation and most of the 
products in question no longer contain DEHP and other phthalates.  The benefit of the 
proposal is protecting the health of children, but also providing harmonized provisions 
throughout the Community and establishing a common market in this field.   
 
Warnings to be exhibited on packaging will read the following:  
 
“Warning – do not put in mouth for extended periods  
as could release phthalates dangerous to child health.” 
  
On the childcare article: 
 
 “Not to be kept in the mouth.” 
 
 
EU Commission Proposal for the 22nd amendment of Directive 76/769/EEC 
Brussels, Belgium.  1999/0238 (COD) 
 
• Again, further research and development is needed in mechanisms of EDCs in 
order to establish links between exposure to substances and adverse effects in 
humans and wildlife. Efforts need to be strengthened by the Community’s Fifth 
Framework Programme on R&D 
 
• Testing for identification of substitutes is important in that it must be assured 
that possible substitutes are retested (which often has not been the case). With 
respect to EDCs and this project, the substitute may turn out to be like paraben, 
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where a (preservative) substitute, it is just as, if not more harmful that the 
substance it replaces.  
 
Long-term Action (4 years+) 
 
• Finally, legislative action will be significant in creating a regulation for endocrine 
disrupters.  Directives will be re-examined and altered to contain specific 
accounts of EDCs (67/548/EEC and EEC/793/93 specifically) and regulatory 
adaptations.  Risk management instruments will also be considered.  
 
Community Strategy for Endocrine Disrupting Chemicals- 2001 and 2004 
One noteworthy accomplishment of the short-term actions since the development of the 
EDC strategy has been the creation of a priority list (see figure 5) for listing of priority 
substances), identifying 553 man-made substances and 9 synthetic/natural hormones.  
Based on this progress, in addition to stakeholder consultation and opinion from CSTEE, 
two additional studies were carried out.  The first study is an in-depth evaluation of nine 
candidate substances, which are neither restricted nor being addressed under existing 
Community legislation. This concludes that the study had proven that estrogenic EDCs 
evidently all caused adverse effects on the reproduction and development of fish (EU 
Comm, 2004).   
 
A second study addressed the remaining 435 priority substances, which were said to have 
insufficient data to assess endocrine disruption or the potential for endocrine disruption.  
The aim was to gather data and information on persistence, production volumes and legal 
status of these substances (EU Comm., 2004:5).  From this list, 147 substances were 
known to have evidence of endocrine disruption or potential endocrine disruption.  
Existing regulation covered 129 substances (may or may not be linked to endocrine 
disruption) and the remaining 18 substances are neither restricted or being addressed.   
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HPV and/or 
persistent and/or 
exposure expected 
Not HPV and 
(not 
persistent 
and/or 
exposure 
expected) 
Mixtures 
and/or 
polymers, 
double inputs 
and group 
names 
204 
Substances 
with evidence 
of ED or 
evidence of 
potential ED 
either 
regulated or 
under review 
in existing 
legislation 
Substances 
with evidence 
of ED or 
evidence of 
potential ED 
and not 
restricted or 
not being 
addressed in 
existing 
Community 
legislations 
172 59 
Evidence of ED  Evidence of 
potential ED  
No scientific 
basis (19) or 
insufficient 
data for 
inclusion in 
list (38)  
94 
(Exposure 
concern: high 84 
53 
109 
medium 5 
9 low 4) 
57 
HPV: High Production Volume 
ED: Endocrine Disruption 
 
 
Addressed in existing 
Community legislation  
129 
Not addressed in existing 
Community legislation 
18 
HPV and/or highly persistent with 
evidence (66) of potential ED 
(52) 
118 
435 substances 
Substances in 
‘universe’ 
minus 564 
Candidate list of 
553 substances 
Figure 5: Priority list of substances for further evaluation  
Source: EU Community Strategy for EDCs, 2004 
                  
 
In the community strategy for both 2001 and 2004 there is no mention of the medium 
term goal from 1999 for identification of potential substitutes.  This omission in the 
follow up strategies on EDCs is an indication that substitution has become a lower 
priority.  This is evident from the lenient way substitution is contemplated in the REACH 
proposal. 
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Regarding the Long Term Actions, though they mention the existence of REACH, there 
is no coherent link between the Community Strategy on EDCs and REACH. This 
disconnect was noted by Pia Juul Nielsen from the Danish EPA.  During the interview 
she noted that “it is difficult to see how the strategies for EDCs work in REACH, as it 
does not have a great connection with the proposal.” 
 
REACH covers endocrine disrupters by the authorization procedure for ‘substances of 
very high concern.’  However, in the community strategies, EDCs have been examined as 
a group, which differs from their treatment within REACH.  In our conception it is easier 
to draw conclusions on EDCs as a group, rather than on treating them on a case-by-case 
basis (as the latter approach requires much expertise).  
 
In our interview with Sidsel Dyekjær from the Danish Ecological Council (at the time of 
this project she was working with the Nordic Council of Ministers), she confirmed our 
conception of the benefits of handling EDCs as a group, stating that the treatment of 
EDCs as case-by-case basis is “never optimal” (interview).  Dyekjaer noted that treating 
EDCs as a group could result in these “substances to be substituted or banned.”   
 
Similarly, Mette Boye from the Danish Consumers’ Council in another interview agreed 
that the handling of EDCs on a case-by-case basis is not the optimal approach.  Boye 
argued that, “when it comes to EDCs, if we are going to look at one substance, we do not 
have enough scientific knowledge,” and she recommended using them as a group, as 
more knowledge could be obtained if it was political issue” (interview).  Her 
recommendation matches our conception of the challenge in handling EDCs.  
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4 Analysis of REACH 
This chapter outlines the features of REACH in general, including the letters of REACH, 
a discussion of the antagonists, and the protagonists.  It attempts to situate the proposal in 
relation to the different stakeholders.  The emphasis is on how endocrine disrupters are to 
be managed under REACH and if the proposal is likely to include them in a satisfactory 
manner (Authorization and the CMR problematic).  Since the focus of this project is on 
the effects of EDCs on human reproduction it is important to note changes in the 
treatment of EDCs under the current REACH proposal, as opposed to the status quo.  The 
following will introduce the “Letters of REACH,” general aspects of REACH, and lastly 
outline how EDCs that affect reproduction are treated under the proposal. 
 
4.1 What is REACH? 
REACH stands for the Regulation, Evaluation and Authorization of Chemicals.  It is the 
European Union’s proposal for the future regulation of chemicals, beginning with an 11-
year registration phase.  Since the first EU Council Directive on chemicals in 1967 
(Council Directive 67/548/EEC), the legislative development has resulted in 40 directives 
that interlink, supplement and at times contradict each other.  REACH is supposed to 
“simplify the regulation of chemicals in the EU by merging these 40 directives into 
one.”38  The first chemicals to be phased out or substituted will be the High Production 
Volume (HPV) chemicals, along with identified carcinogens, mutagens and reproductive 
toxicants (CMR).39  The EU hopes that the legal framework of REACH will address 
problems that the previous regulation of chemicals has been unable to.  
 
The main problems include the lack of information about many chemicals, the lack of 
incentives with regard to substitution and/or innovation and labeling.  Finally, in terms of 
cause and effect relations, the lack of endpoints of EDCs is problematic.  
 
 
38 “Proposal Incorporates Classification System Into European Regulatory Plan for Chemicals”, Chemical 
Regulation Daily, march 10, 2004, internet 
39 www.publications.parliament.uk/pa/cm200304/cmselect/cmsctech/172/172.pdf 
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REACH has been the focus of much debate and is highly contested by its advocates and 
antagonists.  The first draft of REACH was ambitious in that there were clear rules and 
responsibilities placed to facilitate the phase-out of highly toxic chemicals. The greatest 
resistance to REACH, and in particular its earlier version, comes from the United States 
of America (USA). The resistance comes from the highest authoritative levels on the 
issue of chemicals: the American Chemical Council (ACC), Synthetic Organic Chemical 
Manufacturers Association (SOCMA), and the US government (the USG “non-paper” 
and Colin Powell).  All of these parties contested the initial (ambitious) REACH on the 
grounds that it would be unworkable, adversely affect the US chemical industry, violate 
World Trade Organization (WTO) rules, hamper innovation and disrupt world markets.40   
REACH has since been modified due to pressure from the US and industry. 
  
On the importance of chemicals for everyday life 
Any given chemical has properties and functions for which reasons it is produced. 
Though the chemicals industry accounts only for 2.6 percent of the EU GDP, chemicals 
are used throughout the production chains of, for example, the textile and electronics 
industries (www.cefic.org). This means that any changes in the movement of chemicals 
(chemicals regulation), whether positive or negative, will manifest themselves throughout 
the chain of production and have far-reaching economic impacts. Therefore, the battle for 
or against REACH is one of “high politics.” 
 
Specification of REACH elements 
REACH will cover chemicals that are marketed in quantities more than one tonne a year.  
• Chemicals manufactured in quantities of more than one tonne per year must be 
Registered.  
 
• Those that are manufactured in quantities greater than 100 tonnes a year must be 
Evaluated.  
 
• Chemicals of special concern must be Authorized. 
 
40 For a description of US agency measures taken to water-down REACH, see ACC, “The REACH System 
and Its Political Objectives” (SOCMA) and “The Chemical Industry, the Bush Administration, and 
European Efforts to Regulate Chemicals (US House of Representatives, Special Investigations Divisions) 
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4.2 Why REACH? 
The REACH proposal must be seen in relation to past regulation regimes, which have 
created entrenched interests seeking influence on how chemicals are regulated. Chemicals 
regulation involves such paramount distributional issues that peddling for influence 
should be assumed, both ‘on and off stage.’  While some interests are old and established, 
others are relatively new, such as NGOs or consumer organizations.  To answer the 
question of ‘Why REACH?’ some knowledge of the actors involved is necessary.  
Depending on who answers this question, the answers will vary greatly.  
 
In the official EU canon, REACH is about the safety of the EU population from short- 
and long-term exposure to dangerous chemicals, but it is also about the long-term 
competitiveness of the European chemicals industry.  The EU considers that a 
competitive edge could result through offering “safer products.”  Keeping in mind that 
many industries use chemicals as part of their products, it is assumed that these 
“downstream” users/producers would also benefit through the knowledge or use of a 
“safer product” label. 
 
Who are the advocates and antagonist of REACH?  
The proponents of a more ambitious REACH program include NGOs, such as World 
Wildlife Fund for Nature (WWF), Greenpeace and Friends of the Earth,41 on the grounds 
that chemicals are affecting human health adversely.  The way of thinking for these 
groups is; since science will not give definite answers in the foreseeable future, current 
evidence must be enough to indicate that an effective chemicals regulation, such as 
REACH, is vital and pressing.  This general point, on the shortcomings of current science 
with regards to knowledge about chemicals was voiced by the UK Royal Commission on 
Environmental pollution: 
 
 
 
                                                 
41 “Overreach: Are Swedes and NGOs Dictating Europe’s Chemicals Regulation?”, Economist  
(US print edition), July 17th 2003. 
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 Given the inherent uncertainties about the way chemicals interact with 
 the environment, it makes sense to assume that the continuing use of large  
 numbers of synthetic chemicals will lead to serious effects, which we  
 cannot predict on the basis of our current or foreseeable understanding 
 of these processes (Royal Comm. on Environ. Pollution, 2003:163). 
                                      
While the above statement is about the effects of chemicals on the environment, it would 
be futile to argue that “serious effects” on the environment would leave humans 
unaffected. Implicitly, then, the Royal Commissions call is for a precautionary approach 
to regulation.  
 
The shortcomings of the application of science and knowledge about chemicals are 
definitely a shared concern for the advocates of an ambitious REACH.  If the science will 
not provide the evidence in time, a precautionary approach (an ambitious REACH) is 
warranted.   Advocates of an ambitious REACH, stress that the chemical industry should 
be pressured to phase out the most dangerous chemicals (substitution), such as PBT and 
‘substances of very high concern’ for example, by giving time-limited authorizations to 
chemicals that have to be phased out.  The aim is, of course, to encourage the chemicals 
industry to innovate and/substitute, so that human exposure to hazardous substances is 
kept to a minimum.  
 
Antagonists of an ambitious REACH 
The antagonists include the European chemicals industry for obvious reasons, as they 
would have to bear the brunt of the costs of substitution and/or innovation.  The concern 
of industry is that European competitiveness could suffer as European products 
potentially become more expensive due to screening costs and more expensive 
substitution.  There are those that believe that the chemicals industry is working hard to 
counter new regulation regimes, but their role is most often behind the scenes.  
 
One article in Politiken, (Rothenborg, 2004:6) describes how the powerful German 
chemicals union and CEOs from the industrial town of BASF were able to use their 
political clout through a few phone calls.  German chemical workers were up in arms 
when their association indicated a possible implementation cost of REACH amounting to 
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1000 billion DKK and two million jobs until 2020.  The resulting pressure made German 
Chancellor Gerhard Schroeder contact Tony Blair of Britain and Jacques Chirac of 
France.  Subsequently, in September 2003 these thee heads of state came out with a joint 
statement to the European Commission asking the Commission to secure that the 
chemicals industry was not “unnecessarily burdened,” since the EU had ambitions to 
become the most competitive region in the world.  The Commission gave in and removed 
thousands of substances that were to be stringently registered and screened (Rothenborg, 
2004:6).  
 
Across the Atlantic, the ACC and SOCMA, the two major chemicals associations along 
with government departments (Trade Representative, specify) various politicians (such as 
Colin Powell) have been doing what they could to work against REACH.  While it is hard 
to quantify the influence this pressure has had, there is little doubt that the pressure to 
dilute REACH was coordinated, significant and successful. 
 
4.3 The “Letters” of REACH 
Registration  
In 1930 the global production of organic chemicals was a mere 1 million tonnes, whereas 
it is now 400 million tonnes a year (www.norden.org).  The increase in the use of 
chemicals has been a near-exponential development.  Despite this, there are still no legal 
obligations for the producers and importers to provide information about many 
chemicals.  No data is currently required for “existing substances.”  As mentioned in 
chapter 3, these are substances that were traded before 1981. “New substances” are those 
that came after 1981.  In terms of the regulation of chemicals after 1981, “existing 
substances” were exempted from having to come with basic data about possible 
environmental and human health effects.  There is currently registration, but since 
“existing substances” occupy 99 percent of the market (www.norden.org),  in most cases 
this is a procedural measure, meaning that in many cases very little is known about the 
substance, but that it will qualify for use anyway.  
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It is expected that REACH should result in many substances being registered, that is, all 
chemicals produced above 1 tonne per year, which is approximately 30 000 substances. 
Chemical producers and importers will have to provide safety data by fixed deadlines, 
though the deadlines will differ from country to country, depending on their regulation 
system(s).  The information shall be collected into a central database, a European 
Chemical Agency, which will be placed in Helsinki, Finland. 
 
Evaluation 
 
Evaluation is for higher volume chemicals, which will be evaluated by experts from 
Member States in cooperation with an EU “central coordinating body” (WWF/EEA, 
2003:5).  The evaluation may warrant authorization, if there is no suitable substitute: it 
could be prohibitively expensive due to the costs of screening of the substance.  
Evaluation could result in risk reduction: meaning, uses of the chemical is allowed, but 
under strict adherence to procedure.  When it comes to the evaluation of chemicals of 
very high concern- meaning chemicals suspected of having very adverse effects, but 
where strong/conclusive evidence has not yet been produced – it may lead to 
authorisation. 
 
Regulatory action may exacerbate a problem due to imperfect information, i.e. a lack of 
knowledge about chemical effects or mechanisms, which paradoxically can leave the 
“best” regulatory action to as, no further regulatory action.  That is, best, because a 
withdrawal or substitution may prove itself to be more costly than its immediate benefits. 
One example could be if a substitution proves very costly in monetary terms, then the risk 
is acceptable according to regulatory authorities.  The issue for many consumers and 
green groups here is the disagreement about what costs are and what benefits are. 
Ultimately, the issue is about how much chemical exposure is “acceptable” for a certain 
amount of money – and who sets the limits and/or conduct the evaluations, which are 
ultimately political in nature.  These issues will be treated in chapter five and six.  
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Authorization 
 
REACH will identify extremely hazardous chemicals as “substances of very high 
concern,” which will require special licenses for their continued use.  Such a licence will 
be termed an “Authorization.”  The authorization procedure can be an effective tool to 
phase out very hazardous chemicals, if the rules are consistent and enforced.  However, 
REACH has been greatly criticized from green groups and consumer groups, including 
the BEUC, for containing legal loopholes, which may nullify the positive changes that the 
chemical reform was envisioned to result in.  
 
The basis of such criticism is founded on the fact that authorizations in the current 
proposal are not time-limited and that therefore there is little incentive for active research 
into substitution.  Danish Consumer Council advisor, Mette Boye, acknowledged that 
authorization could be interpreted as “potentially a huge loophole.”  Many chemicals will 
be authorized in practice if the users can demonstrate “adequate control” or socio-
economic benefits that outweigh risks.  This obviates a fluid border between economic 
and social concerns.  As shall be addressed in the discussions, often times it is the 
economic considerations that ultimately bear the most weight among regulators and 
politicians.  
 
Benefits of REACH  
 
Though REACH is introduced to the public as a proposal for advancing human health, its 
main impacts or benefits will be environmental as the focus on the release of substances 
that are produced over one ton and not which substances that humans are in contact with 
the most (substances in food and in house dust). 
 
In the long-term it is generally expected that the phasing out of hazardous substances will 
save lives through a reduction in cancers and other diseases caused by exposure to 
hazardous substances (Commission, 2003:11).  In monetary terms, the EU would save 
money over many years through saved health care costs on a societal level.  The 
Commission estimates that the proposal will cost the chemical industry 2.3 billion euros 
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over 11 years (Commission, 2003).  There are great disagreements on what REACH will 
cost and who should pay them, but the initial impact assessments conducted by industry 
have been revealed as huge exaggerations by economists.  Overall, there is widespread 
disagreement on what should be expected in terms of market reactions, parties affected 
and how, and what actual benefits will accrue from the proposal.  
 
Substitution 
 It is believed that there are now around 30 000 existing chemicals 
 being sold in volumes greater than 1 ton per annum, with 10 000  
 being sold in volumes greater than 10 ton… REACH is expected  
 to result in some withdrawal. The predicted degree of product with- 
 drawal is not known, but the Commission has quoted estimates of  
 8-12 percent withdrawal of chemicals from production or use… 
        (WWF, 2003:10)   
 
We argue that substitution is likely not to happen on the scale that the Commission 
foresees it and that provisions in the REACH proposal (mainly the loose criteria for 
authorization) without binding clauses will result in largely the same as happened after 
1981, where existing substances (in a sense, the “authorized” substances) were effectively 
out of reach of regulation measures.   
 
Labeling 
Although people are exposed to a wide range of chemicals on a daily basis, a concrete 
fear of human over-exposure is a relatively new concern.  Publicly accessible information 
about chemicals is becoming an issue the public is concerned about, as more people are 
finding out where they are exposed to e.g. EDCs in their everyday lives.42  Proper 
labeling can be an effective way of informing consumers of the potential risks associated 
with using products.  When it comes to consumer groups, more specifically BEUC, they 
bemoan the fact that REACH in its current form does not prioritize consumer issues, but 
instead focus on the treatment of industrial chemicals that are released in large volumes.  
Labeling consumer products has become a major issue as it has become publicly known 
 
42 Human exposure to EDCs include (1) ingestion, through the food stuff such as vegetables, (2) inhalation, 
there are hypotheses that EDCs may interact with e.g. smog (verify, change), and (3) dermal, through the 
use of various creams and make-up. 
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that most chemicals move through the production chain with little safety data attached to 
the order.   
 Public lack of confidence is founded on the reality that the chemical 
 industry has been poorly regulated. For example, it has been allowed 
 to continue selling chemicals for which there is no or very little  
 safety data, and it continues to produce chemicals that accumulate 
 in our bodies and those of wildlife, or which disrupt hormonal 
 systems (WWF/EEB, 2003:5).                                                   
 
 
Consumer organizations on REACH 
The REACH proposal will deal with industrial substances first and foremost.  The use of 
these substances in consumer products is only a secondary concern, which can be seen in 
that producers and importers must register substances used in consumer products if: 
• there is a chance the product can/will leak, 
• they are classified as hazardous, 
• used in more than one ton per producer/year 
 
All conditions must be fulfilled for hazardous substances in consumer products to 
become an official concern, which may result in the withdrawal of some consumer 
products.  Therefore, consumer organizations across Europe have criticized the criteria 
above as being too stringent to have any real effect in terms of improving public health 
(Danish Ecological Council, 2004:10).  In other words, many European consumer 
organizations believe that consumer interests (the safety of consumers) are not 
sufficiently protected in the current proposal. 
 
General problems with the implementation of REACH 
Why has a new regulation proposal been created in the first place?  The following points 
will size up the general problems of hitherto regulation, which will obviate problems that 
exists to this day.  The unresolved issues of the past will impact negatively on the 
implementation of REACH:  
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1. The results of a Danish EPA report (2001) showed that 44 percent of 47.000 
existing chemicals are classifiable as “hazardous.”43 
 
2. Of the new substances (2700), approximately 40 percent are hazardous, which 
with the above point suggests that the current assumption that only 3.5 to 5 
percent of existing substances are hazardous is likely a very optimistic view 
(norden.org).  
 
3. The European Chemicals Bureau (ECB) states that, “A base set of data is the 
minimum amount of data required to make a reasonable, informed judgment as to 
whether or not a chemical is likely to be dangerous.”  Their chart on substances 
produced in the largest volume, >1000 tons per year shows that in 21 percent of 
current cases there is “no data”, 65 percent have “data less than base set” and 
only 14 percent have data at the level of the base set (www.cefic.org).  Arguably, 
this is not an impressive basis of information. 
 
4. Further, the reader also knows at this point that “existing substances” that come 
with no environmental or health data account for roughly 99 percent of the 
market.  That obviates the fact that the chemicals industry has become used to 
utilizing mostly those chemicals, which have very little safety data attached. 
 
Previous regulation has been unable, in a timely fashion, to make chemical producers and 
importers provide adequate information about the chemicals they are putting on the 
market.  To regulate in any meaningful way, basic knowledge of the substances of 
concern is necessary.  This knowledge is not currently “in house,” i.e. the regulatory tools 
have fallen short of their purpose, which is the safe usage and handling of chemicals.  
Now to the question of whether REACH will address the mentioned problems of lack of 
basic knowledge, legal loopholes and the lacking enforcement provisions of additional 
data on substances: apparent anomalies in existing legislation have been preserved rather 
than removed, for instance, the substances to be included or excluded, for different 
reasons, at each stage of evaluation” (EESC, 2004:6). 
                                                                                                 
It is clear that the market in chemicals have some shortcomings when it comes to 
knowledge about basic properties of many substances.  The new proposal should address 
the issue of gaining more knowledge on a range of substances by merging new and old 
substances.  But how implementation will turn out is not clear.  There seems to be a lack 
 
43 wwww.mst.dk/udgiv/publications/2001/87-7944-694-9/html/helepubl_eng.htm 
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of consistency, for example when it comes to prioritization: if REACH is about the 
general safety of the EU population, then what is the rationale of focusing on substances 
that are above one ton, considering that consumers are mostly exposed to synthetic 
chemicals in food and in the home?  The European Social and Economic Committee are 
of the opinion that, “… in the absence of any proper study of the “failings” of the current 
system, it will remain difficult to propose any effective remedies” (EESC, 2004:13). 
 
4.4 REACH and EDCs 
REACH-ing out to the people: responding to public pressure 
Chemicals that have endocrine disrupting properties have been in use for a long time, but 
they have become a major public issue in recent years.  The main reason is that there is 
mounting evidence that endocrine disrupters are affecting humans. NGOs such as 
Greenpeace, Friends of the Earth and WWF have been the most vocal and visible in the 
critique of the chemical industry and the chemical regulation in general.  There has been 
a tendency of green and consumer groups to gain legitimacy in terms of their informative 
capacity and their authoritative moral weight, but they lack executive powers in terms of 
statewide policy action.  Regulatory authorities on the other hand have executive power 
to conduct chemical policy, but experience legitimacy problems in some cases. 
 
Public pressure on government policies regarding hazardous substances is mounting, and 
consumer organizations have gained a growing constituency as alarmist signals about i.e. 
the dangers posed by endocrine disrupters that affect reproduction are sporadically 
released from newspapers, NGOs and some authorities.  Consumer organizations have 
increasingly come to the fore as stakeholders in the development of chemicals regulation. 
To take an example, BEUC, the European consumers’ organization has conducted joint 
statements and investigations with EU institutions, such as the European Environmental 
Agency (EEA). 
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Head of Research in Copenhagen University Hospitals Department of Growth and 
Reproduction has a point on the issue endocrine disrupters that affect reproduction: 
 
Der er stor sandsynlighed for, at nogle af de effekter, stofferne  
dokumenteret har på dyr – også har en virkning på mennesker.  
Lad os finde ud af det inden prisen bliver for høj. Det gælder  
vores børn (Lade, 2005:6).  
 
Translation, 
 It is very likely that some of the effects, that animal studies 
 have confirmed – also have an effect on humans.  Let us find  
 out before the price gets too high. Our children are at stake. 
 
The advocates of an ambitious REACH bring an existential spin on the issue of endocrine 
disrupters; the spin being that what is at stake is the sustainability of human existence 
itself.  By implication that means (a) hazardous substances and specifically endocrine 
disrupters must be at the forefront of government priorities, (b) due to the irreversibility 
of effects and possibility of genetic damages, there is no “second attempt” at combating 
this problem.  Damages on the general health of society may have great socio-economic 
costs.  Head of Research in Copenhagen University Hospitals Department of Growth and 
Reproduction states: 
Reproduktionen er i fare. Seks procent af alle børn der fødes i dag, 
er skabt ved hjælp af kunstig befrugtning.  Testikelkræft og lav  
sædkvalitet er advarsler om, at noget er helt galt.  Det har indlysende, 
store menneskelige omkostninger, men også samfundsøkonomiske.  
Har vi råd til den udvikling? (Lade, 2005:6). 
 
Translation, 
 
Reproduction is in danger.  Six percent of all children that are born  
today, have been created with the assistance of artificial insemination.  
Testicular cancer and low sperm count are warnings, that something  
is completely wrong.  It has obvious, great human, but also socio- 
economic costs.  Can we afford this development? 
 
As is evident from the quotes, regulation of the release of EDCs that affect reproduction 
will be futile if authorities are awaiting ‘full’ understanding, simply because adverse 
human effects are likely manifest themselves before we have perfect knowledge of 
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precisely what caused them and how.  In addition the effects, which are delayed, will 
keep materializing themselves long after the release of endocrine disrupters has stopped, 
as is evident from the example of POPs.   
 
Several chemicals with ED properties are carcinogenic or toxic to  
reproduction or have properties warranting classification for chronic 
toxicity to humans according to the existing regulation. The  
European Commissions’ White Paper states that the majority of  
endocrine disrupting chemicals would have to undergo authorization.44  
                                                                                          
                                                                                                                
What is the problem within Authorization in REACH? 
The problem for green and consumer groups is that innovation or substitution is 
hampered due to a clause in the proposal that states that a producer may avoid using a 
known safer alternative if they can fulfill one of the following: (a) “adequate control” or 
(b) benefits outweigh risks (socio-economic considerations).  As shall be discussed, the 
criteria for both are ultimately political in nature as there are no universal benchmarks for 
either.  In addition, there are so-far no requirement of time-limited authorizations, which 
could have unfortunate effects in that public focus on substances of very high concern 
may dissipate, whereas time-limited authorizations would help keep these substances a 
public priority as well as de facto forcing the industry to innovate or find safer substitutes 
before the license runs out.  
 
Classification of EDCs 
The status of endocrine disrupters under REACH is as of yet somewhat undecided.  The 
final status, meaning inclusion or exclusion of this group of chemicals in the 
authorization system, will depend on their classification. Classification of endocrine 
disrupters has been a contentious issue due to the possible variability of effects.  The 
inability to define endocrine disrupters stems from the fact that scientists do not yet know 
the exact mechanisms that trigger endocrine disruption.  A definition of endocrine 
disrupters and their characteristics is crucial for their inclusion into REACH, since 
classification depends on a definition.  The trouble in other words, is to determine the 
 
44   www.norden.org 
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exact mechanisms of endocrine disruption in order that they can be classified and 
evaluated. 
 
CMR. What is it? How effective is it? 
CMR stands for carcinogens, mutagens or substances that are toxic to reproduction.  
These chemicals meet the criteria for classification as (i) carcinogenic category 1 or 2; (ii) 
mutagenic category 1 or 2 and; (iii) toxic for reproduction category 1 or 2 according to 
Directive 67/548/EEC.  The existing EU criteria for classification and labeling of 
substances toxic to reproduction is presented in box 12.  
 
CMR is one of the categories in REACH that have been singled out for “very high 
concern.”  Under the current REACH draft, only CMRs toxic to reproduction in category 
1 and 2 will be included.  Therefore, some EDCs will be missed, in terms of inclusion 
into the authorization process, as some chemicals (such as bisphenol A and nonylphenol) 
known to disrupt endocrine systems in mammals are classified as toxic to reproduction in 
category 3 (Nordic Council, 2004:82).  
 
A problem exists with identifying substances that are toxic to reproduction in category 3 
where some evidence exists, but not conclusive enough to include it into category 2.  The 
problem is that clear data for larger mammals are hard to come by and it is illegal and 
unethical to conduct tests on people.  The data from animals is problematic as the best 
data is found in the lower end of the animal scale.  As Peter Matthiessen, head of 
environmental chemistry and pollution at the UK’s Centre for Ecology and Hydrology 
says: 
We've got much better data towards the lower end of the animal scale than 
the upper end. To be sure you know what's happening you've really got to 
do an experiment in the lab to replicate the effect. You can do that with a 
shrimp or a fish, but not with a whale (National Geographic, 2004). 
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Box 12: CMR-Substances toxic to reproduction Categories 1-3  
 
Category 1: 
Substances known to impair fertility in humans 
There is sufficient evidence to establish a causal relationship between human exposure to 
the substance and impaired fertility. 
Substances known to cause developmental toxicity in humans 
There is sufficient evidence to establish a causal relationship between human exposure to 
the substance and subsequent developmental toxic effects in the progeny. 
 
Category 2 
Substances, which should be regarded as if they impair fertility in humans 
There is sufficient evidence to provide a strong presumption that human exposure to the 
substance may result in impaired fertility on the basis of: 
- clear evidence in animal studies of impaired fertility in the absence of toxic effects or 
evidence of impaired fertility occurring at around the same dose levels as other toxic 
effects but which is not a secondary non-specific consequence of other toxic effects. 
- Other relevant information. 
 
Substances which should be regarded as if they cause developmental toxicity to 
humans 
There is sufficient evidence to provide a strong presumption that human exposure to the 
substance may result in developmental toxicity, generally on the basis of: 
- Clear results in appropriate animal studies where effects have been observed in the 
absence of signs of marked maternal toxicity, or at around the same dose levels as other 
toxic effects but which are not a secondary non-specific consequence of the other toxic 
effects 
- Other relevant information. 
 
Category 3 
Substance which cause concern for human fertility 
Generally on the basis of:   
- Results in appropriate animal which provide sufficient evidence to cause strong 
suspicion impaired fertility in the absence of toxic effects, or evidence of impaired 
fertility occurring at around the same dose levels as other toxic effects, but where the 
evidence is insufficient to place the substance in category 2.  
- Other relevant information. 
 
Substances which cause concern for humans owing to possible developmental toxic 
effects, generally on the basis of: 
- Result in appropriate animal studies which provide sufficient evidence to cause a strong 
suspicion of developmental toxicity in the absence of signs of marked maternal toxicity, 
or at around the same dose levels as other toxic effects but which are not a secondary 
non-specific consequence of the other toxic effects, but where evidence is insufficient to 
place the substance in category 2.  
Nordic Council, 2004: 84                              
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The Paris-based SCOPE and the North Carolina-based IUPAC has issued a joint report 
that argues that endocrine disruption can be expected in all animals where hormones 
initiate physical changes, including humans (Miyamoto and Burger, Eds., 2003).  The 
issue then, when discussing the efficiency with which the CMR clauses will deal with 
endocrine disrupters is one of evidence.  What counts as evidence and what is enough 
evidence? 
 
In terms of implementation there is a definite problem in that the proposal lacks crucial 
binding clauses, so enforcement of its provisions could prove hard if legal loopholes 
remain.  Without crucial binding clauses and enforcement mechanisms, the reversal of 
the burden of proof (of proving substances are hazardous), i.e. that industry should 
regulate itself, is a worrying prospect.  When it comes specifically to endocrine 
disrupters, the authorization process, which most of them optimistically will have to 
undergo, stands in the way of effective substitution.  Therefore, our position on the 
REACH proposal as it stands, is that it does not deal effectively with curbing of the use 
of endocrine disrupters.  
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5 Assessment and Regulation: Risks and EDCs 
 
This chapter aims to analyze the relationship between risk assessment (RA) and risk 
management (RM) of EDCs, attempting to convey the concepts discussed in the first 
three chapters.  The chapter endeavours to contribute to a better comprehension of the 
applications of scientific data, by reviewing principal instruments used to assess the risks 
that EDCs may possess, and in what way the results from risk assessments are being used 
in the regulatory process.  
 
5.1 What is the relationship between risk assessment and risk management of       
EDCs with respect to human reproduction? 
In order to have a better understanding and a good answer for this question, it is 
important to comprehend the scientific definition of concepts like: risk, risk assessment, 
risk management, risk analysis, and risk communication.  Many publications45 give 
explanations of these terms, and there is also a wide variety of suggestions about their 
use.  Essentially risk assessment is a process for characterizing or estimating risk, 
whereas risk management is a process for weighing risk against other considerations e.g. 
social, economic, and legal (Hart ed., 2004).  “In simple terms, risk assessors ask, how 
risky is this situation?  And risk managers then ask, what are we willing to accept?” (Van 
Leeuwen and Hermens eds.,2001).   
 
Generally, one could say that the risk assessment most be the objective part of the 
process, whereas the risk management most represents the subjective element.  
Nevertheless, the nature of the risk management often has a great influence on the extent 
and deepness of the risk assessment.  “Although risk assessment is mainly a scientific 
task, political decisions are required on questions such as: what exactly are we trying to 
protect, and to what extend should it be protected? Endpoints, unacceptable effects, 
magnitude of uncertainty factor, are controversial topics and based on implicit political 
 
45 The final report of a European Workshop on the Interface between Risk Assessment and Risk 
Management (The Netherlands, 2003:64) presents some definitions of the concepts.  
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choices.  It must be made clear here that questions about risk often have no scientific 
answers” (Van Leeuwen and Hermens eds., 2001).  
 
Regarding the above-mentioned controversial topics, in recent developments of the 
European regulation, an agreement has been reached on a ‘functional separation’ in terms 
of risk assessment and risk management.  The reason for this is the need for ensuring that 
“…scientific assessment is independent and not influenced by outside interests, such as 
industrial sponsors, pressure groups, or by political considerations (Hart ed., 2004).  
Having a functional separation of the tasks ensures their ‘efficient interaction.’  
Therefore, the challenge is to develop an effective interface that accomplishes both 
independent and speedy risk assessment, resulting in efficient risk management of 
chemicals.  
 
The statements of Van Leeuwen and Hermens (2001), and Hart (2004) on the influence 
that risk management may have over the risk assessment bring us to an interesting 
discussion on the policy-science interface with regards to EDCs.  The suggestion of a 
“functional separation” is an expression of the fact that risk management can influence 
risk assessment.  Nevertheless, the converse can also be true.  A further discussion of this 
issue is presented later in this chapter. 
  
Risk analyses put together risk assessment, risk management, and risk communication, 
and in this way represent a larger process. As mentioned before, there are many 
controversies in the definition of the concepts, and on the specific duties that each of 
them represents. In spite of this, during a workshop in The Netherlands (2003), a 
simplified framework of the risk analysis process was outlined (see box 13). 
 
On one hand, the summary contributes to a large extent to the progress of the ‘functional 
separation’ concept, giving the opportunity of reconciliation between the terms, and the 
role of scientists and managers respectively. On the other hand, though the 
conceptualization was conceived looking at the regulations of food safety, the simplified 
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summary is applicable on a great variety of controversial topics, including the endocrine 
disruption phenomenon. 
 
Box 13: Simplified summary of the risk analysis process    
 
1. Problem definition. Managers consult with scientists and other stakeholders to define 
the risk management problem and identify the criteria that will influence the decision.  
 
2. Scientific assessment. Relevant specialists carry out technical assessments for some or 
all of those criteria, including the risk of adverse effects (risk assessment).  
 
3. Policy decision. Risk managers discuss the outcome of the assessments with scientists 
and other stakeholders and make decisions about what management action is appropriate. 
 
(Hart ed., 2004)
 
5.2 How does science assess the risk of EDCs exposure?  
In March 1999, the EU working group on endocrine disrupters of the Scientific 
Committee on Toxicity, Ecotoxicity and the Environment (CSTEE) released a report 
titled ‘Human and Wildlife Health Effects of Endocrine Disrupting Chemicals, with 
emphasis on Wildlife and on Ecotoxicology test methods.’  In the report, the committee 
gave emphasis to the lack of data that could establish a causative position of EDCs in 
diseases and abnormalities in human beings. Nevertheless, it was recognized that 
exposures to certain substances such as PCBs and PCDFs of pregnant women have an 
adverse effect in the physical and mental developments of the offspring. They also 
declared that there were indications that organochlorine compounds may effect neonatal 
neurological development.  A totally different picture was drawn when looking at the 
effects of EDCs on wildlife.  The report stated that there were well-documented links 
between adverse effects on reproduction and EDCs (CSTEE, 1999).  
 
After the CSTEE report, in December 1999, the Commission launched the Community 
Strategy for Endocrine Disrupters (described in chapter 3).  As a first point, the research 
on the issue was agreed to be of extreme significance.  By this means, the Commission 
agreed in the importance of financial support for research on the area in order to come up 
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with novel methods for testing, and more accurate results of the actual effects of 
substances under the suspicion to be endocrine disrupters.  
 
Contrary to the principles and reasons for a “functional separation” between risk 
assessment and risk management, the European Chemical Industry Council (CEFIC), 
since the appearance of the White Paper for the new chemical regulation in Europe 
(REACH), showed a great support for well performed risk assessment, claiming that the 
chemical regulation should be based on an extensive evaluation of risks.  CEFIC stated, 
“A simple suspicion that substances and groups of substances generate effects similar to 
those of CMR, PBT or vPvB substances should not be sufficient to include such 
substances in the authorization procedure” (CEFIC, 2004).  CEFIC was asking for testing 
programs; faster risk assessment processes, and not “simple” suspicions of the hazardous 
properties of substances, in order to include them in the authorization system.  CEFIC 
further asks for a regulation based on sustainable development, meaning a full socio-
economic analysis.  
 
Support of the scientific research 
As mentioned in chapter 3, CEFIC gave 20 million Euros to the European Union through 
their LRI initiative (a Long-range Research Initiative with special attention to endocrine 
disrupters).  CEFIC assigned the economic support to the development of more scientific 
research on the actual mechanisms of those substances suspected to have and endocrine 
adverse effect.  In 2003 the EU created a Cluster of Research into Endocrine Disruption 
in Europe (CREDO).  The Union designated 20 million Euros to the cluster to support the 
technical research on the matter.  CREDO was basically built to produce sound scientific 
data, and it consists of four projects, which together represent over 60 research 
laboratories in Europe.  The four projects have different tasks to develop with regards to  
the assessment of EDCs:  
 
• EDEN: while being the general coordinator of the cluster, EDEN principally 
works with finding novel endpoints, mixture effects, and low-dose exposure 
effects. 
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• COMPRENDO: focus on projects that look towards comparative approaches of 
androgenic/anti-androgenic compounds (AACs). 
 
 
• EURISKED: the project is focused mainly on risk assessment of selected EDCs 
(4-MBC, OMC, benzo-phenone, the fungicide procymidone and pesticide linuron) 
in different organs.  
 
• FIRE: looks primarily at brominated flame retardants (BFRs) and their effects on 
the health of humans and wildlife.  
 
 
With the four mentioned above programs, there are seven associated projects under the 
same sponsorship. These projects look at specific compounds (dioxin, food-derived 
EDCs, BPA, alkylphenols, adipate and phthalate esters) and their likely effects on 
specific wildlife or human health.  Essentially the main objective of making the cluster 
was to create a focus for endocrine disruption research in Europe and beyond, and by this 
means, creating an exchange of know-how regarding the assessment of EDCs and to set 
up research collaborations across the borders of individual associations.  In order to 
provide the setting of the international collaboration, CREDO has as an important task in 
organizing four thematic workshops.  In an effort to communicate to the public, CREDO 
constructed an informative website,46 and is publishing a periodical newsletter. 
 
Integrated Risk Assessment (IRA) 
One of the main activities of CREDO was the organization of thematic workshops.  The 
first of them was on risk assessment of endocrine disrupters, and was held on April 2004 
(Wutke, 2004).  During the workshop a relatively new (2001) conceptualization of risk 
assessment was reintroduce for implementation: The Integrated Risk Assessment (IRA).  
IRA is “a science-based approach that combines the processes of risk estimation for 
humans, biota, and natural resources in one assessment” and is described by the WHO 
(IPCS, 2004) as: 
 
 
 
 
46 www.credocluster.org
 93
European Union Regulation of Endocrine Disrupting Chemicals 
That Affect Reproduction: From Rachel to REACH 
 
Assessment of risks to human and non-human receptors from chemical,  
physical and biological agents.  It includes assessments that predict the  
effects of proposed actions and those that estimate the ongoing effects  
of past actions at particular places and assessment of risks from hazardous  
agents independent of location.  Finally, integration extends across all 
phases of the assessment process form the planning of the assessment 
to decision making. 
 
The model was developed by IPCS, USEPA, WHO, and the OECD, and evaluated at an 
international workshop held in Ispra, Italy in April 2001.  According to the conclusions 
reached during the development of the workshop, IRA could lead to enhanced scientific 
understanding that facilitates high quality regulatory decisions.  IRA is seen as a decision 
tool for environmental policy and regulation (UNEP, et al., 2001). 
 
The relevance of concepts like IRA lies on the independency that exists between 
environmental risk assessments and the evaluation of the risks for human health. This 
independency of one another has created structural barriers, which limit the possibilities 
for sharing and cross reading data (Bridges et al., 2004).  It has been mentioned that with 
the implementation of REACH there will be a need for human and ecological health risk 
assessments for between 20,000 and 40,000 existing chemicals over the next decade (EU, 
2003a, 2003b).  Noting this, there is a huge doubt about that this demand will be covered 
using the current methods for assessing risk and its validation (Bridges, 2004). In 
summary, the approach of IRA is aiming at fostering integration of assessment methods 
to evaluate human health and ecological risks (IPCS, 2004). 
 
IRA and EDCs 
In his article titled “Integrated Risk Assessment and Endocrine Disrupter,” Bridges, et al. 
(2004) pointed out the high relevance of IRA when investigating effects of EDCs.  He 
noted that “Endocrine disruption is not a disease in itself… but its effects may result in a 
number of diseases.”  It is here, that the author sees the application of IRA in order to 
understand the impacts on human health and on ecosystems due to exposure to EDCs.   
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Looking at the problem of EDCs and its risk assessment, at present CREDO is 
investigating the practicality of applying the concept of IRA to Endocrine Disrupting 
agents. The research is being done on BFRs (Brominated Flame Retardants) given the 
wide evidence of substantial exposure of man and a number of animal species.  “After the 
introduction of integrated risk assessment, a further major task will be to develop a 
framework for risk comparison and risk benefit analysis among the flame retardants” 
(Bridges, 2004).  The adoption of an IRA to the study of EDCs is one of the challenges 
that have to be defeated in order to come to a better understanding of the EDCs 
phenomenon, and by this means a better control of these hazardous substances. The 
testing methods represent another challenge in the study of EDCs.  
 
The test methods problematic 
Parallel to the progress of CREDO, there are other initiatives for enhancing the testing 
methods, and add novel endpoints that could contribute in the long and difficult process 
of EDC risk assessment. In 2001, the commission organized working groups with 
representatives from the member states, industry and NGOs in order to give the 
commission expert advice in specific issues.  One of the working groups (WG) was on 
Substances of Very High Concern (SVHC) with 4 different tasks.  One of these tasks was 
to justify the consideration of EDCs as SVHC and accordingly to be subjected to the 
authorization system.  As a result of this, the WG recognized the lack of test methods and 
criteria for the identification of EDCs.   
 
One of the first and best attempts to fill the lack of information on EDCs came from the 
OECD, which in 1996 created the EDTA program (task force on Endocrine Disrupters, 
Testing and Assessment). The program was formed with the objectives of providing 
information and coordinating activities, developing new and updated Test Guidelines to 
detect endocrine disrupters, and harmonizing hazard and risk characterizations 
approaches. EDTA developed a conceptual framework in order to supply a structure for 
the testing and assessment of potential ED in which the various recently developed tests 
would fit.  The development of the conceptual framework took into consideration the 
views of Member States (Answers form a Questionnaire and the OECD’s Appraisal of 
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Test Methods for Sex Hormone and Disrupting Chemicals), the industry initiatives 
(European Chemical Industry Council), as well as the agreements reached during 
workshops on EDCs (the Weybridge workshop, and the EMWAT47). 
 
The OECD “conceptual framework” is given in five different levels (see box 14): 
• level 1 is used to prioritise the large universe of man-made and natural chemicals 
by using existing information. 
 
• level 2 comprises of in vitro screening assays, also including consideration of 
(quantitative) structure activity relationship, which may also yield mechanistic 
information, 
 
• level 3 contains in vivo screening assays for detection of specific endocrine 
activities, 
 
• level 4 in vivo assays listed will allow for detection of adverse effects in several 
endocrine systems and finally, 
 
• level 5 contains the most comprehensive in vivo assays for adverse effects, which 
can be used for a definitive risk assessment.   
 
Level Examples: Toxicology/Ecotoxicology 
1.) Sorting / Prioritization  
(existing information) 
Phys. Chem.. properties; exposure; 
available data. 
2.) In vitro assays  
(mechanistic data) 
Receptor binding; transcriptional 
activation; QSAR. 
3.) In vivo assays 
(single endocrine effects) 
Uterorophic assay; Hershberger assay / fish 
vitellogenin assay. 
4.) In vivo assays 
(multiple endocrine effects) 
Enhanced OECD 407; rat pubertal assay / 
fish gonadal histopath. Assay. 
5.) In vivo assays 
(endocrine + other effects) 
1-/2-generation mammalian assay / partial 
or full life cycle assays (fish, birds) 
Box 14: Conceptual Framework from OECD with examples of tests methods for each 
level (Gelbke et al., 2004) 
 
The creation of the Conceptual Framework from OECD, established the guidelines to 
look for the effects that an endocrine disruption may have on human reproduction. 
However, there are concerns about the relative power of some of the studies in the 
 
47 EMWAT stands for Endocrine Modulators and Wildlife: Assessment and Testing. 
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detection of such effects.  The concerns mainly focus on the practical use of the test result 
in Risk Assessment and Classification of EDCs. Another concern related to the 
conceptual framework, is the lack of validation of the methods, and therefore its inability 
for a complete adoption (Nord-Utte, 2002). 
 
Validation of test guidelines is highly relevant but it seems to be a very laborious process, 
and therefore time-consuming and costly.  One of the main concerns within this topic is 
the potential decrease in the number of test guidelines due to delays in their acceptance. 
During the 5th Nord-Utte Network Meeting, it was agreed that a more systematic 
approach for test method validation is needed, mentioning that the validation should be 
flexible, and in this way permit a realistic process case-by-case (Nord-Utte, 2002).  
Saying this, the established framework have several toxicological and ecotoxicological 
screening tests still under development, and it could most likely take several years to have 
the tests validated before they could be considered for regulatory initiatives.  
 
Having as a background the above described problem, the Nordic Council co-ordination 
group for test method development (Nord-Utte) published a document in 2004, which 
concluded that case-by-case assessments requires special expertise given the complexity 
of EDCs effects.  Again we are facing the complexity in getting sound data to perform 
sound risk assessments.  North-Utte stated that well-performed positive in vitro tests, 
which indicate potential EDC activity, should support the upgrading of a substance from 
reproductive toxicity, category 3 to category 2, and by this means, to ‘jump’ into the 
authorization system. Depending on the type of test performed, those substances could be 
grouped in category 2 or even 1.  They also suggested that substances placed in category 
3, based on in vivo evidence, should also be considered by the authorization system.  The 
Nordic group basically proposed an update of the criteria used for the classification of 
CMR, and thereby, covering the effects of EDCs by this classification.  
 
Regarding our findings related to the test methods problematic, Pia Jul Nielsen from the 
Danish EPA, confirmed the lack of technical facts with regards to EDCs, and the need for 
enhanced test methods in order to move towards a better regulatory decision-making. She 
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mentioned that the idea of preparing the Nord-Utte (2004) document came after the 5th 
Nord-Utte Network Meeting in 2002, where it was agreed that there was a need for a 
more systematic approach for test method validation.  
 
Exposure monitoring 
The test methods used to embody the actual hazardousness of many chemicals are just 
one part of the risk assessment; the knowledge of exposure levels represents a 
complement of this issue.  The estimation of the dose as well as the frequency and 
duration of the exposure are highly important components, however, their estimation is 
often not available, especially with regards to EDCs.  The controversy lies on the 
existence of natural chemicals that may act as EDCs and thereby contributing to the 
likely adverse effects that synthetic EDCs contain.  Another difficulty within the process 
of the risk assessment of EDCs is the fact that the measurements are performed on 
individual chemicals, taking no consideration of the mixtures of chemicals that humans 
and living creatures in general are always exposed.  The topic about mixtures “…raises 
the question of whether additive effects might occur or whether synergy could magnify 
the toxicity of the chemicals under study” (Purchase, 1998).  In addition, it is important to 
consider the timing of exposure.  Studies mainly focus on reproductive disruption which 
seems to be, for the most part, during prenatal exposure (Colborn, 1996). 
 
Low dose – long exposure  
“The dose makes the poison” is the assumption in which most of the regulatory responses 
are made. However, this assumption appears to be very incompatible for EDCs.  The 
called non-monotonic dose-response curve (NMDRC) has become visible in many 
experiments that test the safety of chemicals in use.  These kinds of dose-response curves 
are characterized for their non-linear behaviour, being by definition a type of non-linear 
curve. “Some of the NMDRC are shaped like U’s, with high responses at low and at high 
levels of contamination, while others are shaped like inverted U’s with the greatest 
response in intermediate ranges” (www.ourstolenfuture.org). 
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Several authors, working with different substances suspected to be EDCs, have suggested 
that more long-lasting exposure to low concentrations of endocrine disrupters may be 
more harmful than short, sharp exposures to high doses that are not environmentally 
significant.  With regards to this issue, some studies have focused on butyl benzyl 
phthalate (Ashby et al, 1997 and Sharpe et al, 1995), bisphenol A (Ashby et al., 2003; 
Nagel et al., 1997; Sakaue et al., 2001; Talsness et al., 2000 and Tinwell et al., 2002) and 
nonylphenol (Colerangle and Roy, 1996; Lee, 1998; Odum and Ashby 2000; Odum et al, 
1999).  Nevertheless, there are other studies which are unable to confirm the findings that 
support the occurrence of ED effects at dose levels lower than the no effects level defined 
by classical toxicity evaluations (Ashby et al., 2004).  
 
According to a peer review organized in 2002 by the National Toxicology Program 
(NTP), and the National Institute of Environmental Health Sciences (NIEHS) in USA, the 
low-dose effects of EDCs depend on the substance and the end point measured.  As part 
of their conclusions, the experts stated “several factors may account for discrepant 
findings on low-dose effects of particular endocrine-active agents” (Melnick et al., 2002).  
Among those factors they counted:  
• Intrauterine position 
• Strain and sub strain differences 
• Diet 
• Differences in caging, bedding material or housing 
• Seasonal variation 
 
Again, results from the different studies reflect many controversies; representing one 
more piece of the complexity involved within the risk assessment of EDCs.  The dose-
response topic is still on the table and more studies need to be done in order to elucidate 
the ambiguities that typify the issue.   
 
5.3 How is risk and exposure to EDCs managed? 
As an important part of the management of the likely risk that EDCs involve, the 
European Union launched the Strategy on Endocrine Disrupters (described in chapter 3). 
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The strategy is based on the European Commission conceptualization of the 
Precautionary Principle, and in this way its integration with existing procedures, such as 
risk assessment of individual industrial chemicals and pesticides, is highly important 
(Assmuth et al., 2001).  The subsequent reports that follow the Strategy, issued in 2001 
and 2004 (see box 10 in chapter three), have shown concrete results and solid advances 
within the issue regarding short and medium action plans.  Nevertheless, with regards to 
regulatory policy-action, conceived as long-term goals, there is no connection between 
the strategy and the new chemical regulation proposal REACH.  This disconnect brings 
us to the realisation of the weakness of the strategy, when entering the political arena.  
 
As mentioned in chapter 3, there is as of yet no coherent regulation of endocrine 
disrupters, as a direct cause-and-effect relation has not proved their possible effects.  The 
main problem is that substances need to be classified before they can be evaluated and 
eventually, regulated.  Classification and the test guidelines matter appear to be the main 
difficulties within the area of management. The recognized fact that “…endocrine 
disruption is not an adverse effect per se, but rather a potential mechanism of action” 
(Webb et al., 2003) makes the management of EDCs a quite difficult task to achieve. 
Returning to this topic, which was discussed during the interview with Nielsen, she 
recognized EDCs as mechanisms of action, and based on that, stated that “it would be 
smoother if one can use existing regulation and enhance it, instead of trying to manage 
the risk associated to EDCs as a group.”  The before mentioned statement of Nielsen may 
bring us to the issue of management of EDCs on the case-by-case basis.  
 
Assmuth et al., (2001) noted that in many countries within the EU “…risk management 
actions have been planned or implemented on substances or classes of substances which 
are known or suspected to cause endocrine disruption.”  As it stands, endocrine disrupters 
are regulated on a case-by-case basis.   
 
In summary, the hitherto regulation of EDCs that have or may have an adverse effect in 
human reproduction, shows a handling of the substances on a case-by-case basis.  
Nevertheless, there are opinions that point out the drawbacks that this approach may 
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have.  In our interview with Mette Boye, she stated, “it sounds nice that they are being 
looked at individually, but that can also be used as an excuse to delay action on 
substances which may be desirable by industry to use due to functionality and/or cost.” 
 
Taking in consideration the opinion of Mette Boye, one very important negative aspect of 
the case-by-case approach, is the fact that we may be missing some important chemicals, 
e.g. those contain in personal care products, while concentrating assessment efforts on 
others that may not be that relevant.  This issue becomes highly pertinent when looking at 
consumer aspects.  During the interview with Boye, she stated that, “when it comes to 
EDCs, if we are going to look at one substance, we do not have enough scientific 
knowledge.”  She mentioned that EDCs as a group could produce more knowledge based 
on common characteristics and in this way, has better political coverage.  
 
The management of EDCs as a group have also been suggested by WWF, which came 
with another classification approach in a Discussion Paper in 2002.  WWF proposed to 
place EDCs in sub-categories (alike to those for CMR) depending on the level of 
available evidence for endocrine disruption, and this means to include them as a group 
within the new proposal (Norden-Utte, 2004) (see box 15).  
 
The “as a group” approach may also have drawbacks; nevertheless it could be 
recommendable to explore this possibility, especially when the development of new 
chemical regulations is looking towards the enhancement of human and environmental 
health.  Consumers feel more comfortable having the impression that politicians and 
regulators have better control over the chemicals that may represent a threat to their 
reproductive health.   
 
The new proposal 
As discussed in chapter 4, REACH aims “to contribute to sustainable development and to 
protect human health and the environment” (Nordic Council, 2004).  The proposal may 
include EDCs under the authorization system, on a case-by-case basis, as EDCs could 
qualify as carcinogens or as toxic to reproduction.  This could activate their submission to 
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authorization, but REACH only relates to those substances toxic to reproduction (CMR) 
placed in categories 1 and 2.   
 
Box 15: The WWF proposed classification of EDCs 
Category 1A EDC  
• Substances that alter the function of the endocrine system and 
consequently cause adverse health effects in an intact organism  
 
Category 1B EDC  
• Substances as defined is 1A, but where the causal mechanism is still 
unclear, but strongly suspected to be mediated via disruption of the  
      endocrine system   
 
Category 2 EDC  
• Substances where there is less evidence for endocrine mediated effects, 
and/or where endocrine disruption is strongly suspected or known but 
where   there is debate whether the effects reported should be considered as 
adverse. 
 
Category 3 EDC  
• Substances suspected to be endocrine disrupters on the basis of simple in 
vitro tests for endocrine disruption or non-validate QSAR screens, unless 
there are data sufficient to negate the concern. 
 
Some EDCs and suspected EDCs are classified in category 3 or not classified, and 
therefore not considered in the REACH authorization system.  Two examples of these 
substances are bisphenol A and nonylphenol (as mentioned in chapter 4).  
 
The way in which regulation of EDCs is conducted may be improved under REACH, but 
that impinges on how scientific knowledge (i.e. uncertainty) is applied in determining EU 
policy. As Late Lessons from Early Warnings shows, it can be expensive to act on 
hazardous substances too late.  The converse is also a supposed lesson, but as will be 
shown in a later discussion, the group does not agree with the idea that acting too early 
yields unnecessary costs.   
 
REACH may add a very interesting point for discussion with regards to the relationship 
of risk assessment and risk management relating to EDCs.  When looking in terms of the 
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proposal, one could presume that it is actually the management that is setting the “rules” 
by saying “no data – no market.”  For all the new substances (in the strict sense of the 
word) this statement may direct the focus of assessors to the requirements of the 
managers.  Another influence of RM over RA can be seen with respect to the funding of 
scientific research.  A different picture can be drawn when looking at the “existing 
substances.”  The fact that lack of knowledge on actual adverse effects of substances 
stops policy action, makes us to state that a “no data – no phase out” approach is being 
applied for “existing and new” substances.  
 
Rationalizing the issue  
In the beginning of this chapter we pointed out the fact that RM can actually have an 
influence over the RA (Van Leeuwen and Hermens eds., 2001; Hart, 2004).  After the 
analysis of the gathered information on the assessment and management of EDCs, we 
attempt to rationalize the issue as follows:  
   
REACH aims at harmonizing new and existing substances, and applying the “no data, no 
market” principle to acquire safety data on existing substances. As mentioned, it is 
existing substances that lack safety data, but as there are no binding clauses for 
substitution have 11 years of grace, the pressure for substitution is rather weak.  The 
harmonization will most likely result in “no data, no phase out” for existing substances, 
which can be seen as RA determining RM, as the substances in production cannot easily 
be taken out of use without socio-economic repercussions.  
 
The fact that CEFIC, in lieu of a concern that “well-performed risk assessments” are 
secure seems to have funded the research for the CREDO program, indicating an 
endangerment of RA impartiality of test-results.  The stringent demands for safety data 
on new substances compared to existing ones, is an example of regulators (RM) 
demanding a de facto “no data, no market” for new substances.  We attempt to 
summarize our understanding of the interrelationship between RA and RM regarding 
EDCs that have an adverse effect in human reproduction in Figure 6. 
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inclusive48 management decision processes, with the clear understanding that trust in 
information influences risk perceptions and associated behaviours.”  With regards to 
EDCs, public trust is particularly important because people may have the impression that 
they possess little personal control over the potential danger, especially when looking at 
the likely adverse effects that those chemicals may have on their reproductive capacity.  
In this way, one can clearly see the importance of a transparent management of those 
chemicals that may possess the threat.  In summary, transparency = trust. 
 
When looking at the EDCs problematic, one can surmise that the management so far does 
not necessarily reflect societal values.  There is a general public concern over many 
substances that are suspected to have endocrine disruption effects.  Special concern has 
been placed on those compounds contained in consumer products, however the 
management of those substances still is “up in the air” and REACH appears to ignore 
consumer issues even though it is officially meant for the enhancement of human and 
environmental health.  Here, it may be relevant to consider the role of the perceived risk 
from EDCs in consumer decision making, which without being an exclusive determinant, 
may have an important influence on it. 
 
Regarding the issue of consumers, there is no agreement between the alliances of green 
and consumer groups vs. industry associations on when legislative or regulatory action is 
warranted.  Their respective scientists disagree on what ought to constitute “acceptable” 
or “unacceptable” risks.  As Boye has noted, the discourses on endocrine disrupters are 
dichotomous and their implied solutions equally so.  The effectiveness of the CMR 
clauses cannot be quantified as the final draft of the REACH proposal is not yet finished, 
market reactions are uncertain and hence the impact on the safety of consumers is 
uncertain. 
 
We are of the opinion that consumer issues, especially regarding CMRs in consumer 
products, have been largely ignored, as the REACH proposal will authorize chemicals of 
 
48 Fewer (2003) stated that an inclusive management implies that societal values cannot be excluded from 
any part of the process.  
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very high concern (including endocrine disrupters) if socio-economic benefits are 
politically deemed to be of greater significance. In addition, the fact that toxic to 
reproduction category 3 fails to include bisphenol A and nonylphenol is unsettling as is 
the institutional response of “awaiting more research” does not bode well, if looking at 
how POPs are still a lingering problem.49
 
5.4 How much risk is acceptable, but more importantly, is it necessary? 
Research on creating novel testing methods could bring robust endpoints, and thus serve 
as tools for the prioritization of chemicals for further testing, and/or their possible 
restriction or ban.  Before being used in the regulatory process, the method(s) should be 
validated, and in this way, internationally accepted.  This could result in an extremely 
long period of time elapsing before the methods are validated and then used in the 
regulatory process.  Another concern is on the design of the test protocols.  Some of the 
methods established in the OECD conceptual framework have loopholes that may 
represent a sticking point in the practical use of the tests results in Risk Assessments, 
consequently in the risk management of EDCs.  
 
We have reached the core of the issues we have reached the moment of main questions: 
• Are EDCs a real problem? 
• Are we using science in an “optimal” way? 
• Will we keep asking science for a “yes” or “no”, what to do? 
• But more importantly, how to do it?  
 
The seriousness of the effects of endocrine disruption means that the longer it takes for 
the political and hence regulatory reaction, the more complex it will become to establish 
cause and effect mechanisms.  This is especially true when considering the exponential 
rate of release of chemicals in general and their cocktail interactions with endocrine 
disrupters. 
 
 
49 The first POP in human tissue was found in 1944, but there is no global ban to this day (WWF, 2004). 
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The current application of science is having trouble determining the effects of single 
substances, not to mention confounding mixtures of chemicals. It begs the question 
whether the current regulatory system is adequate to determine, in time, which substances 
have endocrine disrupting properties.  Wait too long and the possible effects on humans 
are likely to endure if they do occur (behavioural, reproductive and/or genetic damage). 
 
Modern society is unable to cope with a world “free of chemicals,” as mentioned in the 
introduction to this project we are all surrounded by chemicals.  Synthetic chemicals 
came as an answer to many needs we faced in the past; production of them made our life 
easier and allowed us to develop into the society now known.  Many of the chemicals, 
which are suspected to be endocrine disrupters, and could have an adverse effect the 
human reproduction, belong to those chemicals that fill the “needs” we have as 
individuals and as a society, but certainly there are many others that may be totally 
unnecessary.  
 
Therefore, it is here that the concept of risk acceptance comes into the “game.”  Surely 
those endocrine disrupting chemicals that represent a risk, we as a society should be able 
to “assess” and “manage” in order to cope with them.  Unquestionably, the risks that 
those chemicals represent are of different nature, and all those risks have to be balanced 
in a way that should result in an adequate management.   We have to, however, 
emphasize that human reproduction assures our permanency on the earth as a species, so 
the question we can raise is: are we willing to put the same weight on that risk and many 
others, which relate to personal needs or economy?  Surely, there is not enough data to 
determine the probability of the effects that certain chemicals or groups of them may 
have on the human reproduction.  To say “acceptable risk” is a subjective determination, 
and “…it is especially true in the case of hormone disrupting chemicals for which it may 
be considered that there is no “safe dose” of exposure” (Greenpeace et al., 2004).  But 
when thinking of that they may threaten our future, we could ask: how much risk is 
acceptable, but more importantly, is it necessary? 
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The use of the precautionary principle issue (briefly discussed in chapter 3), take us to the 
risk acceptance arena.  The risk assessment of EDCs, as any chemical assessment, brings 
many uncertainties, and therefore it brings also many debates about whether it is better to 
err on the so called “false positives” (if there is an error, it will more likely be a false 
indication of danger) or “false negatives” (if there is an error, it will more likely be a false 
indications of safety) (Carnegie Commission on Science, 1993).   
 
As a group, we consider that this dilemma with regard to EDCs that have an adverse 
effect on reproduction could be summarized as:  
 
Economic costs (false positives) vs. playing the “Russian roulette” (false negatives) 
 
Saying this, the last question for this section could be: who is ultimately taking and 
accepting the risk?  
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6 Discussing Risk and Uncertainty 
This chapter will define risk and place it in a historical perspective.  It will introduce the 
theoretical background for discussing chemical regulation in general and endocrine 
disrupters in particular.  The sociological theory of Risk Society will be related to the idea 
of Reflexive Modernization and the chapter will discuss endocrine disrupters as entering a 
scene of complexity, not only in technical terms, but also in the socio-political context. 
Lastly, the chapter will discuss the use of science in regulating endocrine disrupters, the 
resulting prioritization and risk acceptance with regards to consumers. 
6.1 What is Risk? 
 Risk is the potential harm that may arise from some present process 
 or from some future event.  It is often mapped to the probability of some 
 event which is seen as undesirable.  Usually, the probability of that event 
 and some assessment of its expected harm must be combined into a  
 believable scenario (an outcome) which combines the set of risk, regret  
 and reward probabilities into an expected value for that outcome.50
                                            
 
The above is a general description of the concept of risk, but it is important to note that 
there are many interpretations across different professions about the parameters of what 
constitutes a risk.  That has to do with the different perceptions about what “probability” 
is, perceptions about what is “desirable,” and just as importantly, that which is not 
desirable.  In chemical regulation, risk is calculated as:  Risk = Hazard x Exposure.  
While this seems like a simple formula, as the discussion progresses, it will become clear 
that it is not necessarily the case. 
 
Risk in a historical perspective: 
Humans have engaged in risk analysis for literally thousands of years (norden.org).  Risk 
analysis (or simply “informed choices”) was made whenever humans gathered fruits, 
roots and vegetables, as they had to carefully weigh the advantages against the 
disadvantages of choosing foods to sustain the human body most efficiently.  For 
example, some communities could make a risk analysis of hunting and fishing.  The risk 
 
50 http://encyclopedia.laborlawtalk.com/risk 
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analysis would suggest that diversification of nourishment sources would protect better 
against hunger than any one choice: the harvest or catch could be meagre in one year.  
Later, the processing of food in one way or the other (curing, cooking or otherwise 
preparing food) could further preserve the food, but since it was not consumed 
immediately, safeguards to protect that same food had to be employed.  There was 
therefore a risk analysis (an inner weighing) on which course of action was safer in the 
long run.  And so, through the course of history, humans have always had to do risk 
analysis. 
 
The problematic of risk analysis can be illustrated by game theory, where humans band 
together to limit the risk of individual hunters all going hungry, because of the lack of 
coordinated action.  The risk analysis of these hunters was the following: “if I try to catch 
the rabbit on my own, I may fail and go hungry, but, if I band together with other hunters, 
I will have a greater likelihood of getting, at least, a share.” The risk analysis is thus 
between two choices: 
• High risk (hunting alone), means high return (if the rabbit is caught, sharing is 
unnecessary)… but the risk of failure is high! 
 
• Low risk (hunting together), means lower but more likely return (the rabbit is 
more likely to be caught)… but the meat must be shared! 
 
Despite the relevance of risk analysis in social life, the level of complexity was relatively 
low, as societies lived apart to a much greater degree than the modern world of today.  
With the advent of the state as an international agreement on sovereignty in the Treaty of 
Westphalia (1648), the “problem field” of risk analysis could be contained within states.  
However, the concept of Risk Analysis as an institution is a relatively new construct.  
 
Risk Society: the theoretical background 
The theory employed for this project is the Risk Society as conceived by sociologist 
Ulrich Beck.51  The risk society is a Modernization theory that deals with the 
 
51 The idea of “Risk Society” was first articulated by German sociologist Ulrich Beck, with his book 
“Risikogesellschaft” in 1986. The theory enjoyed enormous respect, first in the German context (the 
ecological debate), then internationally. The book was translated into English in 1991, in which language it 
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terminological inadequacy that ‘post-Modernity’ presents.  The theory contends that we 
live not in a post-modern world, but rather in a second Modernity.  The first Modernity 
arose with the emergence of industrial society, which dethroned feudal relations and the 
Church (religion) in terms of control of society.  Science provided, in place of the church, 
the new reference points for accepted truths and world-views.  While the reference points 
of the first Modernity was founded in the nation-state, with globalization came what 
Ulrich Beck calls the “second Modernity.”  In the second Modernity, the reference points 
for accepted truths in society at large disintegrate in the process of globalization. 
 
Globalization makes the movement of business (companies) and people possible.  The 
state, on the other hand, is still territorially bound in terms of creating revenue (tax) and 
control (authority).  The theory contains a narrative about a ‘modernization of 
modernization,’ where the reference points of society’s self-reflection (sociology) on the 
family unit and state are becoming out-dated due to globalization.  A realization of this is 
crucial and Beck calls for a new understanding as the repositioning of reference points 
diverge. Whereas the state used to be about the distribution of ‘goods,’ it must now 
mediate the distribution of ‘bads’ – risks, in our case, of exposure to endocrine disrupters.  
 
In terms of chemical regulation, the theory argues that science is in effect upholding the 
fiction that such things as, “acceptable levels” of risk regarding exposure to hazardous 
substances exist.  The theory argues that scientific assessments based on probabilistic 
measures of risk are outdated due to the disintegration of the calculable in the second 
modernity.  That is, diverging perceptions of risks are materializing and hence the 
calculability of probability is undermined. Institutions, the theory states, still calculate 
risk under the fiction that risks are still contained within states.  They are therefore, in 
effect, masking/distorting the actual (bad) state of the environment and legitimizing 
human exposure (risk) to hazardous chemicals.   
 
has become one of the most powerful social analyses provided by sociology in the late 20th century (Lash 
and Wynne, 1997: 1). 
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Placed in a world of functional separation (different fields of expertise), scientific 
institutions are hard to influence from a citizen’s or a public point of view.  As the 
environment suffers, and increasingly do humans, assurances from the authorities that ‘all 
is well’ (lack of urgency) are less and less convincing.  Institutional legitimacy lost has 
benefited groups who have increasing success in challenging the conventional wisdoms.  
What happens from here is, according to the theory, precisely the challenge. 
 
The reason for choosing this theory is that it discusses chemical regulation in both the 
national and international context.  It is very useful for analyzing institutional and 
structural issues in relation to the handling of endocrine disrupters that affect 
reproduction by the EU, as it exposes many issues hidden, but latent in the regulation, 
among them the relation between risk and democracy. 
 
As our problem field concerns how the EU deals with the issue of endocrine disrupters, 
we will not venture into an exhaustive theoretical analysis about the wider (global) 
implications of EU chemical regulation.  However, the likely major trajectories of policy 
action will be identified and discussed through the thinking of (World) Risk Society.  
Risk Society becomes World Risk Society due to the fact that policy action on endocrine 
disrupters has implications far beyond the borders of the EU due to globalization and the 
high EU share of the global chemicals market.  Some extrapolation of trends or 
shortcomings in the EU management of EDCs, to the general regulation of chemicals will 
necessarily have to be made for the sake of theoretical consistency. 
 
Lastly, the idea of Risk Society is intimately coupled with the concept of Reflexive 
Modernization. It is thus necessary to first explain the concept and its implications for 
risk analysis, before discussing what the concept can reveal about endocrine disrupters 
and chemical regulation in general. 
 
Reflexive Modernization: 
The concept denotes a reflection on the problems posed by Modernization.  Beck stresses 
on many occasions that a reflexive reflection, a continual compulsion to reflect on the 
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current situation does not necessarily mean that one is optimistic about the future, which 
many may take it to mean.  That is, according to the theory, because potential dangers 
may be realized as well as potential solutions (see box 16).  In the preface of the book 
Reflexive Modernization, Beck, Giddens and Lash state: 
 
The notion of ‘risk’ is central to modern culture today precisely because 
so much of our thinking has to be of ‘as-if’ kind. In most aspects of our 
lives, individual and collective, we have regularly to construct potential 
futures, knowing that such very construction may in fact prevent them 
coming about. New areas of unpredictability are created quite often by 
the very attempts that seek to control them (Beck et al.,1994: preface). 
                                                                                                     
That means that knowledge (‘certainty’) of risks will also expose new areas of concern 
(unpredictability).  That applies directly to the issue of endocrine disrupters as it lays the 
foundation for the wider discussion on risk, complexity and their relation to endocrine 
disrupters.  The question is, what do these ideas mean for the analyses of the management 
of endocrine disrupters and their implications for chemical regulation in the EU? 
 
Box 16: Close-up: the reflexivity of a company 
Danisco has recognized the trend that hazardous substances are increasingly being 
pressured to be phased out, and it seems that Danisco has taken the consequence of this 
analysis and introduced Soft-n-Safe, which can replace the use of phthalates.  It was 
made clear in our interview with Chief Operating Officer in the Division of Emulsifiers, 
Torben Svejgaard, that it is not the responsibility of the company “to save the world.” 
 
The introduction of Soft-n-Safe must therefore be seen as a precautionary measure.  This 
is in our analysis a budding understanding of the risk society, as they have started to 
anticipate the risks and take action to avoid risk.  The company has clearly understood the 
potential economic damage that bad publicity can cause for them or the high cost of 
sudden substitution.  The introduction of Soft-n-Safe is thus precautionary and an 
example of the reflexivity of Danisco policy and by implication at least a partial 
acknowledgement of the power of the political consumer.  
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6.2 Complexity, Risk and Regulation 
 
Scene of Complexity 
When discussing the risks of hazardous substances, in our case, EDCs that affect 
reproduction, it is clear that the complexity of chemical regulation does not end with the 
technical properties of the endocrine disrupters, on the contrary.  The issue of endocrine 
disrupters is a controversial one, where green and consumer groups are largely alarmist in 
their opinions on the release of endocrine disrupting chemicals.  They employ existential 
reasoning to highlight the need for immediate action to curb hazardous substances, such 
as toxic to reproduction.  Those groups are countered by industrial and regulatory 
agencies’ arguments that more research is needed to properly identify human endpoints 
for endocrine disrupters (or the mechanisms that cause it).  In this regard, the problematic 
of endocrine disrupters pose disturbing challenges as: 
• some effects are demonstrable at very low exposures; 
 
• dose-response curves do not necessarily fit the classic monotonic assumption 
fundamental to regulatory toxicology;  
 
• under some (but not unusual) circumstances, there will be no threshold level 
below which there is no effect, and  
 
• contaminants exposures take place in mixtures and these mixtures can interact 
additively, synergistically or not at all.52 
The above are all challenges because they violate the assumptions that have determined 
the parameters by which the safety of humans was measured, and by logical extension, 
that includes the general safety of consumers.  The management of endocrine disrupters 
by regulatory authorities are subject to political negotiation and constraints, such as 
economic factors.  This is due to the fact that the EU is a supranational institution, and 
common policy action must be agreed and coordinated between the respective Member 
States.  Within the internal politics of the EU, there is a myriad of relevant actors, who 
have divergent interests and speak with different discourses that imply different courses 
of action.  There is much difference in the way, for example, consumer organization 
 
52 All four points from www.ourstolenfuture.org. These have also been discussed in the previous chapter. 
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BEUC or Green groups sees the use of substances that affect reproduction, and for 
example industry organizations, such as CEFIC.  
Endocrine disrupters are unusual with regards to the parameters investigated for adverse 
effects on humans, since it can be a mechanism and not simply an effect.  They also enter 
a political and economic context, where dramatic changes in the use of such substances 
are not a readily available option.  As noted by the Nordic Council, endocrine disrupters 
will only “optimistically” qualify for Authorization under REACH; nevertheless there are 
important substances that cannot qualify for this system due to their current classification 
within the CMRs (e.g. bisphenol A and nonylphenol).   
6.3 Risk and Regulation 
From a regulatory perspective, managing risk in European chemical regulation becomes 
increasingly difficult as the cumulative load of risks amasses (the rate of release of 
chemicals is exponential).  It necessitates that regulators make judgment-calls on what is 
desirable and what is not, they thereby create a priority list of societal goals.  Regulators 
are left to make judgment-calls on what is more desirable for society:  
 
(a) Human exposure to hazardous chemicals with tangible socio-economic benefits, 
but with reduced health levels? OR,  
 
(b) Reducing human exposure to hazardous substances and sustain an associated loss 
of economic benefits, but enhanced health benefits?  
 
Few opinions are dichotomous ideal-types.  However, based on the relationship between 
greens/consumers versus industry/regulators, it can be surmised that it is their lack of 
agreement on the relationship between (a) and (b) that pit them against each other.  
Socio-economic benefits are not a given due to differing opinions on the ‘desirable.’  As 
such, this observation is confirming risk society theory in that reference points have 
indeed diverged.  The battle is in our case about the balance between health concerns and 
socio-economic considerations.  In this regard, it is noteworthy that REACH is based on 
article 95 of the EC Treaty on the Internal Market, instead of Article 174 on the 
Environment (IEEP, 2003:33).  If the proposal truly aims, first at foremost, at improving 
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human health and the environment, why is the legal base one that makes it difficult for 
member states to have stricter standards?  
 
The irreversibility and seriousness of effects of endocrine disrupters that affect 
reproduction have resulted in a heated discussion between greens/consumers and 
regulators/politicians on the optimal ‘nature of precaution’ – what kind of regulation is 
desirable? What should be the prioritization?  As the Risk Society theory claims, science 
has lost its monopoly on accepted truths, which in effect results in diverging perceptions 
of the desirable versus the undesirable and the acceptable versus the unacceptable.  To 
discern this divergence in perception, we now turn to an analysis how the risk to humans 
is located and prioritized by the EU versus where greens and consumers would like to see 
policy action first.   
 
The duality of consumers:  
In some instances in this project, we have put greens and consumers together.  The reason 
for this is the fact that, when it comes to hazardous substances (which EDCs are a part), 
greens and consumers largely agree that the use of such substances is unacceptable.  
However, when it comes to other issues, consumers contain a duality, in that they are 
placed between the dichotomous categories of greens and industrialists and may move in 
the continuum between them.  This is in the sense that, while consumers place 
importance on safe products, they also recognize the price and convenience gained from 
products.   
 
The state as the prisoner of industry: 
We have also put industry and the policy makers together in some of the discussions. 
This is code for the relationship between industry and the state (policy-makers).  While 
politicians rely on the people for votes (re-election is desirable), they rely on co-operation 
with society’s units of production (companies and industry in general).  Without a 
growing economy and increased wealth for its citizens, governments and politicians have 
a hard time retaining power.  That entails a balancing act between citizens and industry, 
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the problem however is that elections are relatively far between, while ‘business is 
always open.’ 
 
Locating Risk 
The underlying issue at this particular risk assessment – risk 
management boundary, as well as other environmental policy fields, is 
how to arrive at a socially acceptable compromise between demands for 
environmental protection on the one hand, and low economic costs on 
the other, using the best available scientific understanding. Such a 
compromise is a matter of political values (Mayer, 1998:22).                                                              
                                                                                          
Scientific methodology demands a consistent approach to any subject, but this fails when 
it comes to prioritization in REACH, at least if chemical regulation is about limiting 
human exposure to hazardous substances (see box 17). 
 
It is widely known that most accidents happen in the home, but what may not be as 
obvious to readers is that it is also the place where people are much exposed to synthetic 
hazardous chemicals in general.  In terms of identifying where to gather information 
about the pathways to human exposure, the dust your home would be a good place to 
start.  With regards to endocrine disrupters that has wide implications in terms of 
reducing exposure to humans: two reports from Greenpeace used house dust as an 
indicator of (hazardous) chemical exposure in the home, found that significant exposure 
takes place in the home, despite manufacturers’ claim that most substances are contained 
in the consumer products (Greenpeace, 2003a.,2003b: introduction).  That means that 
endocrine disrupters found in children’s pyjamas, furniture, toys and in some carpeting 
are leaking, which leads us to the discussion on prioritization of hazardous substances. 
 
The prioritization of substitution in general in the REACH proposal focuses on the 
substances that are produced in more than 1 tonne a year per producer and as such, its 
prioritization is on reducing chemical exposure to humans in terms of volume.  If the aim 
is to protect human health/consumers first, this prioritization is wrong.  We know from 
the discussion in the last chapter that the persistence and bio-accumulative potential can,  
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Box 17: Risk Society on RA and RM 
Beck argues that scientists have an advantage over those who will use their test results 
and conclusions. Thus, we understand our theoretical framework to see RA and RM as a 
priori delineating ‘the field of the possible.’  About scientists, he states that: 
 Their possibilities of exerting practical influence lie in how they design 
 scientific results. Thus the “purely objective” interpretation of “need”  
 and “risk” in the various fields of action provides a cloak behind which  
 the directions of future developments are negotiated (Beck, 1992:174).            
                                                                                   
In our conception, the relationship between Risk Assessment (RA) and Risk Management 
(RM) is not necessarily a straight-forward one of simple functional separation.  While 
RA, as discussed, is mainly the ‘objective’ part and RM as the ‘subjective’ part of 
chemical regulation, we are of the opinion that influence can go in both directions, in 
addition to what Beck contends: a meta-category of RA-RM together, influencing 
conventional politics.  
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in a sense, “store” hazardous effects for years before going into effect.  That means that 
even small doses of exposure to endocrine disrupters can have hazardous effects many 
years after its release due to synergy. 
 
To employ the thinking of Reflexive Modernization this knowledge demands action in a 
consistent manner. Reflexivity in this case means: (1) identify the risk: in our case the 
exposure in the home and through leaking consumer products, (2) prioritize addressing 
the major risks first: addressing substances that are hazardous even in small doses, such 
as bisphenol A.  The intrinsic properties of hazard (persistence, bio-accumulative 
potential) as these - coupled with synergistic effects- are in effect, ticking time-bombs of 
endocrine disruption.  That means that even small amounts of EDCs that affect 
reproduction may remain sporadically active over many years and affect humans on an 
on-going basis.  It is thus clear that prioritization, following the logic of the risk society 
theoretical framework, should be placed on gathering information about exposure to 
endocrine disrupters in households and consumer products where human exposure to 
endocrine disrupters is proven high. 
 
6.4 Questioning the use of science in regulating EDCs 
Risk Society and Science 
   In the phase of risk society, recognition of the incalculability of the 
hazards produced by technical-industrial development compels self-
reflection on the foundations of the social context and a review of 
prevailing conventions and principles of ‘rationality’ (Beck, 2001:78). 
 
 
What is evident from the quote is that conventional wisdom is disintegrating and that 
very realization compels those ‘awakened’ to rethink the conventional and the 
“accepted.”   This is an explicit call to question established authorities and in our case this 
means a rethinking of the current scientific application of data (prevailing conventions). 
We here make the following general observations: 
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(a) The current scientific standards and procedures for determining the risks of 
using hazardous substances is what is “rational,” which makes other risk 
determination “irrational” by implication: 
 
With regards to especially endocrine disrupters that affect reproduction, it must be 
noted that, in our opinion, their health-devastating potential on a societal scale 
makes the common institutional response of ‘awaiting more research’ a dangerous 
policy action.  The hitherto management of hazardous substances has generally 
shown a great time-lapse between the initial identification of harm to humans and 
institutional policy action.  Therefore, if it turns out that endocrine disrupters will 
not be phased out in a timely fashion (substitution fails and adverse effects 
materialize on a societal scale) the current application of science will de-
legitimize itself, as lay people will know what is hazardous before regulatory 
authorities deem it a relevant risk for humans. 
 
Especially green groups have highlighted the fact that in their conception, no such 
thing as “adequate use” can exist for hazardous substances (especially PBTs and 
vPvB, some of which are EDCs). These hazardous substances must therefore be 
phased out in a timely fashion.  This will clash with the scientific concept of 
“acceptable levels,” which implies that as long as the exposure is kept below these 
levels, humans can be exposed indefinitely to these substances. 
 
(b) Arguments that are not derived from accepted scientific practice will most 
often simply be disregarded as simply “unscientific:” 
 
Risk society makes clear that institutions are one area of expertise among others, 
but has become impenetrable in terms of influence by other forms of wisdom (lay 
knowledge).  In normative terms, it is disturbing that substances that are persistent 
and bio-accumulative are used on a continual basis, though effects on humans 
have been documented.  For example, substances that are toxic to reproduction in 
category 3 – hazardous substances are suspected of disrupting reproduction, but 
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are not investigated until evidence is presented that more or less definitively prove 
a causal relationship. Cause-and-effect relations will become increasingly 
complex as the volume of substances in the environment grows by the day. 
Reflexivity here would mean a realization that demands of scientific results 
(“clean results”) will become increasingly unattainable unless methods improve.  
The endocrine disrupters issue shows that models and assumptions need to be 
continually tested.  Note the outdated assumption that only 3.5 - 5 percent of 
existing substances are hazardous, despite indications in new substances and the 
Danish EPAs test of 47,000 existing substances that find that around 40 percent 
are hazardous (norden.org). 
 
(c) Low priority in practice of the importance of the environment to humans:  
One of the major axioms of EU environmental policy in general is the adherence 
to sustainable development and the precautionary principle.  In ideal terms that 
means, a balancing of socio-economic concerns and preserving nature for the 
benefit of coming generations.  In terms of actual chemical policy, the EU has 
placed a high priority to socio-economic concerns (REACH has been diluted 
much since its first conceptions).  When it comes to wildlife, much documentation 
exists that endocrine disruption for some species is widespread.  The application 
of scientific data in the management of endocrine disrupters contains a multitude 
of politicized judgments: risk assessment to some degree and hazard evaluation to 
a high degree. 
 
Science contains the concept of “acceptable levels.”  When it comes to hazardous 
substances, the notion cannot in our conception be taken as an objective truth.  It is our 
contention that the notion of acceptable levels is a sort of fiction produced by regulators 
through the assessment process, as unrealistic assumptions are made to create exposure 
models that determine what is “acceptable.”  In order to really know what is acceptable 
or un-harmful, it presupposes knowledge about the subject (such as background levels).  
In terms of endocrine disrupters, we are dealing with unknowns.  The example of 
bisphenol A, showed that some effects are demonstrable at extremely low exposures and 
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violate previous assumptions about substances.  For endocrine disrupters in general, there 
could be no threshold level below which there is no effect.  The classic dose-response 
curve has proved to be an assumption that did not hold for some endocrine disrupters.  
That means that assumptions about the effects of given concentrations are unreliable at 
best.  
 
It must be highlighted that assessments on the toxicity of chemicals in general are done 
by looking at single substances. As endocrine disrupters have showed, the synergy effects 
of mixtures can completely alter the mechanisms expected from knowledge about single 
chemicals.  We are dealing with chemicals about which little is yet known, what does the 
scientific approach reveal when it comes to curbing the use of endocrine disrupters?  
 
The use of Science will not give you “yes” or “no” answers.  Science will simply give an 
insight into what is being studied.  It will reveal mechanisms, but not necessarily how far 
those mechanisms extend or which intervening factors do precisely what (e.g. synergy 
effects).  The problem is then, not the science and its foundation, but the application of it.  
 
The theory of risk society breaks with the acceptance of the primacy of science as the 
only accepted tool for producing knowledge.  The risk society outlook means that 
scientists are in a sense dethroned from their privileged positions of defining the 
boundaries of problems and have lost their intellectual monopoly when it comes to 
definitions throughout the minutiae of chemical regulation.  The general problem with 
science, and hence the application is that: 
 
         Scientists… appear, at times, to see themselves as better placed than 
the public or politicians to establish definitions of environmental 
quality but, when doing that, they make a range of social assumptions 
about what is possible, desirable and achievable. This is not surprising, 
yet it is frequently denied in public statements about “scientific” or 
“non-scientific” approaches (Mayer, 1998:22).   
                                                                                   
Utilizing both ‘scientific’ and ‘un-scientific’ reasoning, green and consumer groups have 
challenged the conclusions that regulators and politicians are drawing from their 
application of scientific data.  As the discussion on the relationship between risk 
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assessment and risk management showed, the border between the ‘objective’ (i.e. the 
scientific) and the ‘subjective’ (the political) is not always clear-cut.  The “acceptable” in 
terms of exposure to endocrine disrupters, then, is ultimately political.  This takes the 
discussion to the connection between risk and democracy. 
 
Risk and Democracy 
 
Everyone is aware that there is a risk implied when using any given chemical and one 
will find many an assertion that the public and consumers “accept” these risks.  The 
authors put to its reader, that consumers as a collective have never accepted the risks. 
The counterargument that one “chooses” based on the choice of product is weak, in that 
few consumers are consistently political when shopping.  It would presuppose an 
extremely knowledgeable consumer with perfect information and it would belittle the 
power of such constraining factors as the cornucopia of discourses arguing for this or that 
and the opposite.    
 
Divergent perceptions of risk are one thing, but the management of risk rests with EU 
institutions, while consumers are at a receiving end when it comes to risk.  Risks arising 
from chemicals are ‘invisible’ and therefore their implied democratic deficit is also 
‘invisible.’  The constraints faced by the general public have relegated participative 
democracy to an issue of participating simply through consumer choices.  Despite the fact 
that REACH is the most comprehensive chemical regulation plan that has ever been 
devised by the EU, the institutional communication to the public has been slow and 
patchy, which would indicate institutional reluctance to share important information that 
concerns all citizens/consumers.  
 
The REACHinfo.dk website compiled by consumer and green groups, state quite rightly 
that there is no forum or communication centre that effectively follows the development 
of REACH, which is why they made a website that did just that.  That displays in our 
conception an obstacle in terms of willingness of EU institutions to inform people about 
the new proposal, i.e. a democratic deficit when it comes to decisions on the management 
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of hazardous substances.  If the public does not have an insight into chemical regulation 
in general, it is unlikely that their response to endocrine disrupters is going to be 
informed or tempered.  To have a good consumer response to endocrine disrupters, it is 
therefore imperative that risk communication is impartial and on-going. 
 
Risk communication and media 
Any reader would have to be somewhat educated to follow the academic debate on 
chemicals.  One would have to piece together information that is scattered between states 
and institutions, and would have to distinguish between political and scientific 
argumentation, and finally would have to be vigilant about distinguishing between 
discourses (e.g. green versus industry).  One must, in other words, focus when learning 
about the pros and cons of hazardous chemicals. 
 
The media must be confusing for many consumers in that it is hard to discern “the truth” 
in the massive information load available, with so-called “evidence”- evidence that at 
times seems to point in every direction, to put it bluntly.  Chemical regulation is 
extremely complex – even the technical and legislative aspects. When it comes to 
communicating risk to consumers, the level of the “acceptable” becomes impossible to 
gauge, when opinions diverge.  We here point to especially discourse as the “noise” when 
discussing substances that affect reproduction. A word like “evidence,” in its very 
meaning implies a sort of absolutism, as in “this is the way it is and this is the truth.”  The 
solution according to such understanding is a given.  But when is something “acceptable” 
when it comes to human reproductive ability? 
 
The last line of defence for institutions is non-transparency for the public and consumers 
in general, it can be hard to see through both EU jargon and scientific jargon.  That 
presents a problem for the communication of the risks of EDCs that affect reproduction, a 
discussion that should have been held by an enlightened public, aided by newspapers, the 
Internet and television etc.  Instead, the paramount issue of communicating the risks 
associated with substances that affect reproduction, has been hi-jacked by two main 
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discourses, (1) the Green discourse and (2) the Scientific discourse.  These two discourses 
work against each other in terms of communicating the issue to the public.  The issue can 
be reduced to greens arguing that, there is a grave threat to humanity posed by substances 
that affect reproduction that need to be countered by forced substitution of hazardous 
substances, and the scientific side invoking either one of two axioms: (a) socio-economic 
benefits is the bottom-line, (b) more knowledge is needed, meaning more research (… in 
the meantime socio-economic benefits accrue).  
 
This is where, in our opinion, Beck delivers his strongest criticism on the way science is 
applied: more knowledge is needed, i.e. more research, but as he contends, “new areas of 
unpredictability are created quite often by the very attempts that seek to control them” – 
that means that the EU response to endocrine disrupters that affect reproduction, which is 
“await more research” is a non-argument according to risk society theory.  The 
institutional fiction that there is no urgency in phasing-out such hazardous substances as 
endocrine disrupters, makes their reassurances seem increasingly hollow as the Green 
discourse gains the attention of a confused public; “confused” because the institutional 
response is “await more research,” but the impression left behind is that if the substance 
was so hazardous, surely the authorities would have banned it… and yet suspicion 
lingers.  
 
Though chemical regulation affects the entire EU population, the public availability of 
information has been sparse for a variety of reasons, among them that chemical 
regulation is a complex field of study.  REACHinfo.dk is a web-site by the Danish 
Natural Conservation Association (Naturfredningsforening), the Danish Consumer 
Council, WWF Denmark, Greenpeace and the Ecological Council, which provides the 
general public with information about REACH along the argument that;  
 
 For most people, it is basically impossible to gain an overview and keep 
 updated about what is happening with REACH. There is no media, which 
 in an easily accessible way gives an overview regarding relevant events 
 and insight into the central political and scientific argumentation. 
                                                                    (REACHinfo.dk,2004:1) 
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The quote highlights a problem with risk communication from the point of view of EU 
regulatory authorities.  The problem is one of not worrying consumers unnecessarily as 
wrong messages can cause panic.  As stated by Mette Boye from the Danish Consumer 
Council in our interview, the challenge is to temper communication to the public as to 
inform without necessarily being alarmist.  The reason given was that public must have a 
possibility to counter the problems, otherwise one runs the danger of desensitization to 
bad news and pessimism in the long run. 
 
Coming back to diverging perceptions, the discourse is obviously divergent in the green 
versus the industrial discourse, which makes any risk communication hard.  That means 
that the concept of ‘risk acceptance’ is necessarily in dispute, especially concerning 
exposure to hazardous substances that are persistent, bioaccumulative and toxic to 
reproduction.  What is ‘acceptable’ to industry or regulatory authorities may not be 
acceptable for mothers who fear unloading, for example, parabens to infants? 
 
Risk acceptance 
The provisions in REACH regarding substitution of hazardous substances exclude such 
substances as bisphenol A and nonylphenol and the use of the substances hence 
continues.  That means that humans are affected to one degree or another, the fact that 
there are people who have been affected by endocrine disrupters cannot be disputed, but 
it remains unclear which substance ultimately caused the disruption.  That state of affairs 
is not compatible with the world-view of the greens, which have demanded substitutions 
of hazardous substances, but are skeptical due to the lack of time-limited authorizations 
and lack of binding clauses in REACH.  
 
In our opinion, the concept of Risk Acceptance is a sort of illusion, as consumers are at 
the receiving end, unable to see the implications of their consumer choices.  The political 
citizen is increasingly becoming a mere consumer.  Whereas the citizen has direct 
influence on politics, the consumer has so far been relegated as a receiver of risks, which 
he/she will then wittingly or unwittingly accept.  The counterargument is that, consumers 
have the option of “shopping politically” and thereby punish companies that produce 
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unsafe or unethical products, such as toys that contain DEHP.  It is our conception that 
most consumers have neither the informational resources nor the time and energy to make 
shopping a continuous (political) exercise, furthermore, the safety of products ultimately 
is not the responsibility on consumers.  
 
The responsibility to manage risk, in our case the danger of disrupted reproduction, rests 
with the authorities that deal with chemical regulation.  Boye is of the opinion that, 
people expect that the authorities make sure that their products are safe (interview).  The 
same view was expressed by Secretary General of the European Environmental Bureau 
(EEB), John Hontelez: 
 
 People expect politicians to make their priorities quality of life, 
employment, social cohesion and safety, which means robust 
environmental policies. Economic growth can achieve all this, but 
putting growth unconditionally first risks undermining these very 
objectives (EEB, 2003). 
                                                                                                          
Given the real complexity of chemical regulation and chemicals’ mechanisms, it is our 
contention that the consumer of today must make an unreasonably vigilant effort to stay 
informed about issues, such as endocrine disruption, in order to avoid risks. The 
conclusion here is that “risk acceptance” by consumers in the EU population as a whole is 
a misnomer in that consumers in many cases “accept” risks unwittingly for example 
through their personal care products (creams may contain paraben).   
 
This chapter has situated risk within a context of a society that is increasingly aware of 
risks (the emergence of green and consumer power).  The development of consumer 
awareness is not a given, however, analysis using the risk society theory has exposed 
flawed scientific application of data when it comes to endocrine disrupters.  
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7  Conclusions and Recommendations 
EDCs have been a cause of alarm since the signs of endocrine disruption in wildlife 
pointed towards effects in humans in reproduction.  Since this time researchers have been 
trying to estimate to what extent this evidence in wildlife mirrors that in human beings. 
The connection between this evidence has been a problem, because of the complexity in 
producing concrete cause and effect relations.  While products that contain EDCs are 
extremely useful in some respects, their inherent properties and burdensome presence in 
the environment is a rising concern even for the most optimistic. 
 
Operational difficulties of regulatory agencies to identify EDCs and find realistic avenues 
to facilitate the eventual phase out of these substances, represents one major problem in 
chemical regulation.  Development of common testing methods has proven to be difficult, 
and thus classification has suffered, representing one major challenge of safe 
management.  REACH came as an attempt to address the inadequacies of past regulation, 
responding to the growing concern for human health and the environment through 
sustainable development and the precautionary principle.  This thesis seeks to address the 
importance of maintaining a healthy population and environment by asking the question, 
“given the hitherto chemical regulation in the European Union, what changes are needed 
to handle endocrine disrupting chemicals that cause adverse effects to human 
reproduction?” We answer this problem formulation, in the following conclusions and 
recommendations: 
 
Due to the fact that endocrine disrupters have been identified as potential mechanisms of 
action, the current classification system does not properly define them; a new definition is 
needed in order to have further, more effective regulation.  By eliminating case-by-case 
management of EDCs, and treating them as a group of hazardous substances, you may 
find more common characteristics, leading to more political coverage.   
 
As a consumer one does not expect to find hazardous chemicals in personal care products 
like ‘wet wipes,’ shampoo or baby pacifiers.  Increased public awareness can change 
consumer patterns, inevitably affecting the production of such commodities laced with 
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chemicals.  Consumers therefore expect that politicians and regulators do their best to 
remove these products from the market.  Consumers may gain a stronger voice by 
creating awareness, due to the serious effects of endocrine disrupters and making the 
problematic more of a political issue, by creating a powerful political consumer.  
 
Ever since the first chemical regulation directive in 1967, management has been mainly 
concerned with the harmonization of the internal market.  This is also evident within the 
proposed REACH document, in that although it claims to be about the protection of the 
health of the EU population, the legal basis (article 95) is again on the internal market 
instead of the environment (article 174).  The focus is then misplaced.  Ultimately, the 
prioritization in REACH will ignore consumer issues, while continuing to place 
importance on the efficient functioning of the single market.  
 
If assessment of hazardous substances is to be impartial, there must be a functional 
separation between risk assessment and risk management; resulting in independent and 
non-biased research. In an effort to create further research on endocrine disruption–
attempting to create increased public confidence in the chemical industry – CEFIC 
contributed 20 million Euros to the LRI initiative.  Under this initiative came the creation 
of CREDO cluster for research on EDCs.  Thus, the role of industry in funding research 
and development is controversial and evidence shows possible conflicts of interest  
(RM influences RA). 
 
The substitution principle is one of the main elements of the REACH proposal 
encouraging the phasing out of hazardous substances.  However, the successful 
application of the principle is doubtful as there is no time limit for replacement, even 
when a safer alternative exists (there is no enforcement mechanism).  Consequently, there 
is no strong pressure for producers to phase out known hazardous substances, even if 
safer substitutes already exist.  We presume that even when substitution has occurred it 
has often resulted in the replacement of one hazardous substance by another (paraben).  
Only minimal testing was conducted in the faith that it was going to be safer than the 
former substance.  After substitution, no further testing was conducted to test this 
optimistic assumption (Soft-n-Safe). 
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EDCs do not adhere to political boundaries, implying a global problem which needs 
global management regimes.  International coordination is needed to promote positive 
change and limiting human exposure to hazardous substances.  This could be developed 
through integration of general guidelines that include incorporation of the EDCs 
problematic into future declarations, harmonization of test procedures, and development 
of common definitions of EDCs.   
 
With respect to EDCs the fundamental basis of REACH contradicts the two key 
components: the precautionary principle and sustainable development.  Both concepts are 
political tools due to differing widespread definitions will always be a product of the 
specific interpretation.  Comparable to the test guidelines, a common definition is needed 
for consistent application and implementation. 
 
Using the risk society theory, we conclude that the application of science is short-sighted; 
if science is characterized by continually questioning itself (“what is true today is not 
necessary true tomorrow”), the policies of regulators should not place a disproportionate 
weight on science.  Arguments for policy action rely heavily on current scientific 
standards and public perceptions are considered “unscientific” and do not fulfil the 
authorities’ high expectations to define risk acceptance.  This is reflected in the practice 
that substances are considered safe until proven hazardous.  
 
Risk society theory stresses a re-examination of the use of science, allowing us to apply 
this conceptualization to the control of EDCs.  We recommend among other things, a re-
examination of the use of scientific data, thus ultimately resulting in a betterment of 
revised chemical regulation to be consistent, flexible, enforceable and open to public 
scrutiny (including lay knowledge).  
 
We conclude that regulation thus far has been a continual exercise in applying band-aid 
solutions. Unless REACH closes existing loopholes and adds compulsory stipulations it 
may turn out to be yet another band-aid solution.   
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Recommendations: 
Generally speaking with regards to endocrine disrupters, there is so much at stake that it 
is paramount that enough resources are devoted to developing agreed test-methods. A 
high prioritisation must be placed in achieving this objective swiftly, as the next 
challenge will be to get the rest of the world to substitute endocrine that threaten our very 
ability to procreate. The intrinsic hazardous properties of endocrine disrupters demand a 
global solution: a repeat of the practice having a domestic ban, but selling the hazardous 
substances in the Third World (like asbestos) will not solve the problem of curbing 
EDCs. This is due to the hazardous cocktail of persistence, bio-accumulative potential, 
synergy effects (the effects seen in low-dose, long-exposure). 
  
• Change the legal basis of the REACH proposal from Article 95 on the 
Internal Market to Article 174 on the Environment, such that Member States 
may enact more stringent regulation of substances they suspect are hazardous. 
Without this change, it is rather clear that the real focus is EU harmonization in 
terms of the Internal Market and not environmental or human protection.  
 
• The realization that there is no longer any state/science monopoly on “the 
truth,” one explanation or one perception of risk, could facilitate content 
declarations with an additional Green/Consumer perspective on the consumer 
product.  Risk evaluations differ: the discourse battle between regulatory agencies 
and Green/Consumer groups is illustrative of the disagreements.  Let the content       
declarations reflect this. 
 
• Information is required to empower consumers. To become their own watch-
dogs and become conscious of the actual state of the environment, science and 
     current reference points for human exposure (“acceptable levels”). 
 
 
 
 131
European Union Regulation of Endocrine Disrupting Chemicals 
That Affect Reproduction: From Rachel to REACH 
 
• Substances of highest concern need to be assessed first and substitution 
should be based on intrinsic properties of hazard (such as persistence, toxicity  
     and bio-accumulative potential). 
 
• If industry should regulate itself, it is crucial that implementation of a strict 
regime is assured in European legislation. Without stringent substitution 
demands and appropriate enforcement mechanisms, regulation is reducible to 
discourse.  
 
• Make time-limited Authorizations. That entails a denunciation of the concept 
“adequate use” and an acknowledgement that risk evaluations are too complex 
and flexible.  Hence, scientific modelling on the capacity of the environment to 
continually absorb vast amounts of xenobiotics is unrealistic, as are the 
assumptions about the pathways to human exposure. 
 
 
Secondary recommendations: 
 
• Ultimately, all of the above point to a reconsideration of the role of the state or the 
EU (also according to Risk Society) to break out of its territorially bound 
authority to regulate actors that can be global (chemicals industry).  
 
• We suggest the approach from the Canadian government on cigarette packages, 
which display illustrative worst-case scenarios from smoking, e.g. pictures of  
      black lungs, rotten teeth or an “impotent” cigarette. 
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8  Wider implications of Risk Society 
Our application of the risk society theory was limited to the EU and hence conclusions 
were mainly pertaining to the area.  However, as Beck states, “Risk society fully thought 
through is World Risk Society.  For its axial principle, its challenges are dangers 
produced by civilization which cannot be socially delimited in either space or time” 
(Beck, 2001:19). 
 
The theoretical background of the (World) Risk Society warrants an extrapolation of 
trends identified in the problematic of endocrine disrupters. The theory also calls for 
interdisciplinary argumentation (the inclusion of lay-knowledge) as its conclusions aim to 
apply on a global scale.  The issue of endocrine disrupters is complex, but the following 
is a list of factors that we identified as potentially relevant in affecting the EDC 
problematic in a major way: 
 
 
The future and fate of the EU: economically and socially will determine what is 
possible to do in terms of regulation, primacy of any of the following points could result 
in endocrine disrupters becoming a lower priority. Issues here include among others (a) 
the structural pressures on the EU due to the enlargement in 2004, there is a large 
environmental bill waiting in Eastern Europe, (b) the results of the referendums on the 
EU Constitution and the chaos that could ensue, (c) the fate of the Euro and the 
competitiveness of the European Union.  Economic considerations are ultimately first 
priority in politics. 
  
Discourse: we share the same understanding of discourses and understanding of 
“coalitional interests” that Mette Boye identified in her Masters thesis, “Hormonkampen” 
(Copenhagen University: 2001).  We believe that coalitional interests centre around their 
own discourses that highlight their solutions within the EDC problematic.  Each 
discourse will have its own set of assumptions and paradigms that are not necessarily 
obvious to individuals in the public. 
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Time constraints: it is generally agreed that due to the (neo-) liberal response to 
international competition, there is a tendency for work to take up more of ones time. 
Increasingly, people are ‘living to work,’ instead of ‘working to live.’ Therefore, public 
participation will inevitably suffer.  
 
Specialization of Work: There is an ongoing worldwide specialization of work, 
accelerated in the Western hemisphere, where “knowledge economies” is the ideal. 
Developed countries aim to live by providing services and developing technologies. The 
specialization in this case is state-wide: experts are cultivated and heralded, as they are 
expected to create the “knowledge economy.” The implication for many will be that they 
will eventually become enveloped into a myopic structure, where each worker (or expert) 
sees a diminishing part of the whole. It is our analysis that this could breed a culture 
where communication among experts is flawed due to the nature of the problem, which is 
that the expert knows his domain best. For example, green groups and their aura of being 
“experts” in “protecting the environment,” juxtaposed with industrialists who are experts 
in making money. How then, does one distribute influence/power? 
 
“Class:” this must be understood broadly in this case. The increasing pressure of 
globalization creates in our conception two dichotomous social classes: the ‘Haves’ and 
the ‘Have Nots’. The haves are increasingly pushed to becoming ever more flexible in 
their work-lives, and work longer hours. In Europe, unemployment rates have become 
generally high.  There is further social fragmentation going on in Europe, as increasingly 
strict immigration rules and rising xenophobia has led to talk of a “Fortress Europe,” 
where immigrants in many cases receive lukewarm welcomes and low-paid jobs. 
 
It is clear that there are enough problems in the modern world, but what is our capacity as 
humanity, to counter the problems of risk society?  We now turn to a final discussion on 
levels of prediction to ascertain, if possible, whether reflexive modernization can or will 
take hold before it is “too late.” 
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In an age of globalization, where humans are increasingly interconnected in both spatial 
and social terms, arguably and consistent with the risk society theory, the sameness of 
opinions (of risks or opportunities) and therefore of action- no longer applies! The status 
of science and scientists as “untouchables” must be challenged before humanity runs out 
of options and out of time. For some final words, we have allowed Canadian scientist, 
David Suzuki, to sum up the human problem of anticipating and lastly we pay tribute to 
lay-knowledge that - though being ‘un-scientific’- has reached a level of understanding 
that we as “modern” societies have only started to realize and fear is true:  
 
“In the 25 years that I have hosted The Nature of Things,53 we have 
covered many issues that have failed to be resolved or have worsened – 
depletion of marine fishes, deforestation, toxic pollutants in air, water and 
soil, species extinction, habitat destruction, urban sprawl. Yet each year 
that goes by without taking decisive steps to solve the serious problems 
that face us ensures that when we are finally forced to act, solutions, if 
possible, will be much far more difficult, expensive and disruptive… 
 
So it is ironic that today with all of the amplified brainpower of scientists, 
computers, engineers and telecommunications, we no longer seem able to 
do what our ancestors did to get us here: look ahead, identify the dangers, 
then take action to avoid the pitfalls and hazards. Instead, we are often 
told by those with vested interests in the status quo that the claims of 
danger are based on "junk science", or that taking action will cost too 
much or threaten the economy.”54
 
 
 
 
 
 
53 Canadian science and nature documentary program, hosted by Dr. David Suzuki.  
54 http://www.cbc.ca/natureofthings/newsletter/20050103_article_suzuki.html 
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“Only after the last tree has been cut;  
only after the last fish has been caught;  
only after the last river has been poisoned;  
only then will you realize that money cannot be eaten.”  
 
-Cree Indian prophecy- 
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Appendix A – List of interviewees 
 
Name Company and Contact Info Interview  
   Position   Procedure 
Pia Juul Nielsen Senior Advisor   Danish Environmental Protection Agency  
  
 
Biocides and Chemicals  Ministry of Environment and Energy 
Personal Interview 
And  
  Assessment Strandgade 29 Questionnaire 
    1401Copenhagen K, Denmark   
    Tel: +45 3266 0118   
    pjn@mst.dk   
       
Ragnor Pedersen Credo Cluster  Credo Cluster - Centre for Toxicology  
  
 
Scientific Project Manager University of London School of Pharm.  Questionnaire 
    29-39 Brunswick Square   
    London WC1N 1AX, UK   
    Tel: +44 20 7753 5811   
    ragnor.pedersen@ulsop.ac.uk   
       
Sidsel Dyekjær Nordic Council of   Nordic Council of Ministers (presently)  
  
Ministers  
 
Environmental Advisor  Store Strandstræde 18 Personal Interview 
    1255 Copenhagen K, Denmark And  
    Tel: + 45 3396 0282 Questionnaire 
    smd@norden.org   
       
   Mette Boje Danish Consumer Council   Danish Consumer Council 
 
 
  Senior Environmental   
 
Environment and Health Advisor Personal Interview 
  Advisor Fiolstræde 17, PO Box 2188 And  
    1017 Copenhagen K, Denmark Questionnaire 
    Tel: +45 7741 7736   
    mb@fbr.dk   
        
Torben Svejgård Danisco  Danisco A/S Texturants  
  
 
Chief Operating Officer  Langebrogade 1, PO Box 17  Personal Interview 
  Division of Emulsifiers  1001 Copenhagen K, Denmark   
  Director Tel: +45 3266 2004   
    emulsifiers@danisco.dk   
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Appendix B – Interview Notes from Interviewees 
Questionnaire 
Ragnor Pedersen, PhD-CREDO Cluster 
10 March, 2005 
 
I am happy to help but these are big questions for complicated issues and as much as I am 
willing to tell you what I think, the effort should be two-way - so I would also like to hear 
your thoughts and ideas.  I hope these quick answers are helpful to you... 
 
BLK: Where do you see or anticipate the REACH proposal to succeed? Fail? 
RP:   I believe REACH will succeed in making the process of chemical regulation more         
         efficient and shifting the burden.  How far this goes is difficult to predict. 
 
BLK:  With respect to reproductive EDCs, how do you see their place with in   
           REACH? CMR? 
RP:    This needs to be debated - as ED is a mechanism rather than an endpoint, like     
          CMR.  We need to find a way to include the ED issue within reach. 
 
BLK:  Do you see a separate regulation proposal specifically for EDCs? 
RP:     No 
 
BLK:  What do you consider to be the key ingredient to help reproductive EDCs receive  
           recognition in REACH? 
RP:    We need a better understanding of the links between the mechanism of ED and the  
          effect endpoints. 
 
BLK:   How/will substitution and or innovation play a role in regulation of EDCs? 
            ie: phthalates and parabens (not yet recognized) 
RP:      I don't know. 
 
BLK:   In your opinion, what is the main concern behind regulation of EDCs? Human    
            health? Cost-benefits? Risk Management? 
RP:      It depends on 'whos' concern it is.  But mainly wildlife and human health. 
 
Please do contact me again if you have further questions.  Do also let me know what you 
think and I would be interested in your papers on this or final report. 
 
Ragnor Pedersen, PhD 
Cluster of Research into Endocrine Disruption in Europe 
Centre for Toxicology – University of London School of Pharmacy 
29/39 Brunswick Square, Bloomsbury London WC1N 1AX, UK 
Tel/Fax: +44 20 7753 5811 
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Torben Svejgaard – Danisco 
Chief Operating Officer 
17 March, 2005 
 
Research 
 
• Torben was mostly concerned with food additives so REACH did not play a 
strong role.  
• Danisco sells food emulsifiers to plastic company (antifog, polyethylene products) 
• Torben mentioned that it took approximately 2 years research to create this 
product.  It was ready in 1999 but took six years to be approved.  
 
Regulation 
 
• Danisco is more involved in the commercial aspect of business, rather than 
anything politically motivated.  
• As for timing of the publicity of Soft-n-Safe, he claims that they “don’t 
necessarily mention phthalates as they don’t have the background information, 
however, they could support it.”   
o “At the end of the day, the consumers should push for it!! They are the 
ones that demand it.” 
 
Evidence 
 
• Torben says with respect to ED effects that Danisco “wants to make safe, good 
products, but of course we want to make money.”  He continues, “never 
compromise safety. Top of the agenda.” 
• Torben also says, “when is enough enough for proof?”  
• Testing: they have done the minimum required tests for the product, which equals 
about 20-25 tests (rat, ADME, Daphnia). 
• Testing is very much product dependant 
• Had an external analysis done for Soft-n-Safe 
 
Effects 
 
• Torben said the effluents were only acetic acid at approx. 2% - about 98% OK 
• ELINCS approval 
• Superdirective application through Danish EPA 
 
Other Comments 
 
• Patent has been granted to US but not Europe 
• 0-1 billion Dkk is realistic for profit 
• Torben believes in consumers because consumers decide what they will buy, 
“premium products” 
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o Marketing has a push and pull of PVCs producers (increase in costs, so 
might not be interested) 
 
• ANALYSIS : EU contact material and DK don’t approve (?) I think this was 
about the testing.  
• times.  
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Pia Juul Nielsen 
Danish EPA 
18 March, 2005 
 
Assessment of EDCs 
 
• EPA is very concerned with EDCs but they need scientific background to stop 
these substances 
• With respect to ‘burden of proof’ Pia said there were ‘complex answers’ and case-
by-case examples 
• Pia did not consider politics to play a strong role in assessment of chemicals as 
there are experts discussing the detailed items 
o Industry and other interest groups can give their ideas to enhance or 
postpone evaluation process 
• Becomes political when you vote about it. Science is on one side…. 
• Ulla Haas – reproductive toxicologist 
 
Regulation 
 
• Pia suggested that there were events happening everywhere (esp. wildlife) which 
would suggest endocrine disruption, but it wasn’t until 1992 when Niels 
Skakkebaek in Denmark made headway on research of the topic. 
 
• All risk assessment is based on NOAEL 
• Difficult to have DK National regulation 
o Have to think about substitution etc 
• “principle of proportionality” 
 
• NORDEN – OECD adhoc 
• “how to interpret EDC assessment through these tests?  
o Assessment needs expertise 
• No assessment previously (really) 
• Learned effects by seeing it and looking back at what it was 
 
 
 
 
EDCs within REACH 
 
• Pia suggests that EDCs are just a mechanism and that the existing tests do not 
catch all the EDCs (2002 sub) 
o Enhance with further endpoints 
o CMR could also have other effects ie: thyroid allergies 
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• No scientific evidence on if the parabens are EDCs 
o Parabens were a substitution too 
o Increase in allergies in DK 
 
• Products are “suspected” to have EDC effects but don’t know for sure 
 
• Hersh uterotrophic used by industry by screening test  
o Level 4/5 are internationally accepted 
 
• Pia felt the EPAs main concern was with  
1. test methods  \    creates problems 
2. criteria           /    with class of EDCs 
3. Authorization – especially with other problematic chemicals 
4. refer to council meeting 2003 
5. harmony between economy and all areas 
      EDCs Health situation 
                Wildlife 
                Industry 
                No scientific guidance 
 
• Pia would like to see regulation that is enhanced.  She says EDCs are a 
“mechanism and it’s not easy. It would be smoother if you can use existing 
regulation and enhance it.” 
• Regulation in REACH is not complete 
o Information strategy(what is industry going to deliver) 
• Category 3 – could be covered  with authorization as well and assure the tests 
that are tested positive – easy to use current regulation 
• Pia could not comment on the Soft-n-Safe product as they were currently 
looking at it. 
• Pia believes there are certain rules for using the precautionary principle 
o Should have new scientific information (proof is considerable-realistic 
assessment) 
o Not all pieces are there for the puzzle “ KNOWLEDGE GAPS” 
• GHS is an OECD concept and will be integrated with EU and over the world 
with respect to classification 
 
 
 
 
Other Comments 
 
• Community Strategy – REACH does not have a big connection 
o Difficult to see how the strategy works into REACH 
o Covers legislation etc with in relevant areas of endocrine disruption 
o Maybe direct ED to REACH 
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• S – 1.5 years 
• M – 3-5 years 
• L – 10 years  
o “dynamic” working list 
o not so much progress or impact 
o should be a dynamic work within fixed list 
Complexity is an issue that arose numerous 
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Interview with Mette Boye 
Danish Consumer Council 
4 April, 2005 
 
 
Consumer Articles 
• big debate within REACH and ‘articles’ 
o Focus on production at factory site 
o Also on later life usage 
• Imported chemicals are not included – consumer council very active 
• What to do next? Obligatory importers declaration on chemicals imported 
o ie: chemicals used on textiles in India to treat it 
 
Consumer Product End Result 
• declaration of chemicals in products  
• importers declaration on EU chemicals are not included in this product 
 
REACH has to hold to health – it’s changing all the time. 
 
Considerations of Industry  
• yes they are taken into consideration 
• challenges faced by industry – wishes can be adopted in order to change these 
products with good amount of time 
• Consumer Council advocates precautionary principle (VERY STRONG) 
o Pushing industry to adopt 
 
Consumer Products and EDCs 
• Researchers findings are very alarming especially for Consumer Council 
• Noise about chemical…may not be the ones to be concerned about. 
• “Soft ’n’ Safe – “of course it’s politically motivated” 
 
Substitution 
• amendment with authorization 
o tighten regulation! – MB “depends on substance – goes through REACH 
o REACH – when a substance goes all the way a number of years have to 
pass and companies are aware of the time delay. 
• SubPrinciple at forefront!!! Now it’s not clear 
 
REACH 
• Case-by-case is not a good approach 
o When it comes to EDCs, if we are going to look at one substance we do 
not have enough scientific knowledge 
o EDCs as a group: more knowledge if we have political coverage (Laurie 
has quote from REACH: the only planet guide to follow this point up!) 
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? Difficult?? Political and scientific question 
? ie: parabens can be grouped according to characteristics and can 
provide more information than alone 
? makes sense how due to lack of information 
Media 
1. Chemicals – > articles 
2. Chemicals – > health 
ie: parabens 
 
• Challenge - EU scene is different than DK scene 
• Awareness is very present – air freshener example (suing BEUC) 
• Adjusting expectations in EU and DK –> challenge  
• Media has helped create public awareness to consumers attitudes 
• Huge change EU 
o Not much DK – EPA is doing negotiations 
o Big impact on discussing discourses 
 
REACH should interrupt dealing with other industry business 
 
Innovation 
• EDCs – “YES” it will spur innovation 
• Discussion about REACH/chemicals – innovation is very important 
o Lots of attention- creating public awareness with is attractive for 
companies 
• Regulation may not be progressive 
• Optimistic for innovation 
• Big companies/ambitious companies may be looking also at safer chemicals 
o Confrontation? Yes they have to be worried 
• SME – lots of NOT feeling the same pressure and may continue to produce 
hazardous chemicals 
• Discussion continues with strict regulation to include all industries 
• Business as usual? – old habits are hard to beat! 
o Tiredness…”We’ve heard that before” 
 
Yes to desensitivity – relating to media, consumers and public. One has to always link 
stories to way consumers can react! 
- Back with advice on avoidance, when it can be done – DO IT! 
 
Consumer Power 
• “YES!” can not use consumer power as the only agent. One has to work with 
regulators etc. Can’t work alone. 
• Phthalates in 1990 
• REACH is a product of consumer power and awareness 
 
What do you do with a bomb in your hands? 
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• ie: hair dyes – acute leukaemia 
• story she wrote about this and was TOO alarming to release to public 
• asked consumer mag. to create an indepth story with various effects of hair dyes.  
o Push into right forum 
Hormonekampen 
• Changed your views?  
o More accepting the scientific terms that the debate is going on 
o Scientific discourse and enviro. Problems  
• Have to use the same terms – “speak the same language” 
o Increasingly accepting this way of thinking 
 
REACH to be a success? 
• Success –> discussion 
• Fail –> loose, flawed regulation 
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Sidsel Dyekjær 
Nordic Council of Ministers 
20 April, 2005 
 
Has her personal discourse changed since moving from the Ecological Council to the 
Council of Ministers? 
• Nordic Council is only temporary 
• Nordic countries like to be the front-runners 
o Especially DK but with the change of gov’t, not so much now.  
o Softer than the EU 
o Seen as a locomotive! Deep cooperation 
 
 
Key – Authorization 
• Substance subjected to authorization 
• Similar concern (PCB, vPvB, CMR) 
• Covered case-by-case or fall under any other category  
• Different people have different views on coverage 
• “toxicological tyranny” when looking at risk assessment 
o industry was in with risk assessment and if it was showing concern they 
would demand more details 
o substance produced and no legislation 
 
 
• Transition period for REACH 
• What do you do with old directives when another takes over?  
o REACH transition implementation?? 
• Need a legislative tool is missing 
• Burden of proof is on authorities 
o Very much a political game/issue 
 
• Produced to have a function and the whole idea of assessing for another property 
o PRECAUTIONARY PRINCIPLE 
• Used by ICCA-made articles on PPs stupidity 
• Look at legislative implementation by pointing to PP-Very low  
“buzz word” 
 
What do you think about treatment of EDCs case-by-case? 
• Never optimal 
• Key conflict 
• Groups could be used 
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• Criteria-all endpoints (her argument) 
o Could get groups-substituted-banned 
o ie: PCBs-should be bottom line 
                    -persistence could be key 
                    -bioaccumulation could be tough 
 
• OSPAR has done some efforts to develop criteria as to what is a hazardous 
substance 
 
EDC regulation in EU? 
• ONLY ONE PERSON WORKING ON EDCs!! (her understanding) 
 
• Where is the effort to politically handle these issues? 
• Swan label to EDCs?  (environmentally friendly label) 
o Don’t know, but it would be a case-by-case example 
 
• Optimism/REACH – directed to consumerism by looking at products 
o Help consumers indirectly by looking at products through authorization 
o “long-term” help to companies that don’t know what they are doing and 
also to importers 
 
 
Reversal of burden-of-proof a good idea? 
• Not a very precise description 
• Reversing the burden of getting data** harmonization of existing and new 
substances 
• In the beginning, REACH said –“no data, no market” 
 
Do you see Authorization as a loophole? 
• Reservations about authorization 
o Socio-economic 
o Exceptions of proposal (substances covered by other directives) 
o Adequate control (WWF) 
• Largest volume of chemicals are produced by single industry less than one tonne 
o Branch off to daughter companies 
o Deals with low volumes and consumer products 
 
Product Safety Directive 
• REACH would be with getting to grips with consumer products we need to have 
knowledge about  
 
**The pure fact that you find a chemical in the environment or humans must 
be a point to legislate! ** 
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Green Position on EDCs? 
• Only on REACH 
• WWF has a large document  
• EEB-check out the website 
 
Industry to call for prioritization before authorization 
• There are amendments to articles 
• Chemical agency taking care of it not too centralized 
• Data requirement larger for low volume (1-10 tonne) chemicals 
Sidsel spoke as a representative from the Ecological Council representative 
She believes in consumer power! Connected to NGO power! 
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Appendix C – List from those 66 Substances that contribute to Adverse                                                    
                        Reproductive Effects 
 
CAS NAME HPV/Pers. CONCERN
        
12789-03-6 Chlordane Highly Pers High  
57-74-9 Chlordane (cis- and trans-) Highly Pers High  
143-50-0 Kepone Highly Pers High  
2385-85-5 Mirex Highly Pers High  
9001-35-2 Toxaphene = Camphechlor Highly Pers High  
50-29-3 DDT - (technical) = clofenotane HPV High  
50-29-3 p,p'-DDT = clofenotane HPV High  
3563-45-9 Tetrachloro DDT  Highly Pers High  
50471-44-8 Vinclozolin HPV High  
58-89-9 Gamma - HCH=Lindane HPV High  
330-55-2 Linuron (Lorox) HPV High  
1912-24-9 Atrazine HPV High  
118-74-1 Hexachlorobenzene = HCB HPV High  
117-81-7 Di(2-ethylhexyl)phthalate (DEHP) HPV High  
84-74-2 Di-n-butylphthalate (DBP) HPV High  
80-05-7 Bisphenol-A HPV High  
1336-36-3 PCB Pers High  
5956-65-1 PBB - Brominated Biphenyls Pers High  
688-73-3 Tributyltin Metal High  
No CAS 050 Tributyltin Compounds Metal High  
56-35-9 Tributyltin oxide HPV/Metal High  
26354-18-7 2-propenoic acid, 2-methyl, methyl ester Metal High  
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Appendix D – Levels of Prediction 
 
Considering examples from a range of issues, the account of our responses as societies or 
authorities would suggest that the predictive powers of our experts, though revered by 
many as the best base for decision-making – is recklessness! This group cannot come 
with predictions about where the risk society will take us however, this much is clear: 
 
The population curve is now exponential. The cumulative pressure for resources will 
increase (UN statistics). Note especially, the rise of China and India as producers and 
importers of chemicals. The standard of living is increasing in absolute terms in both 
states, which may increase consumption dramatically. Furthermore, it is common 
knowledge that 80 percent of the world’s resources are consumed by 20 percent of the 
world’s population (UN statistics). There is little proof that that development is reversing, 
on the contrary. 
 
The state of at least 2/3rds of the worlds ecosystems are in such a terrible state, that 
immediate breakdowns can and have occurred (note the disappearance of cod outside 
Newfoundland fish banks in Canada) (Ibsen, 2005) 
 
One of the lessons that can be drawn from the Kyoto Protocol is the fact that Developing 
countries have gotten exemptions due to development issues – it is fair to presume that 
such a compromise is likely to be reached in chemical regulation in developing countries. 
 
“Pollution follows the poor” (Beck,2001:5): therefore, in our conception, policies to 
combat the problem of hazardous substances must be holistic and virulently enforced. 
The ‘global commons’ problem would suggest the need for a world body or regime for 
the treatment of chemicals. 
The gap between rich and poor is on the rise (UN statistics), not only within states, but 
between states and continents, to take one example: the continent of Africa has 
experienced a ca. 30% decrease in real income since the 1970s, and the steep decline is 
accelerating as AIDS and civil wars ravage the continent. 
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